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5 U M I tAbstract
The most common cause of encrustation and blockage of long term urinary catheters 
is colonisation of the urinary tract by Proteus spp. However, the degree of 
encrustation experienced by those with Proteus colonisation differs markedly 
between individuals. This study assessed the range of problems experienced by 
those colonised by Proteus and the factors which may differentiate severe from mild 
encrustation in this group.
21  long term catheter users found to have Proteus on urine screening were followed 
for approximately 3 months with weekly microbiological and chemical urine analysis 
and examination of their catheters.
There was considerable variation in catheter lifespan within and between individuals. 
Some with persistent Proteus colonisation had no encrustation problems, others 
experienced frequent catheter blockage. Proteus was usually a stable component of 
urinary and catheter flora.
Rapid encrustation was associated with a lowered nucleation pH (pHn). There was no 
clear difference in voided pH (pHv) between rapid and slow encrusters, but rapid 
blockers had a lower mean safety margin (pH„ - pHv).  pHv was not a useful predictor 
of catheter blockage.
pHn  was variable within and between individuals, but was higher in those who 
encrusted slowly.  It was dependent on the calcium concentration and, to a lesser 
extent, the magnesium concentration of urine, with rapid encrusters having higher 
urinary calcium.Proteus isolates were assessed for urease activity. Strains with higher urease 
activities produced more alkaline urine, but this did not clearly result in shorter 
catheter lifespans.
Proteus isolates from catheter users were found to have greater antibiotic resistance, 
particularly to trimethoprim and amoxicillin, than other local urinary tract isolates. 
Courses of antibiotic appeared ineffective at altering the urinary flora.
The source of Proteus urinary colonisation, examined using Dienes typing and pulsed 
field gel electrophoresis of bacterial DNA, was commonly found to be the subject’s 
own intestinal flora.
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Many people find that the only way to manage their bladder problems adequately is 
to use an indwelling urinary catheter for bladder drainage as a long term solution. 
Although for many people this is a relatively successful approach, about half of long 
term catheter users will experience recurrent complications which can have a serious 
impact on their quality of life.
The most common and troubling of these complications is catheter encrustation. 
Crystalline deposits build up on the surfaces of the catheter, leading to blockage of 
the lumen and drainage eye holes. This causes painful retention of urine or 
incontinence, needing an emergency visit by a District Nurse or attendance at an 
Accident and Emergency department to change the catheter. To try to prevent this 
occurring, catheters have to be changed very frequently. This is inconvenient for the 
patient and expensive for the health care provider.
In most cases encrustation is due to the presence of urease producing bacteria in the 
urinary tract. Urease is an enzyme which hydrolyses urea to form ammonium ions, 
leading to an increase in the voided pH of the patient’s urine above the value at which 
certain calcium and magnesium phosphates can remain in solution. This value has 
been examined experimentally and termed the nucleation pH.  In other cases patients 
seem to form catheter encrustation without urease producing bacteria present, at a 
relatively normal voided urinary pH, because they seem to have an abnormally low 
nucleation pH.
Bacterial colonisation of the urinary tract, usually asymptomatic, is common in 
patients with urinary catheters and is universal in those with long term catheters.
16Organisms adhere to and colonise the catheter’s surfaces and, embedded in an 
adhesive polysaccharide matrix, they form bacterial biofilm communities.  In this 
biofilm mode of growth they are extremely resistant to conventional antibacterial 
treatments. The organisms in the biofilm attached to the catheter do not cause a 
symptomatic infection, but if they produce urease the urinary pH will rise. Crystals will 
precipitate and are then incorporated into the biofilm to form catheter encrustation. 
Pieces of the crystalline biofilm may detach from the catheter and act as foci for 
bladder calculus formation.
The most potent urease producing organism commonly found in these patients is 
Proteus mirabilis. It is an uncommon urinary tract pathogen in the general population, 
but is much more common in those with catheters and can be a very difficult 
organism to eradicate.
To date, no successful strategy has been established which extends the lifespan of 
catheters in the face of catheter blockage caused by these bacteria.
171.2  Urinary Catheterisation
A urinary catheter is a tube designed to passively drain the urinary bladder, avoiding 
the need for normal bladder contraction, bladder capacity, and urinary sphincter 
function. Catheters can be inserted into the bladder through the urethra, or 
suprapubically through a surgical tract in the anterior abdominal wall. This is shown 
diagrammatically in figures 1.1  and 1.2.
1.2.1  Development of the Urinary Catheter
It has been claimed that urinary catheters may have been used by the oldest 
civilisations known [1], and that catheterisation would have been utilised by 
prehistoric peoples much as other simple medical techniques such as applying 
pressure to bleeding wounds must have without any need felt to document such a 
mundane matter once writing systems were developed [2].  Firm evidence for this is 
hard to come by.
Retention of urine is referred to as a disorder in the ancient Egyptian medical text 
known as the Ebers papyrus (dating from around 1500 BCE), but pharmacological 
therapy is suggested as treatment and catheterisation is not mentioned [3]. Catheters 
are seemingly shown in ancient Egyptian engravings of surgical tools, such as those 
depicted in the tomb of the dentist physician Hesi-Re at Saqqara (dated at around 
2600 BCE) and on the wall of the twin temple of Korn Ombo (commenced in the 
second century BCE) [4], but these diagrams are open to other interpretations.
Translations of cuneiform texts from the ancient civilisations of Mesopotamia, dating 
from the first and second millennia BCE, indicate that medications were applied to the
18body or eyes or into bodily orifices by means of metal tubes [5J. RC Thompson’s 
translation of the British Museum’s holdings, Assyrian Medical Texts, contains the 
following passage:
(By means of) a tube of copper, into his penis you shall blow (the medication) 
with your mouth.
Words in parenthesis were added by the translator for clarity, and are not direct 
translations of equivalent terms in the original text. MJ Geller’s translation of other 
texts [6] mentions a similar process:
If a man’s urine constantly drips and he is not able to hold it back, his bladder 
swells and he is full of wind, his urine duct is full of blisters; in order to cure 
him, bray (untranslatable), crush it in pressed oil, and (blow) it into his penis 
through a bronze tube.
It is unclear whether these tubes were passed into the bladder or merely a short 
distance into the penile urethra, and these do not seem to be descriptions of urinary 
drainage, so is not unambiguous evidence of catheterisation in the usual sense.
The Indian  Vedas (compiled between 1500 and 1000 BCE) and the surgical text The 
Sushruta Samhita (dated between 1000 and 600 BCE) describe the use of hollow 
tubes of metal or wood lubricated with butter or animal fat [7], although some 
controversy exists as to the accuracy of the translation.  It is possible that they were 
only used to treat urethral strictures rather than to drain the bladder. The Yadiguiar of 
I bn Cherif from Asia Minor reveals a passage describing the insertion of plant twigs
19into the urethra, which some have interpreted as a reference to catheterisation [1], 
but may again simply indicate urethral stricture dilatation.
More detailed descriptions of these devices are only found in the latter half of the first 
millennium BCE. The pioneering Hellenistic anatomist Erasistratus of Ceos, probably 
working in Egyptian Alexandria in the first half of the third century BCE, is credited 
with treating urinary retention with a metal tube which he named a ‘catheter* (from the 
Greek ‘to send down’ or 1o lower into’), although the evidence for this comes from a 
first century CE text [8J. Whether or not Erasistratus first coined the term catheter, 
evidence is found in the Hippocratic Corpus of writings from around 400 BCE that 
catheterisation was well known before his time, with it being considered a deficiency 
of a physician not to be able to succeed in inserting a tube into the bladder [8,9]. A 
detailed description of types of catheter and instructions for their use in both men and 
women is found in On Medicine, a survey of current medical knowledge written in 
around 30 CE by the Roman encyclopaedist Celsus Aurelius Cornelius. From this 
time on catheterisation is frequently mentioned in medical texts for dislodging 
impacted bladder stones, instilling medicines into the bladder, and relieving retention 
of urine.  Bronze catheters in a variety of curvatures were found in the home of a 
surgeon during the excavation of the ruins of Pompeii, buried during the volcanic 
eruption of 79 CE.
Soft catheters made from treated or wire-reinforced parchment or textiles were used 
in the 16th and 17th  centuries, but the rigid silver catheters available at the time were 
still more popular. This is the time when side drainage eye holes may have been 
introduced to reduce trauma on insertion.  Further improvements came with the 
development of new materials technologies in the 18th  century, specifically the 
discovery of natural rubber. Bernard and Theden used this to produce pliable elastic 
gum catheters. This material was, however, sensitive to extremes of temperature,
20becoming either too brittle or too adherent to use effectively. This prompted further 
development of metal catheters, with John Weiss producing a flexible jointed model 
before newer rubber products established dominance [10].  Using the treatment 
process developed by Charles Goodyear in 1839, Auguste Nelaton introduced a far 
more effective device made of vulcanised rubber.
The origin of the modem catheter came with the development of the retention 
balloon.  Until that time, catheters were usually used intermittently, either by the 
physician or the patients themselves. Some catheters were designed to be externally 
fixed in place by tapes or sutures from the 16th century,  being constructed from soft 
materials such as wax impregnated cloth to aid comfort, and inserted over a metal 
stylet.  However, these often collapsed or fell out after a short time [11]. This method 
of catheter retention was still in use into the 20th  century [12]. Inflatable balloons 
made from ox intestine had been used by Theodore Ducamp to treat urethral 
strictures in 1822. In 1853, JF Reybard described his design of a rubber catheter 
which had a balloon inflated through a separate lumen to hold it in place inside the 
bladder, and this has been suggested as the origin of the balloon as a retention 
device [13]. An alternate method of retention developed by several different 
physicians in the late 19* century was the wing-tipped catheter, as balloons were 
unreliable until the development of latex rubber. Examples were produced by Wright, 
De Pezzer and Malecot [1]. At the turn of the century a large choice of catheter types 
were available in surgical instrument catalogues [2]. The balloon design was 
eventually developed into a two-piece dipped latex catheter by Frederick Foley and 
the CR Bard Company in 1930, with the inflation channel and balloon cemented and 
tied into a groove in the catheter. The original purpose of this device was to reduce 
haemorrhage following a prostatectomy operation by compressing the bleeding site 
with an inflatable balloon at the tip of the catheter. This was soon seized upon as an 
ideal method of retaining the catheter within any bladder. Following a final refinement
21to the design in 1936 to produce the catheter in a single piece [14], the self-retaining 
Foley catheter has seen little change.
22Figure 1.1: Diagram to show the position of a urethral catheter in a female
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Figure 1.2: Diagram to show the position of a suprapubic catheter in a female
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231.2.2  Modern Urinary Catheters
Although similar in basic design, Foley catheters are currently available in a variety of 
different materials and sizes for use in different situations. They are available in two 
lengths: standard or male length (approximately 40cm) and female length 
(approximately 25cm), to cope with the differing lengths of the male and female 
urethra.  Either can be used suprapubically. Other than this distinction, the ‘size’ of a 
catheter refers to its width or gauge, measured in French scale (F), or Charriere (Ch). 
This measurement system was developed by the Parisian instrument maker JFB 
Charriere (1803-1876), and is equivalent to three times the diameter of the catheter in 
millimetres [15]. The most commonly used catheters are in the 12F to 16F range. A 
maximum gauge of 14F is usually recommended in women for urethral 
catheterisation.
The majority of catheters have a two lumen structure: a large channel to drain the 
urine, and a smaller one to inflate the retention balloon. Some larger catheters have a 
third channel to allow simultaneous filling and drainage of the bladder for continuous 
irrigation, but these are only used for short periods.
Catheters are most commonly constructed from natural rubber latex or silicone, 
although some polyvinyl chloride (PVC) models are available [16]. Latex catheters 
are formed by a process of repeatedly dipping a former rod into liquid latex until a 
tube of the desired thickness is produced. The balloon is attached before the final 
dipping. Silicone catheters are extruded as a continuous tube, cut to length, and the 
balloon and drainage connectors bonded to either end.
Various coatings and treatments can be used to try to improve the surface properties 
of catheters, largely directed at reducing friction. This is especially important for the
24latex variety as it encounters more friction on insertion than silicone. Siliconised latex 
catheters are treated with silicone oil to reduce friction, although this only provides a 
temporary surface modification which is lost after insertion. Alternatively, a layer of 
silicone elastomer can be bonded to the surface. Polytetrafluoroethylene (PTFE) is a 
commonly used low friction coating in many applications, although PTFE coated 
catheters are actually coated with a layer of polyurethane (PU) containing a 
suspension of PTFE particles.  Both latex and silicone can be coated with a hydrogel, 
a polymer that absorbs water when in contact with the urethral mucosa to form a 
layer of soft, low friction gel. More recently, coatings containing antibiotics or metal 
ions have been developed in an attempt to reduce infection or encrustation. These 
will be discussed later, in section 1.4.4.
Hydrogel coated latex is the most popular type of catheter used in long term 
catheterisation. Almost all patients who don’t use these use 100% silicone catheters.
Electron microscopy studies have shown that catheter surfaces are very uneven, 
especially around the catheter eye holes.  It has been proposed that surface 
irregularities on biomaterials may be the sites of bacterial adhesion or crystal 
nucleation [17].  100% silicone catheters are smoother than coated or plain latex, 
except for those latex catheters with hydrogel coatings which expand and smooth out 
in their hydrated state. While it is known that surface roughness has an effect on 
bacterial adhesion, this is not a linear relationship.  Very smooth surfaces perform 
well in resisting colonisation and in lowering the shear force needed to detach 
adherent bacteria, but studies have shown that small increases in roughness aid 
bacterial colonisation more than larger increases, at least in those materials tested 
[18,19]. These experiments have not been performed using catheter materials, so it is 
unclear whether alterations in surface roughness within the physical limits of the 
currently available materials will affect bacterial adhesion in any way. Given thatchemical composition also affects adherence [20], altering surface roughness by 
changing the material present at the catheter surface may have unpredictable affects.
Both latex and silicone catheters have relatively thick walls, resulting in the urine 
drainage channel being quite narrow in comparison to the external diameter of the 
device, especially given that the balloon inflation channel must also be 
accommodated within the available space. The walls of silicone catheters are slightly 
thinner, meaning that for a given external diameter they have a wider drainage 
channel lumen. These catheters also have a drainage channel with a crescent moon 
shaped cross section, while that of a latex catheter is circular (figure 1.3). Latex 
based 14F catheters can have a drainage lumen diameter of approximately 1.5 mm 
compared to 2.5 mm for the 14F 100% silicone catheters [21]. These figures, and the 
ratio between them, vary considerably across manufacturers, and between different 
catheters produced by the same manufacturer.
Figure 1.3: Diagrammatic representation of the difference in cross section between 
100% silicone and latex based catheters
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26One potential problem with latex based catheters is the possibility of the user 
developing a latex allergy, and this may explain the increasing use of silicone devices 
despite their greater cost. Silicone does have noticeable disadvantages as a catheter 
material, however. Catheter balloons deflate slowly during use due to permeability of 
the balloon material to water. In some cases this can lead to the catheter being 
expelled. Silicone is more water permeable than latex, leading to a more rapid 
deflation of the catheter balloon [22]. Another problem associated with catheter 
balloons is that they tend to deflate incompletely after a prolonged period of filling, 
leaving a cuff of material around the catheter tip which may make the catheter more 
difficult to withdraw. An audit study of the nurses managing 154 community based 
catheter users has shown this problem to be reported more commonly with silicone 
catheters, especially when used suprapubically, despite latex based catheters being 
used in 86% of patients [23]. In the same study, the cuffs on a variety of 100% 
silicone catheters were also found to offer more resistance to withdrawal through a 
simulated abdominal wall than hydrogel coated latex catheters.
The role of catheter material properties and drainage channel width in resisting 
encrustation is examined in section 1.4.6.
271.3  Long Term Catheterisation
Indwelling urinary catheters are used in two main ways: on a short term basis for a 
few days or weeks, or on a long term basis for many months or years. Although there 
is no clear cut off between these two groups, it is conventional to define long term 
catheterisation as the use of a catheter for a period of over three months [24], 
although it is sometimes defined as over 28 days [25].  In practice, the term usually 
indicates that catheterisation is considered to be the definitive treatment for that 
individual’s bladder disorder, and that they will remain catheterised for the rest of their 
life.
1.3.1  Indications for Catheterisation
Short term catheterisation is most often used in an acute hospital setting. A catheter 
may be inserted to monitor the rate of urine output in the critically ill patient as a 
surrogate marker for perfusion of vital organs with an adequate supply of oxygenated 
blood. The catheter may also be used to drain the bladder in those individuals 
temporarily unable,  because of illness, to void normally.  It is also used after various 
forms of bladder surgery to decompress the bladder or allow bladder irrigation to 
prevent the build up of clotted blood. While short term catheterisation is usually 
urethral, suprapubic catheters are sometimes used to prevent the risk of urethral 
injury and stricture formation which can occur with urethral catheters [26].
Long term catheterisation is more likely to be used in the community. About 10% of 
long term catheters are used suprapubically. There are several types of bladder 
disorder for which long term catheterisation may be considered, but it is usually 
regarded as a measure to be used only when other treatments have failed, are not
28appropriate, or are not acceptable to the patient. Many bladder disorders may be 
treated surgically, but these disorders often occur in the very elderly or frail who have 
a high risk of complications with such procedures.  In general, a patient may be 
treated with a long term catheter for a chronic condition leading to either incontinence 
of urine or retention of urine.
Incontinence may be the result of several different pathological processes [27]. In 
some cases, it is due to a bladder disorder such as detrusor overactivity, where the 
bladder involuntarily contacts to minimal stimulus leading to loss of urine. This can be 
caused by neurological damage such as in multiple sclerosis or spinal cord injury 
[28], but is also a common idiopathic condition. Another problem, known as stress 
incontinence, occurs when the sphincter mechanism at the neck of the bladder 
cannot maintain enough pressure to retain urine against the normal passive rises in 
abdominal pressure caused by movement or coughing.  Neurological damage can 
affect sphincter function as well as bladder function.  Idiopathic detrusor overactivity 
and stress incontinence are both common conditions, being more common and more 
severe in elderly women, and they can occur together. Long term catheterisation 
would normally be considered only in the most severe cases, when large volumes of 
urine are being lost involuntarily.  Neurological causes may create more severe 
conditions than an idiopathic cause. Functional incontinence is the term used to 
describe loss of urine due to decreased mobility to such a degree that a person 
cannot reach a toilet in a timely manner. In mild to moderate detrusor overactivity a 
person often has enough warning to reach a toilet in time, but this is less likely if that 
individual has a mobility problem. Mobility problems, like detrusor overactivity, are 
more common with increasing age.
Retention of urine may be due to detrusor underactivity to such a degree that the 
bladder cannot contract sufficiently to fully empty itself.  It is also caused by conditions
29which increase the pressure needed to be generated to void urine through the 
urethra, such as the enlarged prostate commonly found in an elderly man [29]. These 
disorders can occur in combination, and are again more common with increasing 
age. Neurological damage can cause detrusor underactivity. It can also result in the 
sphincter at the neck of the bladder failing to relax when the bladder contracts, which 
also leads to urinary retention.
1.3.2  Prevalence
A survey by Roe showed a prevalence of long term catheterisation of 0.03% of the 
population aged over 18 years of age served by the health centres, hospital out­
patient departments, a urology department and the continence advisory service in 
one United Kingdom district health authority [30]. A larger survey conducted over two 
years by Kohler-Ockmore and Feneley, and also including the populations of nursing 
homes not served by the district nursing service, showed a prevalence of 0.07% in 
the over 16 age group [24]. It was shown that the prevalence increases appreciably 
with increasing age. In those aged over 75 years it increases to 0.5% and is 2% in 
those 85 years old [31].
Long term catheterisation is common among those needing long term health care. As 
can be seen in section 1.3.1, although the conditions responsible for catheterisation 
can occur in otherwise fit individuals, they are often caused by a generally disabling 
condition such as spinal cord injury or multiple sclerosis, or are found in people who 
are disabled through chronic disease or old age. Of those people with long term 
catheters, 87% have a chronic medical condition and about a third are resident in 
nursing homes [24].
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residents) were catheterised in a survey of nursing homes in the United States [32]. A 
study in Denmark by Zimakoff et al showed 4.9% of nursing home residents and 
3.9% of those receiving home care had catheters [33].
It is likely that this prevalence data will misrepresent the true extent of catheter use 
among the general population. There is no central register of individuals using 
catheters. Data for these studies have been collected from the records of those 
medical services attending the catheter users, and expressed as a proportion of the 
local population. Not all catheter users are likely to have been recorded, depending 
on the various services surveyed.  For example, there is no data from care home 
residents in the Roe study as these records were not sought. This would lead to a 
significant underestimate, as these individuals are often not attended by community 
nurses but by the care home staff themselves. As shown above, care home residents 
have a high rate of catheter use. The higher prevalence in the Kohler-Ockmore and 
Feneley study compared to the Roe study is therefore likely to be due to the inclusion 
of the nursing home population. However, including care homes could produce an 
error if these facilities were concentrated in certain locations which may be under or 
overrepresented within the sampled area. The catchment areas of the various 
medical teams from which data was taken may not necessarily overlap, and no 
attempt was made to match demographic and social factors in the sampled regions to 
the UK population as a whole. Data for these studies were also collected in areas 
where these investigators worked. Given their particular interest in the problems of 
catheterisation it is possible that these regions would manage continence problems in 
a different fashion from other regions, perhaps resulting in a lower rate of 
catheterisation. The Zimakoff study followed a campaign in Denmark to reduce 
catheterisation in hospitals, and this may have resulted in a reduced rate of
31catheterisation in care homes leading to difficulties in applying these figures to other 
populations.
It is clear that catheterisation is not uncommon among older people and those with 
disabilities. This group of people often have little alternative but to use a catheter. A 
lack of manual dexterity or a degree of cognitive impairment prevents intermittent self 
catheterisation. Condom catheters in males cannot be used by those with retention of 
urine, and many men find them difficult to attach securely. General immobility makes 
the regular changing of diapers difficult and leaving urine in contact with skin 
increases the risk of pressure sores.  Long term catheterisation is likely to be seen 
more commonly as the proportion of the population aged over 80 increases [34].
1.3.3  Morbidity
Catheters are associated with considerable morbidity. The most common problems 
are encrustation, bladder calculi, catheter bypassing, and symptomatic infection. The 
mechanism of infection, encrustation and calculus formation will be dealt with in 
section 1.4 in more detail.
Urinary Tract Infection
Bacteriuria is an almost inevitable consequence of long term catheterisation [35], but 
this does not inevitably lead to the development of symptomatic urinary tract 
infection. On average, long term catheter users will develop one day of febrile illness 
for every 100 days of catheterisation. These episodes usually last for less than 24 
hours and resolve without antibiotic treatment [36,37]. Even so, episodes of cystitis, 
upper urinary tract infection and potentially life threatening systemic bacterial sepsis 
do cause problems in many catheter users [38]. Catheters are the largest cause of
32nosocomial infection in the developed world [32,39]. These infections are often more 
difficult to eradicate than in a non-catheterised patient due to factors discussed in 
later sections.
The changes of chronic upper urinary tract infection are also seen more commonly in 
those with indwelling catheters. Warren et al surveyed the post mortem findings of all 
residents who died aged 65 or older in a large long term care facility over a period of 
two years [40]. They found a significantly higher rate of chronic renal inflammation 
(43% versus 18%) and chronic pyelonephritis (10% versus none) in those residents 
who had been catheterised for a total of > 90 days in their last year of life compared 
to those who had not. Chronic pyelonephritis was defined as chronic renal 
inflammation with renal scarring and distortion of the renal calyces. These finding are 
seen in those with dysfunctional urinary tracts who are not catheterised,  however, 
and it is possible that the disease which required catheterisation contributed to the 
renal damage, rather than just the catheter itself.  In a similar autopsy study, the 
changes of acute pyelonephritis were found more commonly among those with 
catheters in situ at the time of their death than those without (38% versus 5%) [41]. It 
should be noted that chronic asymptomatic bacteriuria is not uncommon in the 
elderly, even in the absence of catheterisation. The prevalence of bacteriuria is  5- 
10% of men and 10-20% of women in the community, and between 25 and 50% of 
elderly residents in long term care facilities [42]. The non-catheterised elderly 
population also has a correspondingly higher incidence of symptomatic urinary tract 
infection than the general non-catheterised population.
Symptomatic infection of the bladder and upper urinary tract is understandably found 
in both urethral and suprapubic catheter users. There does seem to be a lower 
incidence of urethritis, prostatitis, epididymitis, and orchitis in suprapubic 
catheterisation [43], the explanation being that these are a group of infections of
33those structures connected to the male urethra, and a catheter in the urethra would 
be a more direct source of infection than one inserted into the bladder through the 
abdominal wall.
Catheter Encrustation
Most manufacturers recommend that long term catheters are changed routinely every 
twelve weeks, although in many people they do not last this long because of 
encrustation related catheter blockage. Around 40 to 50% of catheter users are 
troubled with this problem [24,44,45]. Deposits of phosphate containing crystals, in 
association with bacterial communities, build up on those surfaces of the catheter 
which are in contact with urine. This leads to blockage of the catheter lumen, and the 
need for more frequent catheter changes, sometimes as often as twice a week. 
Crystalline deposits on the tip of the catheter can cause urethral trauma when the 
catheter is removed, or can prevent removal completely, usually in the case of a 
suprapubic catheter where the scar tissue track is less pliable than a urethra.
Catheter users have been divided into two groups -  ‘blockers’ and ‘non-blockers’
[46].  Blockers are those whose catheters are obstructed by encrustation in a period of 
less than six weeks, and are usually treated by crisis management, having their 
catheters changed as an emergency when they block.  Non-blockers are those whose 
catheters last longer than this, and they usually have their catheters changed at 
routine intervals. This is a reasonable clinical distinction between those with a 
significant medical problem and those without, but it is not clear that this dichotomous 
classification is appropriate for scientific study.  It has sometimes been assumed in 
the literature that those whose catheters last longer than six weeks are not forming 
encrustation.  It is probable that these two groups are not distinct, but simply opposite 
ends of a continuum of very fast and very slow encrustation.  It is certainly the case
34that some catheters are regularly changed every twelve weeks according to 
manufacturer’s guidelines and never cause any difficulties, yet show signs of 
encrustation at removal. At the other end of the spectrum are those whose catheters 
block every two or three days.  It is likely that those who form encrustation, whether 
severe or trivial, are a distinct group from those who do not, due to differences in 
urinary bacterial flora (discussed in section 1.4).  It does not seem to be the case, 
however, that those who block their catheters before they were due to be changed, or 
within any other set period of time, are a distinct group from those whose catheters 
last longer than this. In studies using this definition the ‘non-blocker’ group will include 
both non-encrusters and slow encrusters, who are probably quite different 
physiologically.
Bladder Calculi
Long term catheter users are at increased risk of forming bladder calculi, which,  like 
encrustation, are composed of phosphate crystals and bacterial communities [47,48]. 
Calculi are possibly formed when pieces of encrustation are dislodged from the 
catheter surface, although they could form de novo by the same mechanisms as in 
non catheterised individuals.  Encrustation on the catheter balloon is often left in the 
bladder when the balloon is deflated, forming what are known as ‘egg shell’ calculi. 
Further crystallisation occurs on the fragment surface and the calculus can increase 
in size. The calculus acts as a permanent source of bacteria in the bladder [49] and 
may physically block the catheter lumen.  It also causes bladder irritation and may 
increase detrusor spasm.
35Catheter Bypassing
Bypassing of urine around a urethral catheter often occurs when bladder drainage is 
blocked, either by encrustation of the catheter or by kinking or compression of the 
drainage tubing. Bypassing can also occur in an individual with a freely draining 
catheter as a result of detrusor overactivity [50]. This can cause an involuntary 
bladder contraction which creates a flow of urine exceeding the capacity of the thin 
catheter drainage lumen, resulting in fluid flow around the catheter. In the case of a 
suprapubic catheter, urine can leak urethrally.  In women the urethra has relatively low 
resistance and bypassing is a common problem. Urethral leakage from women with 
suprapubic catheters can occur if urethral damage prevents normal urethral closure. 
This can result from long term urethral catheterisation or from repeated expulsion of 
urethral catheters with the balloons inflated [51]. Since catheters do not fully empty 
the bladder, some female suprapubic catheter users find themselves permanently 
incontinent. Surgical closure of the urethra is a possible solution,  but is a significant 
procedure in a generally infirm population [52].
Chronic Pain
Most catheter users with intact sensation find their catheter uncomfortable to some 
degree. When asked, 69% of patients considered their catheter uncomfortable, with 
19% rating the pain greater than 50% on a visual analogue scale [24]. Painful bladder 
sensations and perineal pain are not uncommon, and can be distressing.
Occasionally this is due to an allergy to the catheter material, often latex,  but is 
usually simply a pressure effect. Discomfort can sometimes be reduced by 
decreasing the diameter of the catheter, and using softer latex catheters rather than 
silicone.  In a person with a urethral catheter this discomfort can be helped by 
changing to a suprapubic catheter, although this is not always successful given that 
the catheter balloon is still in the bladder and possibly causing mechanical irritation.
36A suprapubic catheter is inserted through a surgically created tract sited on the 
anterior abdominal wall, and this area often remains permanently tender. The 
advantage of the suprapubic site is that the patient does not normally sit or lie on it, 
so it is subject to little pressure other than from the catheter itself. Studies have 
shown them to be more comfortable and acceptable to patients than urethral 
catheters in short term post-operative situations [53,54]. In a survey of spinal cord 
injured patients fitted with a long term suprapubic catheter, 27 out of 32 stated they 
were satisfied with this form of management, despite the expected levels of 
encrustation and bypassing being present among the group [50].  However, larger, 
more rigid catheters such as the wider 100% silicone varieties can still be quite 
uncomfortable.
Urinary Tract Trauma
Long term catheters also physically damage the urethra and bladder.  Peri-urethral 
glands are blocked and scar leading to urethral strictures [55-57]. While this is not a 
problem in a male who will be catheterised for the rest of his life,  in a female this 
scarring can occur in the urethral sphincter area and prevent full urethral closure.
This can lead to increased urinary bypassing and urethral leakage. In males an 
erosion of the ventral aspect of the penis can occur due to pressure necrosis of the 
urethra. This causes the appearance of a hypospadias after a prolonged 
catheterisation. Some authorities recommend that long term catheters should always 
be placed suprapubically to avoid this, although it may be a more important 
consideration in those who are expected to return to normal micturition at some stage 
[58,59].
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mucosa of catheter users [60]. These are thought to be due to the siphoning effect of 
a column of urine in the catheter drainage tubing sucking bladder mucosa into the 
catheter eye holes, as these lesions have been eliminated in a catheterised rabbit 
model by allowing air inlet into the drainage system [61].
Haematuria
While not often severe enough to cause clinical problems such as catheter blockage, 
occasional blood in the urine is very common, with 30% of catheter users 
complaining of this, often after a catheter change [24]. Microscopic haematuria is 
present in almost all patients who are tested. Enlarged prostates and the tracks 
through which suprapubic catheters are inserted often have small surface blood 
vessels which are easily damaged by the catheter, and the polypoid lesions of 
‘catheter cystitis’ in the bladder may also bleed.
Malignancy
Several studies have suggested an increased risk of squamous cell carcinoma of the 
bladder among spinal cord injured patients, especially among those using long term 
catheters [62-64]. Squamous cell carcinoma has a less favourable prognosis than 
transitional cell carcinoma, which is the more common tumour in the normally 
functioning bladder.  Kauffman et al studied a group of 62 spinal cord injured patients 
with urethral and bladder biopsies [65]. The incidence of squamous metaplasia was 
higher in those with long term catheters than those without, and among the catheter 
users, was more common in those who had been catheterised for longer than 10 
years. Of those with squamous cell carcinoma, four out of five had indwelling 
catheters. A study by Locke et al found 2 cases of squamous cell carcinoma out of 25
38spinal cord injured patients who had been catheterised for over 10 years [66], 
although these patients were those admitted to the authors’ hospital unit for various 
reasons rather than being randomly selected from the catheterised spinal cord injured 
population. The mechanism responsible for this increased risk is hypothesised to 
involve either chronic mechanical irritation of the bladder epithelium by the catheter, 
or the production of carcinogenic compounds by the bacteria which colonise the 
catheterised urinary tract. The numbers involved in these studies are small,  however, 
and given the known increase in squamous cell carcinoma among all those with 
spinal cord injury it is difficult to determine how much of the increased risk is due to 
the catheter and how much to other factors.
This suggested mechanism for the carcinogenic effect of urinary tract infection is 
bacterial production of A/-nitrosamine compounds, which are well recognised 
carcinogens in animal models [67] and thought to be important in the development of 
several human tumours [68,69]. N-nitrosamine compounds can be endogenously 
produced in infected human urine.  Nitrate is a normal constituent of urine. The 
majority of urinary pathogens can reduce urinary nitrate to nitrite,  including those 
organisms such as Pseudomonas, Klebsiella, Proteus and Escherichia coli which are 
commonly found colonising catheterised urinary tracts [70]. This reaction forms the 
basis for dipstick testing of urine for urinary tract infection. The nitrosation reaction of 
these nitrites with urinary amines, such as dimethylamine, to form A/-nitrosamine 
compounds can also be catalysed by various common uropathogens such as E coli, 
Morganella and Pseudomonas [71]. /V-nitrosamines need to be further metabolised 
by the target organ cells to produce the DNA reactive species which cause 
malignancy. This certainly occurs for some A/-nitrosamines in rat and mice bladders 
as these are the basis for a commonly used animal model of bladder cancer [72]. A 
study on non-catheterised individuals with E. coli or Pr. mirabilis urinary tract 
infections showed that both nitrite and A/-nitrosamines were formed [73]. The levels
39were positively correlated and both rapidly decreased when the infection was treated 
with antibiotics. A/-nitrosamines were not formed in the absence of nitrite. Another 
clinical study showed that the colonised urine of 29 out of 30 paraplegic subjects 
contained nitrosamine compounds, although not all of these individuals used 
indwelling catheters, while the sterile urine of control subjects did not [74]. Although it 
is documented that some rubber products, including urinary catheters, can be 
contaminated with A/-nitrosamine compounds which could confound the results of 
studies such as this, this was controlled for in this particular trial by testing one of the 
drainage devices in sterile urine to see if leached A/-nitrosamines could be detected, 
which they could not. It should be noted that there are a large number of different N- 
nitrosamines which are known to be carcinogenic in animal models, but different 
compounds cause different cancers and the dose needed and the cancers caused 
vary between species, so it is difficult to predict the effect of the particular compounds 
produced in these studies on the human bladder.
A large case control study from the United States has suggested urinary tract 
infection as a risk factor for the development of bladder cancers, including squamous 
cell carcinoma [75].  In this study, Kantor et al used interview data from 2982 people 
with recently diagnosed bladder cancer to look for a past history of urinary tract 
infection, among other factors, which may have contributed to the development of the 
disease. Similar interviews were conducted with 5782 randomly selected non­
sufferers. It was found that those with bladder cancers were 1.6 times more likely to 
report previous infections than control subjects, and twice as likely to report more 
than three infections. The risk of squamous carcinoma was even higher, but the 
number of cases of this tumour in the study was small. The investigators attempted to 
control for the possibility that the infections were caused by the cancers by not 
including infections which had occurred in the year prior to diagnosis, but no 
maximum limit was placed on how long before diagnosis the infection could occur.  It
40is difficult,  intuitively, to imagine how a single uncomplicated lower urinary tract 
infection lasting no more than a few days could give rise to a bladder cancer, but 
even more so when the infection occurred decades before the cancer. Also, the 
investigators did not look for proof of infection, only that the subject recalled being 
given the diagnosis by a physician.  Urinary tract infection can be misdiagnosed, with 
many transient non-infective lower urinary tract symptoms being attributed to infection 
when none is present. By the time the laboratory culture results are available the 
symptoms have resolved and the patient may never realise they did not have an 
infection. The contrary is also true, with infections caused by bacterial counts so low 
as to be dismissed by laboratories as sample contamination. It therefore cannot be 
certain that the correct number of infections was attributed to each participant. An 
even more important source of inaccuracy is the phenomenon of recall bias.  It is quite 
possible that those recently diagnosed with a serious disease would look to attribute 
blame for their condition on previous events in their life, and so may be more likely to 
recall episodes of infection than the control subjects,  possibly explaining a large 
proportion of the observed difference in infection rates. It would seem that the case 
for infection as a risk factor for bladder cancer remains unproven.
1.3.4  Financial Costs of Long Term Catheterisation
The high complication rate of this form of bladder management involves considerable 
time on the part of health care staff, usually district nurses, and presumably a 
significant cost to health care providers.
Getliffe determined that the care of those with long term catheters represented 4% of 
district nurse’s patient caseload in one United Kingdom health district [76]. A survey 
by Sassoon et al showed that a group of 145 community catheter users needed 1000 
district nursing visits in one year and took up 500 hours a month of nursing time [77].
41What is not clear from either of these surveys is the amount of nursing time these 
patients required relating to the illnesses and disabilities responsible for their 
catheterisation in the first place. A large proportion of district nursing time, and 
therefore cost, is spent on travelling to visit a patient.  If the patient required visiting for 
other reasons, the additional time spent attending to a catheter would not justify the 
entire visit being classified as a cost of catheterisation. However, this is not the case 
for emergency visits for blocked catheters. In the Kohler-Ockmore and Feneley study, 
457 catheter users generated 149 emergency hospital referrals for catheter 
complications in 6 months,  104 of which were dealt with by Accident and Emergency 
departments, and 60% of which were for blocked catheters [24]. An even greater 
number of emergencies were dealt with in the community by District Nurses.
Evans et al performed a 3 month pilot study of 7 community patients with long term 
catheters in the United Kingdom in 1999. Participants were chosen to represent a 
range of catheter complication rates,  underlying pathologies and degrees of 
dependency on care [34]. Costs taken into account were those directly incurred by 
the patient, such as laundry bills, as well as those incurred by health care and social 
service agencies.  Indirect costs, such as loss of earnings, were not measured. 
Managing those catheter users who did not suffer complications was inexpensive, the 
cheapest amounting to £119 over 3 months. When complications occurred the costs 
increased substantially, with one user costing £2585 over the same period, mostly in 
National Health Service expenditure. Again, it should be noted that some of these 
costs would have been incurred as a result of the underlying illness rather than as a 
result of the catheter. An allowance was made for this in terms of general nursing 
care for the more disabled patients in this study, with only a proportion of the cost of 
each visit being ascribed to the catheter, although the authors admit that they 
considered this costing a ‘best guess’ rather than an accurate figure. Patient costs 
may also have been overestimated. Catheter users may be frequently incontinent
42due to catheters blocking and bypassing,  but may be totally incontinent without a 
catheter. Alternatives, such as pads and external drainage devices, also leak urine. 
The catheterised person may have increased laundry costs compared to an individual 
with normal continence, but these may be equivalent or even reduced compared to 
any realistic alternative. However, the difference in cost between uncomplicated and 
complicated catheters, and the fact that 83% of the costs in this study were those 
incurred by hospital treatment for catheter problems, suggests that the catheter itself 
was contributing significantly to overall health care costs in addition to basic care for 
the catheter user’s underlying medical problem.
While larger studies will be needed to develop a more accurate financial model, it is 
clear, given the high complication rate, that long term catheterisation is not a cheap 
form of continence management. This should provide the incentive needed to 
investigate improvements in health technologies and management strategies in this 
area.
431.4  Catheter Encrustation
Half of all long term catheter users experience a phenomenon known as catheter 
encrustation [24]. Scanning electron microscopy has shown that the encrusting 
material is composed of large crystals of struvite (magnesium ammonium phosphate 
hexahydrate) and a poorly crystalline apatite (a form of calcium phosphate) 
embedded in a matrix [78]. Large numbers of bacterial cells are also seen in this 
matrix [79]. These structures of crystal,  bacteria and matrix are known as crystalline 
biofilms. They can develop rapidly as a coating on those catheter surfaces in contact 
with urine, obstructing the flow of urine through the catheter eye holes and drainage 
lumen, and so causing a catheter to block.
1.4.1  Urinary Tract Pathogens
In uncatheterised, otherwise healthy individuals resident in the community, 80% of 
urinary tract infections are caused by Escherichia coli, and 10 to 15% are caused by 
Staphylococcus saprophyticus, this last being especially prevalent among young 
women. Enterococcus faecalis, Klebsiella and Proteus infections do occur in this 
group, but not commonly [80].
In those with urinary catheters the pattern changes, reflecting the organisms seen in 
nosocomial infection: that is, those infections acquired in hospitals and long term care 
facilities, or as a result of a medical procedure. E. coli are present in 50% of cases, 
but Proteus and Klebsiella infections make up a significant proportion of the 
remainder.  In individuals with long term catheters or structural abnormalities of the 
urinary tract, up to 44% of urine cultures contain Pr. mirabilis. Pseudomonas 
aeruginosa, Ent faecalis, and Staphylococcus aureus are also seen quite commonly, 
along with Citrobacter, Serratia, Providencia and Candida spp. Colonisation with
44multiple bacterial species is found in up to 95% of urine cultures from long term 
catheter users [81-84].
1.4.2  Bacterial Biofilms
Until relatively recently, the study of bacteria was concerned largely with the study of 
the organisms as they exist in their planktonic state. Planktonic bacterial forms are 
those which are present as individual organisms suspended in a liquid medium.  It is 
now recognised that bacteria predominantly exist in communities attached to solid 
surfaces, both in the environment and in their infections of human hosts. These 
communities are known as biofilms [85].
A biofilm is defined as a group of microbes immobilized at a solid surface, in single or 
multiple layers, embedded in or surrounded by an organic polymer matrix, primarily of 
microbial origin [86]. Biofilms play a central role in the pathogenesis of human 
disease [87]. They form dental plaque leading to periodontal inflammation [85], form 
on the urothelium of the kidneys as a prelude to invasion of the renal parenchyma in 
pyelonephritis [88], are found on many implanted surgical prostheses [89], and are 
responsible for haematogenous infection from intravascular catheters [90]. They have 
been observed on the majority of ureteric stents [91] and urinary catheters [92] 
removed from both symptomatic and asymptomatic individuals.
The formation of a biofilm on an implanted device such as a catheter takes place in 
several steps. When a biomaterial is introduced into a body fluid, such as urine, blood 
or saliva, macromolecules rapidly adsorb onto the biomaterial’s surface to form a thin 
organic layer known as the conditioning film. The molecules in the film equilibrate 
with those in suspension until the most stable, most adhesive layer is formed.  It is to 
this layer which the first micro-organisms will attach, and several proteinaceous
45compounds in the conditioning film play a role in bacterial adhesion [93}.  Bacteria 
possess fimbriae: long protrusions which extend beyond the bacterial capsule to 
provide specific adhesion molecules for attaching to defined ligands on host epithelial 
cells, and these ligands may be present in conditioning films. The glycocalyx of a 
planktonic bacterium forms its thin capsule. It is comprised of a sticky polysaccharide 
layer, which allows non-specific adhesion to solid surfaces lacking receptor ligands.
Once a bacterium is temporarily attached to a surface in this manner, it upregulates 
gene expression to synthesize new adhesion molecules to consolidate surface 
adhesion. This is accompanied by an increase in glycocalyx production to form a 
diffuse extracellular polysaccharide slime layer, rather than a thin capsule.  Part of this 
conversion from reversible surface attachment to permanent surface adhesion is 
mediated by signalling molecules released from the bacteria. In a location with a high 
density of surface attached organisms, the local concentrations of these secreted 
signalling molecules increase to a level which triggers the gene expression 
responsible for conversion to the surface adherent state. With a low density of 
organisms this does not occur, making it more likely that they will detach from the 
surface. This response to local population density is known as quorum sensing.  In 
this case it allows preferential attachment of bacteria in microcolonies, rather than as 
individual cells.  It has been shown that catheter associated biofilms of Pseudomonas 
aeruginosa release acylated homoserine lactones (AHLs), a class of these quorum 
sensing signal molecules [94]. In some species, such as Pr. mirabilis, the altered 
gene expression triggered by these signal molecules causes an even more radical 
change in phenotype to produce a swarmer cell, which can move rapidly across 
surfaces to extend the biofilm (this is described in more detail in section 1.5).
These microcolonies of surface adherent organisms, phenotypically distinct from their 
planktonic cousins, coalesce to form a biofilm. The colonies grow within a dense
46matrix of extracellular polysaccharide. The proportion of the volume of the biofilm 
taken up by matrix as opposed to bacteria varies from 75 to 90%, depending on the 
organism [95]. Microcolonies and biofilms may be comprised of single or multiple 
species of bacteria.
A mature biofilm is conventionally described as comprising of three layers [96]:
•  The linking film, comprising the conditioning film and the initial layer of 
bacteria which adhere to it.
•  The base film, consisting of slowly growing compact organisms.
•  The surface film, which is made up from loosely attached bacteria and can 
give rise to planktonic organisms.
There appear to be water filled channels between the cell clusters which may act to 
allow transport of nutrients into, and waste products out of, the biofilm. The surface 
film seems to be involved in nutrient transport, and can reduce the diffusion of 
detergents and antibiotics into the lower layers of the biofilm [97].
It should be noted that the presence of a biofilm does not indicate a disease state. 
Catheter and ureteric stent biofilms can exist without any symptoms of local or 
systemic infection.
1.4.3  Catheter Associated Urinary Tract infection
The urinary catheter is the leading cause of infections acquired as a result of a 
medical intervention [32,98], due to the large number of devices in use [24,33], and 
the fact that they connect an area of the skin frequently colonised with pathogenic 
organisms [99] to a warm body cavity containing an ample nutrient supply.
47Catheters can be drained by either a closed or open method. Closed drainage 
involves the connection of a sterile catheter to a sterile drainage bag before catheter 
insertion. This connection is not subsequently broken, and care is taken to avoid 
introducing infection through the drainage tap of the bag by using unwashed or 
ungloved hands or letting it touch the floor.  Using this method, bacteria should not 
have an opportunity to colonise the catheter lumen or the interior of the drainage bag. 
An open drainage system originally described the use of an open ended catheter 
emptying into a separate receptacle, but in modem practice this does not occur. Even 
so, few long term catheter users experience a truly closed system.  Drainage bags are 
usually changed on a weekly basis leading to almost inevitable contamination of the 
catheter lumen, urine sampling can lead to bacterial introduction, and leg bags are 
sometimes disconnected so a larger ‘night bag’ can be attached overnight.
The mechanism of bacterial colonisation of the bladder is best studied in the context 
of short term catheterisation, where a catheter is inserted into an uninfected bladder 
for the first time. In an open drainage system, 93% of those given indwelling 
catheters develop bacteriuria within 4 days [100]. With the development of closed 
drainage, rates of bacteriuria can remain below 20% after two weeks in the best 
series [101,102]. While this has been a great advance in the use of catheters for brief 
periods, the rate of colonisation has been calculated as between 3% and 10% per 
day [103-105], suggesting that the development of bacteriuria is practically inevitable 
for long term catheter users. Of those undergoing long term catheterisation using 
closed drainage, 50% had bacteriuria after 10 days [103], and over 90% after 4 
weeks [106].
The low rates of bacteriuria found in the first few days after catheter insertion 
suggests that organisms are not introduced with the catheter if a proper aseptic
48catheterisation technique is used. The bacteria mostly gain access to the bladder in 
the days following catheterisation. The two suggested routes for bacteria to ascend to 
the bladder are either through the urine drainage channel of the catheter, or in the 
periurethral space between the exterior surface of the catheter and the urethral 
mucosa.
Garibaldi et al assessed the rate of development of bacteriuria in a group of 1213 
hospitalised patients undergoing short term catheterisation using closed drainage 
[99]. All patients had a swab of the urethral meatus cultured on the day of 
catheterisation. They found that the chance of developing bacteriuria was significantly 
greater in those with a positive meatal culture compared to those without, and in 85% 
of cases the same bacterial species was found in urine as on the meatus. In a trial 
comparing standard closed drainage with the technique of sterilising drainage bags 
with chlorhexidine, Gillespie et al showed that despite the contents of the bags 
remaining sterile,  bacteriuria still occurred [107].  It was noted that the infections were 
caused by species typically found on the perineal skin. This suggests the importance 
of the periurethral route in strict closed drainage situations.
Nickel et al studied the mechanism of bacterial ascension along catheter surfaces in 
an animal model using Pseudomonas aeruginosa [108]. They showed that if the 
closed drainage system was broken, bacteria ascended rapidly by the intraluminal 
route, reaching the bladder in 32 to 48 hours. If the system remained closed,  bacteria 
ascended periurethrally on the outer catheter surface, reaching the bladder more 
slowly, in 72 to 168 hours. In both cases the infection was mediated by 
Pseudomonas biofilms creeping over the catheter surfaces.  In an in vitro model 
developed to look more closely at the intraluminal Pseudomonas biofilm [109], they 
showed that the leading edge of the film was thin and was preceded by individual 
adherent bacteria. They noted that ascent of the biofilm was slowed, but not
49prevented, by the use of antibiotics in concentrations known to be bactericidal to 
planktonic Pseudomonas. They theorised that turbulent urine flow within the catheter 
lumen would deposit some planktonic bacteria on the catheter wall ahead of the 
biofilm. These would form microcolonies and eventually become coherent with the 
advancing main biofilm, thus speeding its ascent. In the presence of antibiotic these 
individual planktonic organisms would be killed, and the bacterial colony could only 
advance by division of cells within the protection of the extracellular polysaccharide 
matrix covering the main biofilm. This division may even be slower than normal, as 
rapid division could make the organisms more sensitive to antibiotic. On the 
periurethral catheter surface there would be no turbulent urine flow, so the advance 
would also be slow compared with the intraluminal route.
It was shown in a study of 15 nursing home residents having monthly urine samples 
over the course of a year, that there was considerable change in the bacterial species 
present [81]. It seems that long term catheter users experience repeated re-infection, 
at least in a long term care facility environment.
1.4.4  Strategies to Control Catheter Associated Infection
Bacterial colonisation of the urinary tract, whether by planktonic or biofilm-resident 
organisms, does not necessarily lead to symptoms of cystitis or pyelonephritis.  It is 
accepted medical practice not to treat bacteriuria in catheter users unless 
accompanied by symptoms [80]. As well as biofilms being commonly found on 
individuals with unproblematic urinary catheters and urethral stents [91,92], a study of 
spinal cord injured patients has shown the presence of biofilms on bladder mucosa in 
individuals who were asymptomatic [110]. This does not mean that colonisation of the 
urinary tract is harmless in all cases. Bacteria are responsible for symptoms of 
catheter encrustation and the possible development of squamous cell carcinoma of
50the bladder. They are also a source of organisms which can go on to produce 
symptomatic infection.
Antibiotics are ineffective at preventing febrile infection in long term catheter users if 
bacteriuria is screened for and treated before the onset of symptoms. This method 
was employed in a randomised controlled trial of long term catheter users by Warren 
et al [111]. Subjects in the treatment group were screened for the presence of 
bacteriuria, and treated with a 10 day course of cefalexin if susceptible organisms 
were isolated. The incidence of febrile episodes when antibiotics were being used 
was similar to that during periods when they were not, but cefalexin resistant 
organisms did emerge in the treatment group patients.
A randomised double blind crossover placebo trial by Rutschmann and Zwahlen has 
shown that long courses of fluoroquinolone antibiotics can reduce the infective 
complications of catheterisation [112]. Symptomatic infection and catheter blockage 
was reduced with a three month course of norfloxacin, as compared to the placebo 
group. While gram negative organisms were reduced in urinary isolates, gram 
positive norfloxacin resistant organisms flourished.  It would seem only a matter of 
time before resistance developed in gram negative organisms, or symptomatic 
infection with gram positive organisms became prevalent. Three months cannot be 
considered an adequate representation of the treatment period required to make a 
difference to the life of a long term catheter user in respect of these issues.
Viable organisms have certainly been seen in biofilms from catheterised patients 
receiving antibiotics, and these could cause symptomatic infection as soon as the 
antibiotic is stopped, or the organisms develop resistance [79].
51Catheter associated infection is known to be particularly difficult to treat with 
antimicrobials. The planktonic bacteria may be cleared, and the symptomatic 
infection may settle, but urine cultures following the cessation of therapy will most 
likely be positive. This can be explained by the organisation of the bacteria into 
biofilms.
As has been mentioned, the extracellular polysaccharide in the surface film limits 
diffusion of some antimicrobial agents into the lower layers of the biofilm [113]. This 
barrier is not the only method of protection that the organisms have, as the surface 
film produced by some species is quite permeable to certain antibiotics. Anderl et al 
developed a method in which biofilms were allowed to develop on permeable 
membranes [114]. A second permeable membrane was placed on the surface of the 
mature biofilm and a filter disc placed on this. These assemblies were incubated on 
antibiotic containing agar. The biofilms were sampled to determine biofilm organism 
viability and the filter discs tested for antibiotic penetration by determining if they 
produced zones of inhibition when transferred to agar growing a test E. coli strain. 
This E. coli system had been calibrated to measure antibiotic concentration. The 
researchers found that Klebsiella pneumoniae biofilms which produced the antibiotic 
inactivating enzyme 0-lactamase were impermeable to, and therefore understandably 
resistant to, the antibiotic ampicillin.  However, a biofilm of a strain of Kl. pneumoniae 
which did not possess 0-lactamase was still resistant to ampicillin, even though it was 
penetrated within 10 minutes by antibiotic at 250 times the minimum inhibitory 
concentration (MIC) determined for the planktonic form of this strain. After 40 minutes 
the penetrating antibiotic concentration increased to 1000 times the MIC, but without 
any reduction in viable biofilm organisms. Similar results were found with 
ciprofloxacin. The antibiotic penetrated the biofilm in concentrations higher than those 
needed to eradicate planktonic organisms,  but produced little reduction in the
52numbers of viable organisms in the biofilm. This suggests that biofilms use other 
mechanisms in addition to a diffusion barrier to resist antimicrobials.
Selection of an appropriate antibiotic is based on the culture of bacteria, in most 
cases from urine. These, however, are the planktonic organisms, not those sessile 
bacteria resident in the biofilm.  Bergqvist et al [115] observed that organisms isolated 
from urine aspirated suprapubically did not match the organisms cultured from urine 
drawn through the catheter.  In a quarter of cases, organisms not present in the 
suprapubically sampled urine were cultured from the catheter urine, suggesting the 
presence of biofilm organisms which, while shed in their planktonic state sufficiently 
to appear in urine sampled through the catheter, did not ascend to reach the bladder. 
Ramsay et al demonstrated that in 11 of 16 catheter and urine pairs studied, the 
organisms in the urine did not fully match those grown from the catheter biofilm [82].
It is often unclear from the polymicrobial urine cultures often obtained from catheter 
users which of the several species present is responsible for the symptomatic 
episode.  It may be that treatment failure is a result of the antibiotic prescribed not 
being targeted at the correct organism.
As has been described, biofilm organisms are phenotypically distinct from planktonic 
bacteria of the same species. As an example, the proteins of the Ps. aeruginosa cell 
envelope have been shown to differ by 30 to 40% between the two phenotypes [116]. 
Antibiotics are active against specific pathways of cell metabolism that may be vital in 
the planktonic phenotype, but may not even be present in the biofilm phenotype, 
leading to the antibiotic being ineffective against this form.
Many antimicrobials have a considerably higher activity against fast growing, dividing 
cells. Slow growing organisms do not express some proteins necessary for the
53binding of these agents [117].  It is known that the growth rate of organisms is very 
low in the deeper layers of a biofilm, giving the colony resistance to antibiotic therapy.
It has been shown that these methods enable organisms in biofilms to resist 
antimicrobial substances at concentrations 1000 to 1500 times greater than those 
which would be lethal to planktonic bacteria [95]. With organisms being bathed by 
sub-therapeutic doses of antibiotics, it is likely that selection of resistant organisms 
will occur. With multiple species in close proximity, the transfer of plasmid mediated 
resistance between organisms or between species is possible [118,119]. While 
antibiotic therapy can penetrate tissues and eradicate planktonic bacteria, once the 
therapy is stopped, new planktonic cells released from the surface of the catheter 
biofilm soon repopulate the urine. These cells tend to be more resistant to antibiotics 
than the original population [70,111].
Preventing the colonisation of the urinary tact in the first place would be a significant 
step in improving the usefulness of long term catheterisation. In short term 
catheterisation, where it is known that bacteriuria can theoretically be delayed for 
several weeks, and where the dominant complication is symptomatic febrile infection, 
any further delay in the rate of colonisation may entirely prevent complications within 
the time frame that the catheter is required for. Several methods of achieving this 
have been tried:
Meatal cleansing
In a closed drainage system, colonisation of the bladder is presumed to occur from 
bacteria on the urethral meatus. Regular cleansing of the meatus with soap, 
antiseptic, or antibiotic solutions has not been shown to delay the onset of bacteriuria. 
Burke et al compared green soap or povidone-iodine solution meatal cleansing in
54samples of roughly 200 short term catheter users against no cleansing in a 
randomised controlled trial [120]. Bacteriuria rates were found to be slightly higher in 
the treatment groups, and this was statistically significant in the high risk female 
patients. Subsequent randomised trials using  1% silver sulfadiazine cream [121] and 
polyantibiotic cream [122] also failed to show benefit from meatal cleansing, although 
they did not show an increase in risk with treatment. Worryingly, a survey of 
periurethral skin flora in patients receiving meatal cleansing with the antiseptic 
chlorhexidine following spinal cord injury showed a rapid change in flora from gram 
positive organisms to gram negative strains such as Pr. mirabilis, Ps. aeruginosa and 
Providencia stuartii [123,124]. As well as being highly resistant to chlorhexidine, 
these organisms are more resistant to other common antibiotics should they cause a 
urinary infection.
Drainage bag sterilisation
Gillespie at al randomised short term catheter users between the standard closed 
drainage technique and a technique where chlorhexidine was added to the drainage 
bag [107]. Despite the contents of the chlorhexidine drainage bags remaining sterile, 
bacteriuria occurred with similar frequency in the bladders of the treated group (51%) 
as in the control group (45%), presumably because the route of infection was 
periurethral. Similar findings have been reported using other methods of sterilising 
drainage bags, such as a study of hydrogen peroxide use in those requiring catheters 
for longer than five days [125]. In this case, as well as bacteriuria not being 
prevented, episodes of febrile infection happened with equal frequency as in the 
control group and bacterial growth of several common nosocomial pathogens 
occurred in the drainage bags. The source of bladder organisms seemed to be the 
drainage bag flora in this case.
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Another technique used to treat or prevent bladder colonisation is repeated irrigation 
of the catheter with antiseptic or antibiotic solutions. To administer these, the 
drainage bag is disconnected and 50 to 100 ml of the solution is flushed into the 
bladder through the catheter. The catheter may then be clamped and the solution left 
in place for 10 to 15 minutes, before being allowed to drain out. It has been pointed 
out that exposure of bacteria to an antimicrobial agent by this method is very different 
to the exposure used to determine the minimum inhibitory concentration (MIC) of an 
agent. This is done by culturing organisms over 24 hours in the presence of the 
antimicrobial in a laboratory. The effectiveness of such short exposures to the 
popular chlorhexidine bladder washout solution was examined in an artificial bladder 
model by Stickler et al [126], against a variety of bacterial strains obtained from 
catheterised individuals.  It was found that in the biofilms that formed, even strains of 
bacteria which were determined to be chlorhexidine sensitive in conventional MIC 
tests survived the washouts.  Further similar work by this group has shown the 
ineffectiveness of various other washout compounds such as povidone-iodine, 
phenoxyethanol, chlorhexidine supplemented with EDTA and Tris, noxythiolin and 
neomycin [127],
Davies et al conducted a randomised clinical trial of chlorhexidine versus normal 
saline as a bladder washout in those catheterised for longer than ten days [128]. 
Neither treatment produced a reduction in bacterial counts,  but there was an increase 
in Proteus spp isolated from the chlorhexidine group. A clinical study using a 
neomycin-polymyxin antibiotic washout solution carried out by Warren et al showed 
no difference in the rate of acquisition of bacteriuria [129]. This group proposed that 
any effect of the antibiotic was outweighed by the influx of organisms when the
56closed system was broken. It was also shown that the bacteriuria in the treated group 
had higher levels of antibiotic resistance.
Comprehensive Antiseptic Policies
A combination of the above approaches has also been implemented. The 
Southampton Control of Infection Team instituted a comprehensive policy of 
chlorhexidine use to prevent urinary tract infection in hospital based catheter users
[130]. Chlorhexidine was used to clean the urethral meatus before catheter insertion, 
and was present in the lubricant gel used to introduce the catheter. Chlorhexidine 
was used for regular drainage bag sterilisation. A chlorhexidine solution was used for 
daily meatal cleansing, after which a chlorhexidine containing cream was applied to 
the periurethral area. Following the introduction of this policy, an outbreak of 
chlorhexidine resistant Pr. mirabilis developed in the hospital, infecting 90 patients
[131]. The outbreak strain, as well as being resistant to chlorhexidine, was also 
resistant to the antibiotics trimethoprim, sulphafurazole, ampicillin, azlocillin, 
carbenicillin, gentamicin and tobramycin [132]. The authors recommended that the 
antiseptic policy should be abandoned.
Systemic Antibiotic Prophylaxis
Prophylactic antibiotics given at the time of initial catheterisation, before bacterial 
colonisation occurs, do not seem to prevent urinary colonisation.
Giving antibiotics at the time of the first catheter insertion may delay the onset of 
bacterial colonisation for a few days, but the reduction in bacteriuria is short lived 
[103]. It is controversial whether such limited effect has a benefit which outweighs the 
risk of spreading antibiotic resistance even in short term catheterisation [133].
57In a placebo controlled trial sometimes quoted as supporting antibiotic prophylaxis, 
Van der Wall et al showed that the use of low dose ciprofloxacin in post operative 
patients needing catheterisation for 3 to 14 days led to significantly reduced rates of 
bacteriuria and symptomatic urinary infection in the treatment group [134]. These 
patients, however, were considered at higher than normal risk of infection due to their 
surgery, and this is reflected in the very high rates of symptomatic infection found. 
The authors of the study do not suggest that these results should lead to prophylaxis 
for all catheterisations. Over the course of the study, although total rates of 
bacteriuria and rates of gram negative bacteriuria were certainly reduced in the 
treatment group, ciprofloxacin resistant gram positive urinary tract colonisation 
developed. Their urinary tracts were also repopulated with ciprofloxacin sensitive 
gram negative organisms once the catheter was removed and ciprofloxacin stopped.
Antibacterial Coated Catheters
Catheters have been developed which release antibiotics from their surface coatings 
in an attempt to prevent bacterial colonisation. Laboratory studies have shown that 
they consistently release concentrations of antibiotic sufficient to produce zones of 
inhibition on agar plates against many common uropathogens. Johnson et al showed 
that nitrofurazone catheters were active against E. coli, Kl. pneumoniae, Citrobacter 
freundii, Staph, aureus, coagulase-negative staphylococci, and non vancomycin 
resistant Enterococcus faecium [135]. Similar studies on a norfloxacin releasing 
catheter by Park et al showed that inhibition of E. coli, Kl. pneumoniae and Pr. 
vulgaris was still present after 10 days use [136]. A chlorhexidine impregnated 
catheter showed activity against E. coli, Pr. mirabilis and Staph, epidermidis in a 
study by Whalen et al [137]. While these studies failed to account for some important 
uropathogens, such as Pseudomonas, such results have encouraged development
58and marketing of antibacterial catheters. It should be noted, however, that 
bactericidal activity against lawns of bacteria on agar cannot necessarily be 
extrapolated to activity against biofilm resident organisms in vivo. These catheters 
also lose activity with time, and so have a useful lifespan which is shorter than the 
twelve weeks which would ideally be expected from an uncomplicated long term 
catheter.
Ciprofloxacin catheters have been tested in a catheterised rabbit model [138]. A 
statistically significant increase in the time for bacteriuria to develop after E.  coli were 
applied to the urethral meatus was seen with the antibiotic compared to the standard 
catheter, from 3.5 to 5.3 days. A delay of this magnitude may be useful for short term 
catheterisation, but would be of no benefit for long term catheter users.
In a human study on post operative short term catheterisation by Darouiche et al, a 
catheter impregnated with minocycline and rifampicin was used [139]. This 
successfully reduced the rate of colonisation with gram positive organisms over a 
mean catheterised period of two weeks, although 7% of patients were still colonised 
with the antibiotic catheters. There was no reduction in the rate of colonisation with 
gram negative organisms,  however, with 46% of treated subjects being colonised. 
Unfortunately, some of the most common uropathogens such as E.  coli, and the most 
troublesome, such as Pseudomonas and Proteus, are gram negative. There is also 
the possibility of promoting the emergence of predominantly gram negative infections 
and resistant gram positive organisms in the local population. The experience with 
chlorhexidine use detailed above suggests that the use of catheters releasing this 
compound may be particularly unwise.
59Silver Coated Catheters
Silver is an effective antimicrobial agent which does not promote bacterial resistance 
and is active against a broad spectrum of bacteria.  It has been used in a range of 
medical devices outside the urinary tract. Silver ions have a bacteriostatic action at 
low concentrations by binding to a wide range of biological molecules and displacing 
essential metal ions. At higher concentrations, silver-DNA binding has a bactericidal 
effect [140].
Silver has been shown to delay ascending infection from drainage bag to bladder 
reservoir in an artificial bladder model of short term catheterisation [141]. A silver 
releasing device in the drainage tubing prevented Pr. mirabilis, E. coli and Ps. 
aeruginosa from colonising the bladder for the 10 days in which the experiment ran. 
In the models with no silver, the bladders were colonised in 5.7 to 7.7 days.
Silver can be applied to catheter surfaces as either an alloy or an oxide.  Several 
randomised clinical studies have been performed measuring rates of bacteriuria with 
these catheters compared to normal catheters in short term catheterisation of 
hospitalised patients. While these studies have had very varied results, a meta­
analysis showed that silver alloy, but not silver oxide, catheters did result in 
significantly lower rates of bacteriuria [142]. The studies analysed have been 
criticised, however, and the efficacy of silver catheters is still considered unproven 
[143].
The release rate of free silver ions appears to be the important factor in determining 
the activity of a silver device [144]. Studies have shown that the effectiveness of 
silver is reduced in the presence of some common constituents of biological fluids. 
Reduced activity has been shown with horse serum, bovine serum, chloride ions and
60albumin [140,145}. These observations may explain the controversy among the trial 
results.
These devices have not been tested in the context of long term catheterisation,  but in 
vitro studies show that Pr. mirabilis will migrate across, and form biofilms on, 
commercially available silver catheters [21,146}. Again, the possibility arises that 
intervention will eradicate easy to treat organisms which rarely cause symptoms, to 
replace them with antibiotic resistant, encrustation promoting species.
Conclusion
None of the techniques discussed offers the realistic chance of preventing urinary 
tract colonisation in those with long term indwelling urinary catheters. It seems that 
the best that can be achieved is the delay of colonisation for, at most, a few weeks. 
Most of this benefit can be obtained by using the simple and well established 
principle of closed drainage. Additional techniques run the risk of promoting an 
increase in prevalence of difficult to manage pathogens while providing only a small 
additional benefit to the individual catheter user.  In conclusion, while the methods 
described above may have some use in the short term hospital setting, perhaps for 
high risk individuals, it would seem that the chronic use of antibacterial agents in long 
term catheterisation is both ineffective and prone to select for problematic, 
antimicrobial resistant bacterial species. Further trials are needed to establish the 
risk/benefit ratio before these become accepted practice.
1.4.5  Crystal Formation
Encrustation describes the deposition of crystals onto the surfaces of a biomaterial 
when in contact with urine.  It is a common occurrence on urinary catheters, both
61urethral and suprapubic, and on ureteric stents. An electron microscopy study of 
encrusted urinary catheters by Cox et al revealed that the deposits are made up from 
large crystals of struvite and aggregates of small apatite crystals, embedded in thick 
layers of bacteria and matrix [147]. Encrustation was therefore shown 
morphologically to be a crystalline biofilm.
Apatite and Struvite
Various apatite minerals exist, being composed of an anhydrous lattice of calcium 
and phosphate with either a hydroxyl or halide group attached:
Ca5(P04)3(0H,F,CI)
One of the strongest, found in teeth and bones, is hydroxyapatite:
Ca5(P04)3(OH)
The associated hydroxyl or halide groups alter the strength of the mineral, with 
fluoride providing more strength than the hydroxyl groups found in the urinary tract 
forms.
The weaker mineral carbonate apatite is more commonly found in catheter 
encrustations, attached to hydroxyl groups:
Ca5(P04,C03)3(0H)
The replacement of a varying proportion of the phosphate groups with carbonate 
groups results in a more poorly defined crystalline structure.
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MgNH4P04.6(H20 )
Both struvite and carbonate apatite are found in the large ‘staghom’ calculi found in 
the kidneys of those with chronic urinary tract infection. These stones are simply 
large crystalline biofilms, and form in much the same way as catheter encrustation, 
although without the presence of a foreign biomaterial, the initial crystals probably 
form on biofilm debris from the infected renal papillae. Apatite stones can also form in 
the absence of infection.
Effects of Urease
Calcium and magnesium salts are normally found dissolved in urine.  In most 
individuals, crystal precipitation does not occur, even on the surface of a foreign body 
in the urinary tract such as a ureteric stent. Calcium and magnesium salts are held in 
solution in urine even when quite concentrated. The factor mainly responsible for the 
encrustation of urinary devices and the formation of staghom calculi is the presence 
in the biofilm of organisms, such as Pr. mirabilis, which posses the enzyme urease. 
This acts on the abundant urea present in urine.
Urease catalyses the hydrolysis of urea to ammonia and carbamic acid:
(i)  H2NCONH2 + h2o  — NH3 + H2NCOOH
Carbamic acid spontaneously decomposes to ammonia and carbonic acid:
(ii)  H2NCOOH + HzO -> NH3 + HzCOj j
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these reactions exist in equilibrium with the ions hydrogencarbonate and ammonium:
(iii)  H2C 03 + H20   H30 + + HCCV
(iv)  NH3 + H20  <- OH' + N H /
The net result of this ammonium production is an increase in the ratio of OH' to H30 + 
ions: the urine becomes more alkaline. Normal urine has a pH of about 6 to 6.5, but 
in the presence of an infection with a urease positive organism, this can increase to 8 
or 9. The reason that this is important is that the substrates which form struvite and 
carbonate apatite are more readily available at high pH.
Effects of an Alkaline Environment
Le Chatelier’s principle states that when an external change is made to a system, the 
system will respond so as to oppose the change.  In other words, if more substrates 
for carbonate apatite are made available, more carbonate apatite will form to remove 
those substrates and attempt to rebalance the system. The reason that more 
substrates are available at high pH is also explained by Le Chatelier’s principle. 
Consider the complete dissociation of carbonic acid to hydrogencarbonate and then 
to carbonate, expanded from equation (iii):
(v)  H2C 03 + 2H20  <-* HC03' + H20  + H30 +  C 032' + 2H30 +
In an alkaline environment, the many available OH' ions will react with any H30 + ions 
produced and effectively remove them from the system:
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The equilibrium system will respond so as to oppose this: in other words try and 
replace the lost H30 + ions by further dissociation of carbonic acid. The more H30 + 
ions removed from the right side of equation (v), the further to the right that 
equilibrium will shift. In other words, a greater quantity of the molecules in the system 
will be in the dissociated state described by the right side of the equation. At the very 
high alkalinity produced by the abundant ammonia, significant dissociation of 
hydrogencarbonate to carbonate occurs.
Phosphates are found readily in the urine as part of the urinary buffer system. The 
buffer step of the reaction is the dissociation of dihydrogenphosphate to 
hydrogenphosphate, but the high alkalinity removes enough H30 + ions to drive the 
production of phosphate ions:
(vii)  H2P04' + 2H20   HP042' + H20  + H30 + <- P O f + 2H30 +
As ammonium is produced directly from the urease reaction,  it can be seen how 
several of the substrates for the production of struvite (NH4+, PO^) and carbonate 
apatite (C032', PO^, OH ) are formed more abundantly in an ammonia-rich alkaline 
environment. This encourages their precipitation out of solution to form the crystals of 
encrustation in the presence of urease.
Nudeation pH
Choong et a! studied the differences in urine chemistry between catheter blockers 
and non-blockers [148]. They experimentally determined the pH above which crystals
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density method validated by ion selective electrodes. They then compared this to the 
pH of the urine voided by the patient (pHv), and the presence or absence of urease 
positive organisms in the urine.
They found that they could divide patients into three groups. In the two largest 
groups, non-blockers and urease-positive blockers, the nucleation pH was similar, 
around 7.4, but the blockers had urease positive organisms in their urine raising the 
voided pH to almost this level, while the non-blockers had no urease activity and their 
voided pH was around 6.5, well below pHn. They also found a small group of urease- 
negative blockers. In this group the pHn  was abnormally low, allowing precipitation at 
normal voided urinary pH. They concluded that other urinary factors must be 
responsible for this lowering.
Although providing useful data, this study raises several questions. As in other 
published studies of encrustation [24,45,46,149-151], the authors initially divided 
patients into two groups on the basis of the time the catheters took to block. Quoting 
from the methodology:
The patients were subdivided into two groups; ‘blockers’ were those whose 
catheters regularly became blocked by encrustation within a 6-week period, 
requiring replacement; and ‘nonblockers’ were those whose catheters could 
be changed at intervals of longer than 6 weeks.
As stated earlier, there appears clinically to be a continuous spectrum of severity of 
catheter encrustation, including those who block catheters in greater than 6 weeks 
and those who do not block their catheters, but have encrustation present at the
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allowed by the manufacturer they would eventually block. While it is true that those 
who block catheters in less than 6 weeks suffer the most inconvenience from their 
catheters, in order to determine the medical cause of the problem it is more important 
to differentiate encrusters from non-encrusters,  rather than blockers from non­
blockers. If the aim is to differentiate those who encrust quickly, and therefore have 
the most severe clinical problem, from those who encrust slowly, and who rarely, if 
ever, block their catheters, then those without strongly urease positive bacteria in 
their urinary tract need to be excluded as their urinary chemistry will not lead them to 
encrust in the absence of these organisms. Although urease activity was looked at in 
this study, it was done as a post hoc analysis of the ‘blocker* group, and not used as 
part of the initial categorisation. There was no mention of the urease status of the 
‘non-blockers’. Bacterial species are also not mentioned, and many urease positive 
organisms do not produce enough urea to alter urinary pH. Once the dichotomous 
variable of the presence or absence of urease has been accounted for, since 
encrustation severity is a continuous variable, data analysis would be better carried 
out using regression techniques rather than arbitrarily dividing the patients into two 
groups and comparing them using a Mann-Whitney or Student t-test.
The results were also based on single samples of urine.  It is possible that urinary 
parameters, including pHv and pHn, vary. This may have a significant effect on the 
propensity of the urine to precipitate crystals, and may also suggest that if pHn  varies 
naturally, it may be manipulated therapeutically.
671.4.6  Strategies to Control Encrustation
As well as the techniques described in section 1.4.4 to prevent bacterial colonisation 
of the catheter, other work has focused on the prevention of encrustation even if a 
biofilm does eventually form.
Acidification
The chemical reactions which form the struvite and carbonate apatite crystals are in 
equilibrium.  In theory, acidifying the environment in which the reactions takes place 
should allow dissolution of the crystals. There are two main methods of achieving 
this: taking acidifying agents systemically which will be excreted and concentrated in 
the urine, or flushing the catheter directly with an acidic solution. These solutions 
used to flush the catheter are often referred to as bladder washouts, but are more 
correctly termed catheter maintenance solutions [152].
The addition of acid (H30 + ions), by any route, is countered chemically in two ways. 
Firstly the natural buffering ability of a solution, in this case urine, which contains 
ammonia and ammonium ions:
(iv)  NH3 + HzO < -►  OH' + NH4+
The addition of acid effectively removes OH' ions from the right side of this equation 
(see equation (vi)). By Le Chatelier’s principle, this causes the reaction to shift to the 
right, counteracting the loss of OH' ions, and removing ammonia from the solution. 
The equilibrium constant of this reaction is such that it has a very effective buffering 
capacity at the alkaline pH present in infected urine, so markedly reducing the pH 
change caused by added acid.
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urea (the intermediate carbamic acid step from equations (i) and (ii) has not been 
shown for simplicity):
(x)  H2NCONH2 + 2 H2O — 2NH3 + H2C 03
Again, by Le Chatelier’s principle, the reaction shifts to the right to replace the 
reaction products removed from the right side of the equation. As the amount of urea 
present in urine is large, ammonia can be replaced very easily.
Over and above this, the activity of the urease enzyme itself is greater in more neutral 
environments, as it works quite inefficiently at higher pH [153,154].
The combination of the highly efficient ammonia/ammonium buffer, ready supply of 
replacement ammonia, and additional capacity of the urease enzyme is extremely 
effective at maintaining the alkaline environment. An in vitro study by Bibby and 
Hukins using purified urease in artificial urine demonstrated the effectiveness of this 
buffering capacity [155]. They calculated that to prevent a pH rise from the 
conversion of the urea in a day’s urine would require 2.7 litres of 0.1  M monobasic 
acid. This would be impossible to supply orally, due to its toxicity. Clinical studies 
have shown that while it is possible to acidify normal urine by ingesting ascorbic acid, 
this strategy is ineffective if the urine is infected with a urease producing bacteria 
[156].
The second role of acid in catheter encrustation is the use of citric acid ‘catheter 
maintenance solutions’, available in concentrations of 3.23% or 6%, the lower 
concentration being used most often. 50 to 100 mL of solution is flushed into the
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then be clamped for 10 to 15 minutes, and the solution then drained. This strategy 
has been shown to decrease encrustation in some artificial bladder models using 
artificial urine [157,158]. A clinical crossover study, however, has shown no 
significant benefit of these solutions in vivo [159].
The microbiology of the crystalline biofilm provides an explanation. As mentioned 
before, crystals form within the biofilm and are encased in bacterial cells and 
extracellular polysaccharide matrix which could protect them from environmental 
change. McLean et al conducted a study using a Pr. mirabilis crystalline biofilm 
created in vitro in a flow cell, a device in which urine can be circulated over the biofilm 
while it is continuously viewed through a microscope. They showed that struvite 
crystals which formed outside of the biofilm were dissolved by a high flow rate of 
acidic urine, while those in the biofilm were resistant [160].
Moreover, concern has been raised as to the effects of repeated exposure of the 
bladder to these acidic solutions. Irrigation of the bladder in general has been shown 
to increase the shedding of urothelial cells, an indicator of bladder mucosal damage, 
even when only using 30 to 60 mL of physiological saline [161]. The 
glycosaminoglycan on urothelial cells which aids in preventing bacterial adhesion is 
known to be removed by acid [162], and in a rabbit model acidic solutions resulted in 
significant urothelial injury [163].
Encrustation Resistant Catheter Materials
In addition to studies on catheters which resist bacterial colonisation, work has been 
done looking directly at the rates of encrustation on different materials. This has been
70done looking at crystalline biofilm formation, and the sterile encrustation formed in the 
absence of infection more commonly found on ureteric stents.
An observational study in 18 catheter users over a period ranging from 8 to 47 weeks 
by Broklehurst and Brocklehurst revealed no difference in unscheduled catheter 
changes between silicone coated and latex catheters, but encrustation was not 
specifically studied [164]. Various antiseptic drug treatments were also being tested 
during the trial period, although these seemed to have little effect on bacterial 
populations and all participants received the same protocol.  In a study on ten catheter 
users, Hukins et al seemed to suggest that 100% silicone catheters were more 
resistant to encrustation by struvite than those made from other materials [165]. 
Electron microscopy of one used catheter from each subject showed that there were 
more crystal deposits on the silicone elastomer and PTFE coated latex catheters than 
on the two 1130% silicone catheters examined, even though the silicone devices had 
been in situ for the longest time.  It should be noted that each patient may have had a 
different propensity to encrust, and while deposits of struvite were found on ail 
catheters the paper does not confirm that all of the patients had a clinical problem 
with catheter blockage. A crossover study by Kunin et al showed less catheter 
blockage using 100% silicone catheters than silicone elastomer coated latex,  PTFE 
coated latex, and simple latex catheters, but they suggested a role for the larger urine 
drainage channel cross section in the silicone catheter rather than the properties of 
the material [151]. Each type of catheter was used for 14 days in each subject before 
being removed, tested for patency, and inspected for encrustation. The silicone 
catheters were reported as being grossly encrusted as often as any other material, 
but were less frequently completely or almost blocked. Hydrogel coated latex 
catheters, which are very popular in modem practice, were not used in these studies.
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showed no significant difference in the encrustation rates of hydrogel coated latex, 
silicone elastomer coated latex, and 100% silicone catheters in terms of mass of 
mineral deposition per unit surface area [166,167]. In a static, sterile system there 
appears to be no effective difference between the commonly used catheter materials 
in their propensity to encrust, but this may not reflect the bacterially colonised clinical 
situation.
Morris and Stickler used an in vitro bladder model infected with clinically sourced Pr. 
mirabilis, using both artificial and pooled human urine to study the resistance of 
catheters to crystalline biofilm formation [21,168]. The use of Proteus produces both 
the alkaline urine to encourage crystallisation, and the extracellular polysaccharide 
matrix on which it can develop.  Identical gauge (14Ch) 100% silicone, silicone 
elastomer coated latex, hydrogel coated latex and silver hydrogel coated latex 
catheters all encrusted rapidly.  In terms of the time taken for the encrusting catheters 
to block, the 100% silicone catheters lasted the longest, but these authors also 
hypothesised that this could be adequately explained by the larger drainage channel 
cross section, rather than the encrustation resisting properties of the material. The 
14F latex based catheters tested had a drainage lumen diameter of approximately 
1.5 mm compared to 2.5 mm for the 14F 100% silicone catheters.
The lack of difference between the rate of encrustation of the different available 
catheter materials in sterile test environments, and the observation that all materials 
subjectively encrust rapidly in infected in vitro and clinical settings, suggests that this 
hypothesis may have some validity. However, while it makes sense that a wider 
lumen would take longer to block, the degree to which catheter size affects catheter 
lifespan has not been formally assessed. Catheter size has not been found to be 
related to catheter lifespan [24,46,149], but it was not investigated as the primary
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were classified as non-blockers. They were presumably not colonised by urease 
producing bacteria and so would never encrust any catheter irrespective of its size, 
and their inclusion would confound the results. Given the known variability in the 
severity of encrustation, and that those with severe encrustation may have been 
changed to larger sized catheters to compensate for this problem, the confounding 
factors are likely to render observational data useless. A rigorously controlled 
experimental study is needed, but has not been performed.  If the association 
between catheter lumen diameter and catheter lifespan were pronounced it would 
indicate that proven catheter blockers would be best served with larger lumen 
catheters, both by switching to 100% silicone, and by simply using larger gauge 
catheters.  Larger gauge catheters are associated with greater discomfort and bladder 
spasm when used urethrally, and so need to be fitted suprapubically, a procedure 
which itself carries a small risk of serious complications [169].
A study by Tenke et al examined the use of heparin as a coating on urological 
devices [170]. They found that although heparin coated 100% silicone catheters 
blocked as quickly as standard 100% silicone catheters when tested in a Pr. mirabilis 
infected bladder model with pooled human urine, encrustation was only found on the 
uncoated catheters. The heparin catheters were obstructed by ‘plugs of clear gel-like 
material’.  In a clinical study, these researchers found that heparin coated ureteral 
stents did not obstruct over the course of a year, whereas silicone and hydrogel 
coated stents blocked in 7 weeks and 5 months, respectively.
Choong et al developed an in vitro model for urological devices using pooled human 
urine and validated it against an animal model [171]. They showed, in a sterile test at 
a slightly acidic pH, that hydrogel coated latex catheters performed better than PTFE 
coated latex catheters. Looking at ureteric stents, they showed that coating in
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silicone resisted encrustation more successfully than plain polyurethane, but the best 
material was polyurethane coated with hyaluronic acid, a naturally occurring 
hydrophilic polysaccharide which is a type of glycosaminoglycan.  It is debatable how 
accurately these results will transfer to an alkaline, infected situation, but it is certainly 
a technology worthy of further study.
Urease Inhibitors
Biofiims do not tend to result in encrustation or renal tract calculi without a rise in pH 
and ammonium concentration caused by the action of bacterial urease. If biofilm 
formation cannot be prevented, using inhibitors of urease should prevent their 
development into crystalline biofiims. Known inhibitors of urease include hydroxamic 
acids, phosphoroamides, and thiol compounds [153].
Acetohydroxamic acid (AHA) is a competitive urease inhibitor with a similar molecular 
structure to urea. It has been shown in a randomised double blind trial to retard 
growth of struvite renal calculi in those with chronic infection [172], although half of 
those treated required a reduction or cessation in therapy because of side effects. It 
can occasionally dissolve existing calculi.  In a small clinical crossover study of five 
catheter blockers, Bums and Gauthier showed a significant decrease in the amount 
of encrustation on the catheter surface and a lengthening of the time it took for 
catheters to block [173]. Unfortunately, the toxic side effects of AHA, such as 
headache, vomiting, diarrhoea, hallucinations and abdominal pain, and more 
seriously, deep vein thrombosis and haematological abnormalities, are quite common 
[172,174]. These are a significant risk for the predominantly efderly, immobile 
population of catheter users.  It has also been shown to be teratogenic in animal
74studies, and theoretically could be carcinogenic with long term or high dose use 
[175]. Its clinical use has not been widespread for these reasons.
A potentially less toxic and more potent urease inhibitor, fluorofamide, has been used 
to prevent calculus formation in a Pr. mirabilis infected rat model [176].
Both AHA and fluorofamide have been shown to prevent the rise in pH and crystalline 
deposition on catheter surfaces caused by Pr. mirabilis in an artificial bladder model 
[177]. Further assessment of these compounds is needed before they are used 
clinically.
Pre-emptive Catheter Changes
Norberg et al found that an individual can be allocated a fairly predictable ‘average 
expected catheter life’ based on their past three to five catheter blockages [178], and 
this allows the catheter to be changed routinely before it blocks. Although it is 
inconvenient and costly to change catheters frequently, it is cheaper and less 
bothersome to the patient than waiting for the blockage to occur and sending an 
emergency nurse. Larger lumen catheters are also used in an attempt to delay 
blockage. What causes the observed differences in catheter lifespan between 
individuals with identical catheters is uncertain.
Blocking pH
One of the techniques employed in the Bristol area to deal with catheter encrusters 
involves the use of a ‘blocking pH’. The theory is that when a new catheter is 
inserted, the patient will initially void acidic urine. The pH will then gradually increase 
as the catheter remains in place. There is supposed to be a critical value of the
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weekly basis using commercially available urine dipstick pH strips, and the catheter 
allowed to block. The last pH reading before blockage is recorded as the blocking pH. 
This is taken to be an individual value for each catheter blocker. Subsequent 
catheters are then changed as soon as the voided pH is equal to or greater than the 
previously determined blocking pH on the grounds that catheter blockage is 
imminent.  It is possible that this blocking pH is related to, or identical to, the 
nucleation pH.
This technique has apparently reduced the rate of catheter blockage in at least one of 
the areas in question (unpublished data), but the numbers who use this method have 
been small and the technique has not been formally trialled. This method has gained 
popularity in Bristol, and the author is aware that it has spread to other areas of the 
United Kingdom. It has been suggested as a management technique in the nursing 
literature [179]. However, there is no published clinical or laboratory evidence to 
support it, and it is not even certain that such a change in pH occurs with increasing 
catheter life.
761.5 Proteus mirabilis
In some ancient Greek writings, Proteus was described as the immortal Old Man of 
the Sea, a herder of sea beasts and servant of the sea god Poseidon.  He was sought 
after due to his powers as an oracle, but used his ability to change shape at will to 
attempt to evade those seeking his council. In Homer’s Odyssey he is eventually 
captured by Menelaus and forced to reveal the fates of several heroes of the Trojan 
War. The name Proteus was therefore given to a group of remarkable polymorphic 
Gram-negative bacteria identified in 1885 by the German bacteriologist and 
pathologist, Gustav Hauser.
1.5.1  Classification
The genus Proteus is classified in the phylum Proteobacteria, as part of the family 
Enterobacteriaceae whose members are often found as inhabitants of the 
gastrointestinal tract of warm blooded animals. Proteus spp are gram-negative, 
facultative anaerobic bacilli. They are not able to ferment lactose, and so are not 
grouped with many of the other Enterobacteriaceae as coliforms.
The currently recognised species of Proteus are Pr. mirabilis, Pr. vulgaris, Pr. 
penneri, Pr. myxofaciens and Pr. hauseri, with three genomospecies remaining 
unnamed. The classification has altered over time. Pr. penneri and Pr. hauseri were 
originally classified as biogroups 1  and 3 of Pr. vulgaris. Organisms once thought of 
as belonging to the Proteus genus have now been placed in other genera: Pr. 
morganii, Pr. rettgeri, and Pr. inconstans are now classified as Morganella morganii, 
Providencia rettgeri and Providencia spp, respectively. The similarity of the
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literature, where they are sometimes referred to as the tribe Proteeae.
1.5.2  Epidemiology
Proteus is found widely distributed in soil and water in the environment, where it is 
involved in the decomposition of animal matter. In humans, Proteus is found as part 
of the normal flora of the gut. Its main pathological role is in infections of the urinary 
tract, but it is also a cause of wound infection, pneumonia and gram-negative sepsis.
In normal human faeces, Pr. mirabilis is found in between 2.7% and 24% of subjects 
[180-183], although colony counts are low compared to more common species such 
as E. coli. However, Pr. mirabilis is responsible for the majority of clinical infections 
involving Proteus spp. A survey by Senior found  that 96.5% of urinary tract infections 
involving Proteus or M. morganii were due to Pr. mirabilis, compared with 1.5% due 
to Pr. vulgaris [184]. Pr. vulgaris is isolated from the human gastrointestinal flora 
relatively rarely, found in between less than 5% of cases [180-182]. This has been 
proposed as a major factor in the lower frequency of Pr. vulgaris urinary tract 
infection [185]. Pr. mirabilis is well known as a cause of nosocomial disease, but can 
sometimes be found as a community acquired infection in otherwise normal 
individuals. Pr. vulgaris and Pr. penneri tend to only be present in individuals with a 
particularly high risk for nosocomial infection, such as residents of long-term care 
facilities.
It is thought that Proteus bacteriuria is probably acquired from the Proteus species 
present commonly in the gastrointestinal tract, as the majority of urinary isolates of 
other infection causing bacteria are, but they could also be transmitted between
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medical profession [42,186].
1.5.3  Strain Discrimination
It is possible to distinguish between different strains of Pr. mirabilis by a variety of 
methods. This is useful for epidemiological studies, as identical strains are likely to 
share a common source [187]. These methods are usually divided into phenotypic 
techniques, which examine bacterial behaviour and expressed proteins, and 
genotypic methods, which examine the genetic material of the organism. Phenotypic 
methods can be criticised as bacterial strains could express identical proteins while 
having considerable differences in their genome.
A very simple phenotypic method is Dienes typing, as originally described by Louis 
Dienes [188]. It was found that if two strains of Proteus were inoculated to the same 
agar plate and incubated overnight, they would swarm across the plate as usual until 
the leading edges of the two swarms met.  If the two strains were distinct, they would 
inhibit each other. A clearly visible line of demarcation would form between the two 
swarming strains.  If the strains were identical, or at least very similar, their swarming 
edges would merge, and no demarcation line would be seen.
A more discriminatory but considerably more complicated method is Pulsed Field Gel 
Electrophoresis, or PFGE. This is a genotypic method which uses enzymes known as 
restriction endonucleases. These enzymes cut DNA at points along its length which 
contain a certain nucleotide sequence, different for each type of enzyme. This 
produces a series of DNA fragments of differing lengths depending on where and 
how often the target nucleotide sequence appears in the original DNA. These 
fragments can then be sorted according to size by gel electrophoresis.  By passing an
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embedded, the negatively charged fragments will move through the gel. In 
conventional electrophoresis, larger fragments will find it more difficult to pass 
through the pores in the gel, and so will not move as far in a given time. This 
produces a characteristic pattern in the gel when the DNA is stained, with fragments 
being seen further from the start point in inverse proportion to their size. DNA from 
different bacterial strains will have a dissimilar arrangement of the target nucleotide 
sequences, so the fragments produced by restriction enzyme digestion will be of 
different sizes and give a different pattern in the gel. Comparing these patterns 
enables different strains to be distinguished.
However, conventional gel electrophoresis only works up to a certain size of DNA 
fragment. Above this limit the fragments rotate to line up with the electric field and 
travel through the gel lengthwise, so differences in length no longer make a 
difference to speed of travel, and these fragments cannot be separated. 
Unfortunately, cutting a very large piece of DNA such as a bacterial genome into 
small enough fragments to separate by conventional electrophoresis would produce 
so many fragments of very similar size that they would form a continuous blurred 
band on the gel, rather than a distinct, readable pattern.
PFGE allows much larger DNA fragments to be used in the gel. The direction of the 
electric field is regularly changed, or pulsed. This forces the DNA fragments to rotate 
to line up with the field before they can start to move again. This takes more time the 
longer the fragment, and even very large fragments will separate on the gel. This 
means that a whole bacterial genome can be cut into a few very large fragments and 
so produce an easily readable gel pattern.
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studies of Pr. mirabilis. The ability of a typing technique to differentiate unrelated 
strains is measured as a discrimination index (Dl), which is the probability that two 
dissimilar strains will be placed in different groups by the technique [189]. A Dl > 0.90 
is considered desirable. The Dl of these two typing methods in studies of Pr. mirabilis 
was examined by Pfaller et al [190]. They calculated a Dl of 0.980 for Dienes typing 
and a Dl of 0.992 for PFGE. Sabbuba et al calculated similar Dl values (0.988 for 
Dienes typing and 0.993 for PFGE) while using these techniques to demonstrate that 
the Proteus strains in the urine and catheter biofilm of catheter encrusters were 
identical [191], and that in those with bladder stones, that the stone and catheter 
biofilm strains were also identical [49].
1.5.4  The Urease Enzyme
Several virulence factors have been characterised for Pr. mirabilis, although the most 
important from the perspective of catheter encrustation is that it is a urease positive 
organism. It possesses the enzyme urease, which catalyses the hydrolysis of urea to 
produce ammonia and carbamic acid. The urease test is one of the procedures used 
to identify bacteria. They are incubated in a medium containing urea and a pH 
indicator. If the pH increases, the bacteria are classified as urease positive. Although 
a great many organisms are classified as urease positive on the basis of this test, Pr. 
mirabilis has by far the greatest ability to produce ammonia of any human urinary 
tract pathogen. A study of urinary isolates from catheterised residents of a long term 
care facility found that although the urease enzyme of the Pr. mirabilis isolates had a 
relatively low affinity for its substrate, it could hydrolyze urea at a rate 6  to 25 times 
that demonstrated by the urease enzymes of other species [192]. The lower affinity of 
the Pr. mirabilis urease enzyme for substrate (Km of urease = 13 mM) is unimportant 
in practice, as given the extremely high concentrations of urea in urine (up to 500
81mM) the active site of the enzyme will still be almost constantly occupied [193]. The 
urease of Pr. mirabilis is a 250 KDa nickel metalloenzyme, located in the organism’s 
cytoplasm [153]. It is the production of ammonia from the abundant supply of urea in 
urine that is responsible for the dramatic rise in urinary pH found in individuals with a 
Pr. mirabilis urinary tract infection. Urease production is especially high when Proteus 
is in its swarmer state [194], as detailed in section 1.5.5.
As described previously, high urinary pH leads to precipitation of phosphate 
containing crystals in the form of renal and bladder calculi and encrustations on 
implanted devices.  It could be theorised that these crystalline deposits act to protect 
the bacterial community in a way which may be superior to the level of defence 
offered by a non-crystalline biofilm.  It should be noted, however, that in the absence 
of foreign material in the urinary tract, even a chronic Proteus infection does not lead 
to calculus formation in the majority of cases. This would seem to suggest that crystal 
precipitation is not the primary purpose of urease.
Ammonia is present in normal uninfected urine as an important part of the urinary 
buffer system. It is produced from glutamine in the proximal convoluted tubule of the 
kidney in amounts proportional to the acid load in the body. The conversion of this 
ammonia to ammonium ions in the collecting ducts traps hydrogen ions in the urine 
and allows for controlled acid excretion from the body.  However, extreme alkalinity 
caused by high levels of ammonia is toxic to all cells.  Even Proteus itself will not grow 
once it has raised the pH above a value of around 9 [195].
Experiments in rat and mice models of pyelonephritis have shown the importance of 
urease production in Pr. mirabilis infections ascending from the bladder to the kidney. 
If urease activity is absent, either because of chemical inhibition by acetohydroxamic 
acid (AHA) [196] or the use of a urease negative Proteus mutant [197], bacterial
82counts in the renal parenchyma are reduced, although bacterial counts in the urine 
may not be. The presence of urease activity also leads to greater renal damage on 
histology [196]. Even in a model of the haematogenous route of infection, where 
urease negative mutants caused pyelonephritis as often as urease positive strains, 
renal necrosis was only seen when there was urease activity [198,199].
Very high alkalinity, which could be produced locally by urease producing organisms, 
is thought to decrease the activity of complement [2 0 0 ], one of the immune system’s 
key antibacterial measures, and this may confer a survival advantage on Proteus.
1.5.5  Morphology and Physiology
Proteus can exist in two distinct morphological and physiological forms, known as 
swimmer cells and swarmer cells. Although this ability is not unique to the genus, 
Proteus seems able to swarm much more readily, and in a greater range of 
environmental conditions, than other bacteria.
In liquid suspension Pr. mirabilis exists in the planktonic swimmer state. It is a 1 to 2 
pm rod with multiple flagella covering its surface for motility, and a coating of fimbriae 
for adhesion to surfaces. As a swimmer cell, it is morphologically similar to many 
other members of the Enterobacteriaceae family.
On contact with a solid surface, Proteus has the ability to convert to the swarmer 
state. Instead of normal growth by septation and division, the bacterial cells elongate 
dramatically to form multinucleated,  highly flagellated filaments 2 0 to 80 pm in length 
[201]. These cells line up in parallel to form rafts that are able to move rapidly over 
surfaces en masse. Physiologically, there is a significant increase in protein synthesis 
[194], A new type of flagellin protein is expressed, and potential virulence enhancing
83factors such as ZapA metalloproteinase, haemolysin and urease are produced in 
amounts 30 to 80 times higher than in the swimmer state. Large quantities of 
glycocalyx are produced to form a loosely attached extracellular polysaccharide slime 
layer, rather than a thin capsule. This is thought to both enhance adhesion and 
provide a low friction surface for swarming [2 0 2 ].
On solid surfaces in vitro, Pr. mirabilis exhibits short, coordinated bursts of swarming 
activity interspersed with a reversion to a surface bound vegetative swimmer state. 
This produces characteristic concentric rings on an agar plate, representing periods 
of swarming to colonise a section of surface, interspersed with consolidation in the 
vegetative state in which intensive cell multiplication occurs, before another period of 
expansion by the leading edge of organisms differentiating to form further swarmer 
cells [203]. Those cells other than those in the leading edge of an expansion are in 
the vegetative state. The rings represent the differing densities of these vegetative 
organisms in those areas which were swarmed across, and those areas where cell 
multiplication occurred.
This ability to form swarmer cells seems to allow rapid colonisation of solid surfaces 
and the establishment of extensive Proteus biofiims. Using a simple laboratory 
model, Stickler and Hughes demonstrated that Pr. mirabilis could swarm rapidly over 
the surfaces of all the major types of catheter [204]. They suggested that swarming 
may play a role in both the initiation of catheter associated infection and the 
subsequent spread of the biofilm over the catheter surface.  Recently Jones et al 
reported that a non-swarming mutant of Pr. mirabilis had lost the ability to migrate 
over 100% silicone catheters [205].
841.6 Aims of the Study
Several studies have examined the differences between catheter blockers and non- 
blockers. The main difference, however, has clearly been the presence of urease 
producing organisms, usually Proteus, in the urinary tract of the catheter blockers. 
While it is known from clinical observations that the frequency of catheter blockage by 
encrustation is extremely variable, both within and between individuals, the factors 
that modulate the rate of encrustation are not understood, and there is little data in 
the literature on the variability of the times catheters take to block in patients 
colonised with Proteus.
The aims of this study were:
1.  To conduct a prospective study on a group of catheterised subjects who have 
Proteus urinary tract colonisation and record the frequency of catheter 
blockage by encrustation.
2.  To examine the relationship between the nucleation pH of a subject’s urine 
and the rate of encrustation.
3.  To investigate the factors influencing the nucleation pH of urine in these 
individuals.
4.  To test the hypothesis that the rate of catheter encrustation is dependent on 
the urease activity of the colonising strain of Proteus.
5.  To report on the antibiotic sensitivities of the Proteus isolated from the 
catheterised subjects.
6 .  To determine whether the source of the Proteus mirabilis strains that colonise 
the catheterised urinary tract is the subject’s own faecal flora.
7.  To observe the stability of Proteus as a component of the bacterial flora of the 
catheterised urinary tract and its relationship to other species.
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A group of long term urinary catheter users who were found to have Proteus urinary 
tract colonisation were investigated in a simple prospective observational study.
These patients were followed for a period of several months during which their 
catheters were analysed to determine the rate of deposition of encrustation on them. 
Weekly microbiological testing of urine samples was used to measure the variation in 
urinary flora.  Patients were also tested for carriage of Pr. mirabilis in their 
gastrointestinal tract.
The urease production of different Proteus strains isolated from different patients was 
examined, as were rates of co-infection with other bacterial species.
The voided pH (pHv) and nucleation pH (pHn) of each patient’s urine was measured 
weekly to establish the variability of these values over time. The possible relation of 
pHn  to other factors was also assessed with weekly measurements of total urinary 
calcium and magnesium.
Ethical approval was granted by the Southmead Hospital Local Research Ethics 
Committee before the study commenced (ref:  project 070/02).
872.2  Sample Collection
2.2.1 Recruitment
Patients with long term urinary catheters, either suprapubic or urethral, were 
approached through the catheter clinic at the Bristol Urological Institute’s BioMed 
Centre, through local nursing homes, or through district nurses in the Bristol area. 
Both those with catheter problems and those without were approached. A single urine 
sample was taken as a screening test and cultured using our standard culture 
techniques (section 2.4) for the presence of Proteus spp.  If this was shown to be 
positive the patient was approached for full enrolment into the study. Consent was 
obtained from the patient or relatives according to the local ethical committee 
guidelines. The first individuals to consent made up the cohort in the study, but as a 
significant proportion declined to take part those included cannot be considered a 
formally random sample of Proteus colonised catheter users.
2.2.2 Sample Collection 
Urine Collection
Urine samples were obtained on a weekly basis throughout the trial period by a visit 
to the participant’s residence. The participant was usually visited at the same time on 
the same day each week. The participant’s catheter was clamped for 10 minutes prior 
to collecting the sample and the first 2 ml of urine was discarded, in order to ensure 
that bladder urine was collected rather than urine which had been pooling in the 
catheter tubing. Samples were collected in sterile plastic containers without 
preservative. A pH reading was taken immediately and the sample then sealed and 
refrigerated over ice for transport. Testing of pH was performed using a hand held
88glass electrode pH meter.  Urine samples were transported to the laboratory and 
plated onto culture medium on the day of collection.
Catheter Coilection
Catheters were collected whenever they were changed routinely or as the result of an 
emergency blockage. The catheter was kept refrigerated in a sealed, sterile container 
from removal until laboratory analysis. The date of catheter insertion and removal, 
along with the type and size of the catheter, was recorded.
Faecal Samples
A single faecal sample was collected by rectal swab from those participants who 
consented to this part of the study and cultured using standard techniques. This was 
compared with a urine sample collected at the same time. Four of the original study 
participants did not consent for faecal sample collection, so an additional four patients 
were recruited solely for this part of the trial in the same manner as for the full study.
892.3  Chemical Analysis
2.3.1 Voided pH
The pH of each subject’s urine was measured immediately on collection of the 
sample using a Checker 1  portable glass electrode pH meter (Hanna instruments, 
Leighton Buzzard, UK), which measures to a resolution of 0.01  pH units. Calibration 
of all pH meters used in the study was done using the same pH 4 and pH 7 standards 
(Fisher Scientific, Loughborough, UK).
2.3.2 Nucleation pH
Evaluation of nucleation pH was based on the method of Choong et al [148] as 
described by Suller et al [206]. Experiments were performed in a water jacketed 
chamber at 37°C. An electronic meter was used to measure pH (FisherBrand Hydrus 
300). Urinary pH was first reduced to 4.0 by adding aliquots of concentrated 
hydrochloric acid to the sample. The sample was then alkalinized in increments of 
0.25 pH units with 10 M sodium hydroxide solution up to a pH of 10, or until sufficient 
data points had been recorded above the supposed nucleation pH to allow a straight 
line to be plotted. This process took approximately 45 minutes for each sample. At 
each increment the optical density was measured at 550 nm using a distilled water 
blank on a Cecil Model CE 1011  spectrophotometer.  1  ml of sample was removed 
and centrifuged at 3500 rpm for 3 minutes to remove precipitates. The supernatant 
was diluted in 5% nitric and concentrations of calcium and magnesium remaining in 
solution measured using atomic absorption spectroscopy as described below. The 
nucleation pH was determined from the resulting plot of pH versus optical density, or 
pH versus [Ca] and [Mg].
90The nucleation pH (pHn ) was defined by an abrupt change in the slope of the graph 
showing either an increase in turbidity or a decrease in dissolved [Ca] or [Mg] caused 
by precipitation of crystalline Ca and Mg containing salts. As described by Choong et 
al, plotting pH versus [Ca], [Mg] or optical density produces two straight line 
segments which intersect at the pHn. Regression lines were calculated by least 
squares analysis for these two portions of the graph and used to determine the pH at 
their intersection. An example is shown in Appendix 1. This method was found to 
have good repeatability with small variances. For example, a typical triplicate pHn  
determination gave values of 6.74, 6.80 and 6.74 with a mean of 6.76 and standard 
deviation of 0.03.
The pHn  calculated using both the metal concentration and optical density methods 
was found to be equivalent on analysis of the initial urine samples, and in samples 
from healthy volunteers, as in the Choong et al study. The optical density method 
was therefore adopted as standard for the remainder of the study due to its simplicity, 
and the ability to use smaller urine samples.
2.3.3  Urinary Calcium and Magnesium Concentration
Urine was acidified to a pH of 4.0 using concentrated hydrochloric acid. The sample 
was centrifuged at 3500 rpm for 3 minutes to remove precipitates. The supernatant 
was diluted in 5% nitric acid to 1  in 10,  1  in 50,  1  in 100,  1  in 200, and 1  in 400, and 
concentrations of calcium and magnesium remaining in solution measured using 
atomic absorption spectroscopy on a PerkinElmer Instruments AAnalyst 200 
spectrometer. Air/acetylene gas was used for magnesium at a wavelength of 285.2 
nm, and N02/acetylene for calcium at 422.7 nm. Calibration curves for calcium and 
magnesium were constructed using commercial Spectrosol standards (BDH 
Chemical Ltd, Poole, UK) diluted in 5% nitric acid, made using analar grade nitric acidand ultra high purity water, to concentrations of 0.5 - 5.0 pg/ml for calcium and 0.2 - 
2 .0 pg/ml for magnesium.
2.3.4  Encrustation Analysis
Sample catheters were cleaned of material from their external surface by wiping 
carefully with a dampened swab, and divided into 2 cm sequential sections starting 
just distal to the catheter eyeholes. The sections were placed in a solution of 100 ml 
5% nitric acid for two hours at 37°C and sonicated for 5 minutes. The resulting 
solution was filtered using 0.2 pm disposable filters (Sartorius, Goettingen, Germany), 
and then further diluted in 5% nitric acid and analysed using atomic absorption 
spectroscopy as above to obtain total magnesium and calcium concentrations.  From 
this the total mass of calcium and magnesium on the catheter was calculated.
922.4  Microbiological Analysis
2.4.1  Urinary Culture
Standard calibrated loopfulls of urine were streaked onto Cysteine Lactose 
Electrolyte Deficient (CLED) agar, Tryptone Soya Agar (TSA), and chromogenic UTI 
agar (all Oxoid Ltd, Basingstoke, UK). Plates were incubated for 24 hours at 37°C.  In 
the majority of cases multiple colony types were identified. Colony types were 
differentiated by the varying morphologies of the colony forming units and the 
reactions of the indicator substances in the agar media giving different groups of 
species a distinct colour. Each colony type was subcultured onto CLED agar, and 
after a further 24 hours incubation at 37°C these pure colonies were Gram stained. 
Further identification of the colony to species level is traditionally achieved by 
performing a variety of biochemical tests for reactions known to differentiate between 
species. For example, inoculating the colony to a mixture of urea and a buffered pH 
indicator medium will differentiate urease positive from urease negative species. 
Once the possible identities of a colony type have been limited by its source, 
morphology, reactions with the agar culture media, and Gram stain, the order to 
perform these tests most efficiently is obtained from flowcharts available in 
bacteriology laboratory manuals. However, in common with many modem 
laboratories, the colonies in this study were tested in commercially available pre­
prepared test kits in which the sample is inoculated to an array of small wells in a 
plastic tray. Each well contains a different biochemical test which can then ail be 
performed simultaneously. From the pattern of positive tests, the species can be 
identified. The Gram-Positive and Enteric BBL Crystal Identification Kits were used 
(Becton Dickinson Europe, Meylan, France).
932.4.2 Catheter Bioftlm Culture
The tips of the catheters were removed to a level just including the eyeholes. These 
were immersed in 5 ml sterile deionised water in universal containers, sonicated for 5 
minutes in a Transsonic T310 cleaning bath (CamLab Ltd Cambridge, UK) and vortex 
mixed for 30 seconds to shake off the biofilm organisms. Removal of the biofilm was 
confirmed visually.  The resulting suspension was cultured and identified as detailed 
in section 2.4.1.
2.4.3 Faecal Sample Culture
Faecal samples were swabbed onto agar plates, and cultured and identified as 
detailed in section 2.4.1. Any Proteus spp present was isolated and stored for 
comparison with the Proteus isolates from urine samples collected at the same time. 
Typing methods are detailed in section 2.4.7.
2.4.4 Storage of Bacterial Specimens
Isolated strains of bacteria were stored at -80°C on Microbank beads (Pro-Lab 
diagnostics, Neston, UK).
2.4.5 Antibiotic Sensitivities
The minimum inhibitory concentrations (MIC) of a panel of antibiotics were tested 
against the main encrusting organisms in the participant’s urine culture.  E-test strips 
(AB Biodisk, Solna, Sweden) were used to determine MICs.
94The E-test is a non-porous plastic strip calibrated with MIC values covering 15 two­
fold dilutions. The strip contains an antibiotic with a defined concentration gradient 
along its length. When placed in agar, the antibiotic concentration to which the 
cultured organisms are exposed varies along the strip, and the concentration below 
which growth is not inhibited can be read from the calibrated scale on the reverse of 
the E-test strip [207].
Individual bacterial colonies from a pure overnight culture on CLED agar (Oxoid) 
were suspended in 0.85% saline to achieve a turbidity of 0.5 McFarland standard. A 
sterile swab was used to coat Iso-Sensitest Agar (Oxoid) plates with the inoculum. 
Once dry, Etest strips were applied to the inoculated plates. The plates were cultured, 
inverted, at 37°C for 24 hours. The MIC was read from the E-test strip following the 
guidelines in the product literature. In particular, areas of Proteus swarming on the 
plate were ignored.
Antibiotics tested were ciprofloxacin, trimethoprim, gentamicin, amoxicillin, co- 
amoxiclav, cefalothin and nalidixic acid.  Breakpoint values for interpreting the MIC to 
determine whether the organism was resistant or sensitive to an antibiotic were 
obtained from the British Society for Antimicrobial Chemotherapy guidelines for 
Urinary Tract Infections with Gram-negative rods [208].
2.4.6  Urease Assay
The ‘urease activity’ of the Proteus mirabilis isolates was assayed using the modified 
Berthelot colorimetric reaction method of Creno et al [209]. Urease activity is defined 
as the rate of hydrolysis of urea per unit mass of protein, and is usually expressed in 
units of fjmol urea hydrolysed /  minute /  mg protein. The procedure for measurement 
involves producing a protein extract from the cultured bacterial cells. The protein
95concentration of this extract is determined. A known volume, and hence known mass, 
of protein is incubated in a urea solution for a set time, and the amount of ammonia 
produced is calculated with reference to a set of ammonium chloride standards. The 
rate of hydrolysis of urea can be determined by the stoichiometry of the reaction:
(x)  H2NCONH2 + 2H20  — 2 NH3 + H2CO3
It can be seen that each two moles of ammonia derives from the hydrolysis of one 
mole of urea.
(i) Protein extraction
Bacterial strains were incubated in Luria broth supplemented with 0.1% (w/v) urea for 
4 hours at 37°C in a shaking incubator. These cultures were then centrifuged at 4000 
rpm for 4 minutes, the supernatant discarded, and the cells re-suspended in 25 ml ice 
cold 0.1  M sodium phosphate buffer (pH 7.3) with 0.01  M ethylenediaminetetraacetic 
acid (EDTA) to form a protein extract.
(ii) Protein concentration assay
A commercially available assay kit was used (Total Protein Kit, Micro Pyrogallol Red 
Method - manufactured by Sigma).
20 pi of protein extract was added to 1 ml of Total Protein Reagent (0.05 mM 
pyrogallol red, 0.16 mM sodium molybdate with chelating agent, stabiliser, surfactant 
and preservative) pre-warmed to 37°C. A blank was prepared with 20 pi distilled 
water and a standard with 20 pi of the supplied Protein Standard Solution (0.5 mg/ml
96human serum albumin in saline with 0.1% sodium azide preservative) instead of a 
test protein extract. Samples were incubated at 37°C for 3 minutes.
Absorbance (A) was read in a spectrophotometer at 600 nm using a distilled water 
reference. The protein concentration of the sample was calculated as:
(Atest - Abiank) / (Astandard - Awank) * concentration of Standard (mg/ml)
(iii)  Ammonia production assay
A set of ammonium chloride standards was produced to calibrate the assay. 
Standards were produced from 0.001  M to 0.009 M in 0.001  M increments, and from 
0.01  M to 0.1  M in 0.01 M increments.
1  ml reaction mixtures were produced containing 50 mM urea,  100 mM sodium 
phosphate buffer and 0.2 ml of protein extract, ammonium chloride standard or a 
distilled water blank. The mixtures were incubated at 37°C for 10 minutes and the 
reaction terminated with 2 ml of 0.5% phenol and 0.0025% sodium nitroprusside 
solution.
Once the reaction was terminated, 2 ml of 0.25% sodium hydroxide and 0.2% sodium 
hypochlorite solution was added and colour development initiated by incubation at 
56°C for 6 minutes.
Absorbance was read in a spectrophotometer at 600 nm using the distilled water 
blank as a reference. A calibration curve was plotted using the ammonium chloride 
standards, and the amount of ammonium in the incubated culture extracts 
determined from this.(iv)  Urease activity calculation
As 2 mol of ammonia is derived from each mol of urea, and the assay is run for 10 
minutes, the urease activity of a sample is derived as:
[ammonia} / 2 /1 0  / [protein] (pmoi/min/mg)
Three replicates were run for each bacterial strain. Urease activity was expressed as 
pmol urea hydrolysed / minute / mg protein.
2.4.7  Comparison of Urine and Stool Cultures
Where Pr. mirabilis was isolated from both the stool and urine of an individual 
participant on a single day, these isolates were compared by first Dienes typing and 
then Pulse Field Gel Electrophoresis (PFGE).
(i)  Dienes typing
Stored isolates of Pr. mirabilis were plated to achieve single colonies and cultured 
overnight at 37°C on CLED agar. Single colonies of the isolates from the faecal and 
urine samples of each subject were inoculated as macrocolonies on TSA agar with 
up to four isolates on each plate. Each isolate was tested against every other isolate. 
Typing is based on the mutual inhibition of different strains causing the swarming 
colonies to repel each other. After overnight incubation at 37°C, those isolates 
showing a clear band, or Dienes demarcation line, between each other were 
designated as different strains. Those with no such demarcation line were regarded
98as the same Dienes type and were then subjected to PFGE to further investigate their 
similarity.
(ii)  Pulsed Field Gel Electrophoresis
This was performed using the method developed by Sabbuba et al [49].
Bacterial strains were incubated in Tryptone Soya Broth (Oxoid) overnight at 37°C in 
a shaking incubator. Bacteria were harvested by centrifuging the cultures for 10 mins 
at 3000 rpm, and the cells re-suspended in 8 ml of SE buffer, comprised of 75 mM 
sodium chloride (Fisher Scientific Ltd, Loughborough, UK) and 25 mM EDTA (Sigma 
Chemical Co, St Louis Ml, USA). Suspensions were warmed to 45°C and mixed with 
equal volumes of molten 2% low gelling temperature agarose (Type VII, Sigma) at 
the same temperature. This mixture was pipetted into 80 pi disposable plug moulds 
(BioRad Laboratories, Hercules CA, USA). Four plugs were made per strain and 
chilled at 4°C for 15 mins. The plugs from each strain were placed in sterile tubes 
with 10 ml of PEN buffer, containing 0.5 M EDTA and 1% N-lauryl sarcosine (MP 
Biomedicals GmbH, Eschwege, Germany). Pronase (Roche Diagnostics, Indianapolis 
IN, USA) was added to each tube at 1  mg/ml and incubated overnight at 37°C in a 
shaking incubator.  Plugs were then washed with five volume changes of TE buffer, 
containing 10 mM tris and 1  mM EDTA acidified to pH 8 with hydrochloric acid. Plugs 
were gently agitated on a rocking platform for 30 min between each volume change.
2 mm slices were cut from the plugs in a sterile manner and subjected to overnight 
restriction enzyme digestion at 37°C in individual sterile tubes. The digestion mixture 
contained 5 units of Not I restriction enzyme (Promega Corporation, Madison Wl,
USA) per tube along with 15 pi of 10X Bovine serum albumin and 15 pi of 10X Buffer 
(supplied with the enzyme) in sterile deionised water.
99For the PFGE, the plugs were loaded into gels made with 1.2% pulsed field certified 
agarose (BioRad) in 1X TBE buffer, containing 5.4 g/l tris base, 2.75 g/l boric acid 
and 2 ml/l 0.5 M EDTA. The loaded gels were sealed with 1.2% low gelling 
temperature agarose. Bacterial DNA fragments were separated by electrophoresis at 
14°C at 6 V/cm for 8 hours with a switch time of 1 to 30 s, followed by 16 hours with a 
switch time of 30 to 70 s. A CHEF-DR II apparatus was used (BioRad).
Bacteriophage A DNA ladders (BioRad) were included as size standards. Gels were 
stained using ethidium bromide for approximately one hour, and de-stained under 
running water for 10 min. Gels were viewed and photographs taken under ultraviolet 
light.
The epidemiological relationship of the strains was determined using the criteria 
described by Tenover et al [210].
1002.5  Statistical Analysis
Descriptive statistics, t tests, and simple linear correlation and regression analysis 
were performed using the Data Analysis Toolpak for Microsoft Excel 2003 (Microsoft 
Corporation, Redmond WA, USA). Tests of normality, non-parametric tests and 
frequency analysis was performed using the Analyse-it add in for Microsoft Excel 
(Analyse-lt Software Ltd, Leeds UK).
Data was compared using either parametric or non-parametric tests dependent on an 
analysis of the normality of the data using the Shapiro-Wilk W test.
Multiple linear regression analysis was performed using SPSS for Windows (SPSS 
Inc, Chicago IL, USA).
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1023.1 The Prospective Study
Subjects with long term urinary catheters and Proteus urinary tract colonisation were 
recruited. Samples of bladder urine were collected at the same time each week for 
approximately three months and analysed for voided pH (pHv), nucleation pH (pHn), 
calcium and magnesium concentration, and cultured to isolate urinary flora. Any 
catheters which were removed during the study were collected. The reason for 
removal and any visible encrustation was noted, and they were analysed for calcium 
and magnesium content and cultured to isolate biofilm flora. The data are described 
for each participant in section 3.1.1, and summarised graphically in figures 3.2 to 
3.22.
Study participants were expected to be catheter blockers given the presence of 
urease positive organisms in their urine. The traditional division into ‘blockers’, whose 
catheters on average need changing more frequently than every six weeks, and ‘non- 
blockers’, whose catheters do not, was not thought appropriate [46]. They were 
therefore divided into two different groups for the purposes of analysis: those whose 
catheters lasted a mean of less than 28 days, and those whose catheters lasted a 
mean of greater than this time. As with the ‘blocker1  and ‘non-blocker’ definition this is 
essentially an arbitrary division designed to allow analysis of the data in similar ways 
to previously published studies. These groups represent the heaviest (catheter < 28 
days group) and lightest (catheter > 28 days group) catheter encrusters. Regression 
analysis was also used as the variables appeared to have a continuous distribution, 
and this was therefore felt to be more appropriate. Catheters which were expelled, or 
removed when clearly not blocked, were not included in the analysis.
1033.1.1  Summary of Data for each Study Participant
Table 3.1 summarises the demographic details of those catheter users participating 
in the trial. As expected, there is a large representation of older subjects and 
residents of long term care facilities.
Table 3.1: demographic details, catheter details and length of involvement in the trial of 
the main study participants
participant age sex residence catheter size weeks in study
02 78 F nursing home urethral 16 19
03 69 F nursing home urethral 14 19
04 73 F nursing home urethral 14 19
05 90 M nursing home urethral 16 19
06 102 F nursing home urethral 14 17
07 83 F own home urethral 14 15
08 85 F nursing home suprapubic 14 15
09 76 F sheltered accommodation suprapubic 16 14
10 73 M nursing home urethral 16 5
11 81 M own home urethral 16 9
12 85 M nursing home suprapubic 16 5
13 74 F nursing home urethral 12 13
14 86 F nursing home urethral 14 14
15 88 F own home urethral 14 9
16 80 M own home suprapubic 20 14
17 43 F own home suprapubic 18 14
18 53 F own home urethral 18 13
19 86 M own home urethral 14 13
20 81 F nursing home suprapubic 18 13
21 58 M own home urethral 16 16
22 49 F own home suprapubic 18 12
23 71 F nursing home urethral 14 genotyping only
24 84 F own home suprapubic 16 genotyping only
25 60 F own home urethral 14 genotyping only
26 81 M own home urethral 16 genotyping only
The data shown in each summary graph (figures 3.2 to 3.22) is divided into four mam 
sections as shown in figure 3.1  and described below.
104Figure 3.1: Example of a segment from a participant summary graph, with data grouped 
into four sections as shown by the numbered grey boxes on the right.
Patient
week
Section 1  contains data on antibiotic and catheter maintenance solution treatments 
given during the trial. Section 2 shows the graphs of pHv and pHn  as measured on the 
y-axis scale. Section 3 has circles representing the catheters removed during the 
study, with the short coloured bars above each catheter circle detailing the bacteria 
isolated from it. A grey X indicates that no microbiological analysis was performed, 
either because the catheter was lost or was unsuitable for analysis. Catheters are 
marked as being changed when blocked, undergoing a scheduled routine change 
before being blocked, or undergoing an unscheduled change when not blocked. 
Section 4 contains long coloured bars indicating the bacteria isolated from the urine 
as measured by the weekly urine samples.
A key is provided below each figure.
105Participant 02
Participant 02 was a female nursing home resident, monitored for 19 weeks (figure
3.2). She persistently had urinary colonisation with both Pr. mirabilis and Ent. 
faecalis, with the addition of E. coti for weeks 7 through 17. She had a pHv which was 
usually equivalent to, or higher than, her pHn. Her catheters blocked frequently with 
significant visible encrustation. Catheter flora was usually the same as that isolated 
from the urine.
Participant 03
Participant 03 was a female nursing home resident, monitored for 19 weeks (figure
3.3). She had persistent urinary colonisation with Ent. faecalis, M. morganii, and Ps. 
aeruginosa. Despite having Pr. mirabilis on her initial screening sample, this 
organism was not isolated again during the study. The urinary pHv was almost always 
considerably lower than its pHn. Her catheters were changed infrequently, and 
showed minimal encrustation. Catheter flora species were the same as those isolated 
from the urine.
106Figure 3.2: Participant 02 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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107Figure 3.3: Participant 03 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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108Participant 04
Participant 04 was a female nursing home resident, monitored for 19 weeks (figure
3.4). Due to illness, sample collection was not possible for weeks 17 and 18. She had 
persistent urinary colonisation with both Pr. mirabilis and Ent faecalis, with the 
occasional addition of E. coli. She had a pHv which was usually equivalent to or lower 
than her pHn. Catheters blocked showing significant visible encrustation, but with a 
mean lifespan of more than 28 days. The catheters, like the urine, were consistently 
colonised with Pr. mirabilis and Ent. faecalis. E. coli was present occasionally, but 
was not consistent with the urine culture results obtained in the same week.
Participant 05
Participant 05 was a male nursing home resident, monitored for 19 weeks (figure
3.5). He had persistent Pr. mirabilis urinary colonisation, usually with Ent. faecalis 
present. E. coli were found until week 7, and Staph, intermedius from week 11 to 18. 
He had a pHv which was equivalent to his pHn, largely because his mean pHn  was the 
lowest in the study. His pHv was not particularly high for most of the study. Catheters 
blocked very frequently showing significant visible encrustation in each case. The 
predominant catheter organisms were Pr. mirabilis and E. coli. Ent. faecalis and 
Staph, intermedius only appeared in the biofilm at the end of the study period, despite 
being consistently isolated form the urine for around eight weeks beforehand in each 
case.
109Figure 3.4: Participant 04 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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110Figure 3.5: Participant 05 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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111Participant 06
Participant 06 was a female nursing home resident, monitored for 17 weeks until she 
died of a respiratory tract infection (figure 3.6). She received amoxicillin from week 
16, when it was initially unclear as to whether her infection was urinary or respiratory. 
She had persistent urinary colonisation with Ent faecalis, with Pr. mirabilis present 
for every week except 17. Ps. aeruginosa was grown until week 5, and E. coli from 
week 14 to 16. She had a pHv which was consistently lower than her pHn  by at least 
one pH unit. This was despite having a reasonably high pHv. Her first catheter 
showed minimal encrustation when removed. Her last catheter was removed during 
her final illness and was not encrusted. The second, removed as an adjunct to her 
antibiotics, did show encrustation. They grew her usual urinary flora of Pr. mirabilis 
with Ent. faecalis.
Participant 07
Participant 07 was a female living in her own home, monitored for 15 weeks (figure
3.7). She suffered a cerebrovascular accident towards the end of this period and so 
spent weeks 13 to 15 in a hospital stroke unit. She had urinary colonisation with Pr. 
vulgaris and Ps. aeruginosa except for week 14, with Ent faecalis persistent from 
week 3. Serratia marcescens was usually present from week 7. She had a pHv which 
was on average, equivalent to her pHn. Her pHv did become elevated above her pHn 
while she was in hospital with her stroke. Not enough readings were taken during this 
short period to be certain that this is significant, but she did have problems with fluid 
intake during this time. Catheters blocked frequently, and were significantly 
encrusted. Blockage seemed to become even more of a problem in hospital, although 
these catheters were unsuitable for analysis. Pr.  vulgaris was not isolated from the
112catheters. They were colonised with Ps. aeruginosa and Ent faecalis, and with 
Serratia marcescens even before it was isolated from the urine.
113Figure 3.6: Participant 06 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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114Figure 3.7: Participant 07 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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115Participant 08
Participant 08 was a female nursing home resident, monitored for 15 weeks (figure
3.8). She had persistent urinary colonisation with Ent. faecalis. She also had 
colonisation with Kl. pneumoniae,  Staph, aureus, and often E. coli until week 7 when 
these were replaced by the emergence of Pr. mirabilis. She received a course of 
minocycline for a wound infection at her suprapubic catheter site in weeks 5 and 6. 
Her pHn  remained reasonably consistent throughout the study, although urine 
samples in weeks 10 and 12 were of insufficient volume to perform pHn  analysis. 
Following the isolation of Pr. mirabilis from the urine her pHv increased from an 
average of around 5, safely below the pHn, to around 8, equivalent to or higher than 
it. The first catheter removed in week 1 was encrusted, but less so than those 
removed after the isolation of Proteus from the urine. These had crystals present 
along more of their length. Catheters blocked infrequently before Proteus, but very 
frequently afterwards. Ent. faecalis was isolated from the first catheter, and Pr. 
mirabilis and Ent. faecalis after the rise in pHv and frequent blockage started.
Participant 09
Participant 09 was a female living in her own home, monitored for 14 weeks (figure
3.9). She had persistent urinary colonisation with Pr. mirabilis, E. coli and Kl. 
pneumoniae, with Ent. faecalis present except for weeks 5 through 9, and Staph, 
aureus found only in week 11. The urine was sterile in week 6, although there is no 
clear explanation for this. She had a pHv which was usually considerably lower than 
her pHn. Catheters were changed infrequently and routinely, and were only 
moderately encrusted. The last catheter was changed to allow a diagnostic test and 
had very little encrustation. No catheters actually blocked. Catheter flora reflected 
urinary flora except for the absence of E. coli
116Figure 3.8: Participant 08 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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117Figure 3.9: Participant 09 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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118Participant 10
Participant 10 was a male nursing home resident, monitored for 5 weeks until illness 
meant he had to be withdrawn (figure 3.10). He died of a respiratory tract infection 
two weeks later. He received co-amoxiclav in week 5. He had persistent urinary 
colonisation with Pr. mirabilis and Ps. aeruginosa, with Ent. faecalis present only in 
week 3. His pHv was usually higher than his pHn  by a good margin, except for the final 
week when he was taking antibiotics and his pHv dropped by over 2 pH units. 
Catheters were significantly encrusted. The first catheter was unsuitable for culture. 
Ps. aeruginosa was not found on the second catheter, even though it was 
consistently isolated from the urine. Pr. mirabilis was found, as was Ent. faecalis, 
which was not in the urine at that time but had been the week before, and 
Micrococcus luteus, which was never found in the urine.
Participant 11
Participant 11 was a male living in his own home, monitored for 9 weeks until he 
moved out of the study area (figure 3.11). He had persistent urinary colonisation with 
Kl. pneumoniae and Ps. aeruginosa, with Pr. mirabilis present only in weeks 5 and 6, 
despite being isolated from his screening urine sample two weeks before the start of 
the trial. The urine was sterile in week 8, although there was no clear explanation for 
this.  His pHv was consistently lower than his pHn, even during the weeks when 
Proteus was isolated. Kl. pneumoniae and Ps.  aeruginosa were isolated from both. 
The second catheter was removed during the period when Pr. mirabilis was found in 
the urine, but this was not present on the catheter.
119Figure 3.10: Participant 10 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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120Figure 3.11: Participant 11 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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121Participant 12
Participant 12 was a male nursing home resident, monitored for 5 weeks until he 
voluntarily withdrew from the study, although he gave permission for data already 
collected to be used (figure 3.12). He persistently had urinary colonisation with Pr. 
mirabilis, with Ent. faecalis present from week 3. His pHv was very high, and was 
equivalent to or slightly above his pHn. No catheters were removed during the study 
period. One did block shortly before the study period, but was occluded with clotted 
blood rather than encrustation.
Participant 13
Participant 13 was a female nursing home resident, monitored for 13 weeks (figure
3.13). She had persistent urinary colonisation with Pr. mirabilis, Ent faecalis and Ps. 
aeruginosa. She usually also grew Staph, aureus, and E.  coli was found in weeks 4 
to 6. Urinary pHv was often comfortably below pHn, although this was not consistent 
throughout the trial period. Some catheters did block, and were significantly 
encrusted. Others were expelled, and had minimal to moderate encrustation 
according to how long they had been in place for. On average, catheters which 
blocked lasted longer than 28 days. Retrieved catheters grew Pr. mirabilis, E. coli and 
Staph, aureus, even long after E. coli was absent from the urine. Ent. faecalis and Ps. 
aeruginosa were not found. She was not catheterised during week 12, so a urine 
sample could not be collected. Due to her catheter expulsions she was being trialled, 
unsuccessfully, on incontinence pads.
122Figure 3.12: Participant 12 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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123Figure 3.13: Participant 13 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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124Participant 14
Participant 14 was a female nursing home resident, monitored for 14 weeks (figure
3.14). She had persistent urinary colonisation with Pr. mirabilis, Ps. aeruginosa, and 
usually E. coli. She also grew Ent. faecalis up to week 7. A sample could not be 
collected in week 9. She had a pHv which was usually equivalent to, or lower than, 
her pHn. Catheters normally blocked infrequently, although the catheter removed 
accidentally in week 12, which had only been in a week, was markedly encrusted. 
Only the second catheter was suitable for culture, and Pr. mirabilis and Ps. 
aeruginosa, but not E. coli, were isolated.
Participant 15
Participant 15 was a female living in her own home, monitored for 9 weeks until she 
died of a stroke (figure 3.15). She had persistent urinary colonisation with Pr. 
mirabilis, with Ent. faecalis usually present up to week 6, Ent.  durans present from 
week 4, and E. coli seen occasionally. She received treatment twice weekly with 
Suby G (3% citric acid) catheter maintenance solutions throughout the course of the 
study. A sample could not be taken in week 8. She had a pHv which was usually 
equivalent to, or higher than, her pHn. Catheters blocked frequently and were 
significantly encrusted. Pr. mirabilis was consistently isolated from the catheters. Ent. 
faecalis was present until a week before it disappeared from the urine. Ent.  durans 
was seen a few weeks after it appeared in the urine. E. coli was isolated frequently, 
but this was not consistent with the urinary cultures.
125Figure 3.14:  Participant 14 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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126Figure 3.15: Participant 15 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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127Participant 16
Participant 16 was a male living in his own home, monitored for 14 weeks (figure
3.16). He persistently had urinary colonisation with Pr. mirabilis and Ps. aeruginosa, 
with Ent. faecalis present except for weeks 10 through 12. There was occasional 
growth of E. coli and M. morganii. He was taking low dose nitrofurantoin throughout 
the study, and therapeutic doses of ciprofloxacin in weeks 11 and 14. Although pHv 
was, on average, slightly lower than pHn, it varied considerably around it. Catheters 
blocked frequently and were heavily encrusted down much of their length. Pr. 
mirabilis and Ps. aeruginosa were consistently isolated. E  coli was seen on the 
catheters before appearing in the urine, but Ent. faecalis was inconsistent.
Morganella was not present on the catheters when present in the urine, but was 
isolated form the next catheter in week 9.
Participant 17
Participant 17 was a female living in her own home, monitored for 14 weeks (figure
3.17). She persistently had urinary colonisation with Pr. mirabilis, Ps.  aeruginosa and 
Ent. faecalis, with Ent. durans and a non-swarming strain of Pr. mirabilis present 
during the middle part of the study, and E. coli appearing in the final week. She had a 
pHv which was consistently lower than her pHn  by a comfortable margin. Catheters 
were changed routinely every month, and were moderately encrusted. Pr. mirabilis 
and Ent. faecalis were isolated from all catheters. Ps. aeruginosa was absent from 
the first catheter. Ent. durans was isolated from the catheter removed in week 7, but 
not in week 11, shortly before it disappeared form the urine.
128Figure 3.16: Participant 16 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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130Participant 18
Participant 18 was a female living in her own home, monitored for 13 weeks (figure
3.18). She had persistent urinary colonisation with Pr. mirabilis, with Ps.  aeruginosa 
usually also present. Ent. faecalis was grown from week 5, with E. coli being seen up 
to week 6, and again in the final week along with Citrobacter spp. She had several 
courses of antibiotics for urinary tract infections: cefalexin in weeks 1  and 2, 
clarithromicin in weeks 6 and 7, and ciprofloxacin in weeks 7 and 8. She had a pHv 
which was consistently lower than her pHn, despite the pHn being quite variable. 
Catheters were supposed to be changed routinely every six weeks, although only the 
second catheter lasted this long. The first catheter had blocked a couple of days 
before it was due to be changed. All catheters were encrusted. The catheter flora 
reflected the urinary flora except for the lack of Ps.  aeruginosa. Although it had 
disappeared from the urine that week, probably due to a course of antibiotics, E.  coli 
was still isolated from the second catheter.
Participant 19
Participant 19 was a male living in his own home, monitored for 13 weeks (figure
3.19). He persistently had urinary colonisation with Pr. mirabilis, Ps.  aeruginosa and 
Kl. pneumoniae, with Ent. faecalis usually present from week 7, E.  coli appearing 
commonly, and Citrobacter spp seen once in week 3. Despite the presence of Pr. 
mirabilis the urinary pHv was constantly very low, and, on average, 3 pH points below 
the pHn. Catheters were changed routinely every 12 weeks and had almost no 
encrustation visible. The catheter flora reflected the urinary flora except for E.  coli 
being isolated form the first catheter the week before it was first isolated from the 
urine.
131Figure 3.18: Participant 18 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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132Figure 3.19: Participant 19 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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133Participant 20
Participant 20 was a female nursing home resident, monitored for 13 weeks (figure
3.20). She persistently had urinary colonisation with Pr. mirabilis, with Kl. 
pneumoniae present from week 2. Ent faecalis was seen until week 6, being 
replaced from week 7 by Providencia rettgeri. While both measurements were quite 
variable, she had a pHv which was, on average, equivalent to her pHn. The only 
catheter which was removed during the 13 weeks had blocked and was heavily 
encrusted. The catheter flora was the same as the urinary flora.
Participant 21
Participant 21 was a male living in his own home, monitored for 16 weeks (figure
3.21). He had persistent urinary colonisation with Pr. mirabilis, Ps. aeruginosa and Kl. 
pneumoniae, with Ent. faecalis present except for week 8. E. coli appeared in the 
final week. He had a course of trimethoprim for a urinary tract infection in weeks 12 to 
13.  His urinary pHv was equivalent to, or occasionally slightly below, his pHn. 
Catheters blocked frequently. One was removed before a holiday to prevent an 
inconvenient blockage, but was still significantly encrusted. Catheter flora usually 
reflected urinary flora, except for occasional absence of Ps. aeruginosa. Ent. faecalis 
was not isolated from the third catheter. It was not present when this catheter was 
inserted, but had been since.
134Figure 3.20: Participant 20 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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135Figure 3.21: Participant 21 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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136Participant 22
Participant 22 was a female living in her own home, monitored for 12 weeks (figure
3.22). She had persistent urinary colonisation with Pr. mirabilis and Ent faecalis. 
Staph, aureus was present except for the last three weeks. The urinary pHv was 
equivalent to the pHn. Nucleation pH did seem to be lower in the second half of the 
study than in the first (and catheters did seem to block slightly more frequently) 
although there was no obvious explanation for this. Catheters blocked frequently and 
were significantly encrusted, except for the catheter expelled in week 2. Catheter 
flora largely reflected urinary flora, except for the presence of E. coli and Staph, 
aureus on the last catheter. Staph,  aureus had been present throughout the 
catheterisafion period up to that week, but E. coli was never isolated from the urine or 
other catheters of this participant.
137Figure 3.22: Participant 22 - treatments, nucleation pH, voided pH, catheter changes and bacterial isolates over the course of the study period.
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1383.1.2  Variation in Catheter Lifespan
As can be seen in the summary graphs in section 3.1.1, there is some variation in the 
lifespans of catheters used by a single participant, as well as the variation in catheter 
lifespan between participants which will be examined in the subsequent section. 
Figure 3.23 summarises this data for each individual, and descriptive statistics are 
presented in table 3.1.
Rapid and slow encrusters
For the purposes of analysing the data, the catheter users in this study were divided 
into two groups. As this study dealt with catheter users who should all have had 
problems with encrustation, the usual split into blockers and non-blockers based on a 
catheter lifespan of 6 weeks was not thought appropriate. Those having a mean 
catheter lifespan of less than 28 days were classified as rapid encrusters, and those 
with a mean catheter lifespan of more than 28 days as slow encrusters.
Analysis of Routinely Changed Catheters
Three participants had their catheters predominantly changed routinely, which meant 
that recorded values of catheter lifespan were likely to be too short compared to if 
they had been allowed to block. Even so, two of these participants had the two 
longest catheter lifespans in the study. The third, participant 17, had her catheter 
changed every month, when it would be heavily encrusted, and she had a historical 
pattern of catheters blocking every 4 to 5 weeks. It was therefore assumed that using 
the recorded values as actual lifespan values would not affect analysis of the data. Ail 
three were classified as slow encrusters.
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Figure 3.23: Mean catheter lifespan for each study participant with error bars representing one standard deviation. Column coloured white shows 
an individual from whom only one suitable catheter was removed. Striped columns indicate those individuals whose catheters were usually 
changed routinely.
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140Table 3.2: Descriptive statistics representing the variability in catheter lifespan, measured in days, for each study participant (n - number of
catheters, SD - standard deviation, SE - standard error, Cl - confidence interval, IQR - interquartile range).
participant n mean SD SE 95% Cl of mean median IQR range
2 6 26.8 12.5 5.1 13.8 to 39.9 21.0 7.3 15  to  45
3 2 54.5 7.8 5.5 -15.4 to 124.4 54.5 0.0 49  to  60
4 3 35.7 31.5 18.2 -42.5 to 113.8 18.0 27.5 17  to  72
5 15 9.9 3.3 0.9 8.1 to 11.8 9.0 5.5 6  to  16
6 2 55.0 60.8 43.0 -491.4 to 601.4 55.0 0.0 12  to  98
7 5 20.8 11.1 5.0 7.0 to 34.6 21.0 7.0 8  to  38
8 7 14.6 17.8 6.7 -1.9 to 31.1 7.0 5.0 3  to  54
9 2 70.0 2.8 2.0 44.6 to 95.4 70.0 0.0 68  to  72
10 3 21.7 9.0 5.2 -0.6 to 43.9 17.0 8.0 16  to  32
11 2 34.0 1.4 1.0 21.3 to 46.7 34.0 0.0 33  to  35
12 1 48.0 - - - 48.0 - -
13 3 32.0 16.8 9.7 -9.8 to 73.8 38.0 16.0 13  to  45
14 2 46.5 54.5 38.5 -442.7 to 535.7 46.5 0.0 8  to  85
15 13 3.2 0.7 0.2 2.7 to 3.6 3.0 1.0 2  to  4
16 7 15.0 11.8 4.4 4.1 to 25.9 12.0 7.0 5  to  40
17 3 30.7 3.8 2.2 21.3 to 40.1 29.0 3.5 28  to  35
18 3 36.7 6.7 3.8 20.1 to 53.2 40.0 6.0 29  to  41
19 2 55.5 0.7 0.5 49.1 to 61.9 55.5 0.0 55  to  56
20 2 47.5 41.7 29.5 -327.3 to 422.3 47.5 0.0 18  to  77
21 6 13.3 7.0 2.9 6.0 to 20.7 11.5 5.5 7  to  25
22 4 15.8 7.4 3.7 4.0 to 27.5 15.0 12.3 8  to  25
1413.2  Urinary Constituents and Encrustation
3.2.1  Variability in voided pH and nucleation pH
The values of mean pHv for each participant are normally distributed (Shapiro-Wilk 
test P=0.868) with values as shown in table 3.3. It can be seen that an infection with 
a urease producing organism does not inevitably produce a high urinary pH. Of the 
21  study participants,  12 had a mean pHv of less than 7.0, and 4 had a mean pHv of 
less than 6.5. In 5 cases, the value of their mean pHv plus one standard deviation 
was still only neutral, and 2 participants never recorded an alkaline pHv value. It can 
be seen that voided pH is variable between individuals even with Pr. mirabilis 
infections.
The spread of mean values of pHn  also follows a normal distribution (Shapiro-Wilk 
test P=0.860) as shown in table 3.3. Again, the mean value for nucleation pH is 
clearly seen to vary between individuals, with some particularly low or high readings. 
Overall, the spread of values is less than for pHv.
It is clear from a casual observation of the individual graphs for each study participant 
that there is considerable variability in the weekly readings of both pHv and pH„. 
Figure 3.25 graphically represents the spread of these variables in each study 
participant.
142Table 3.3: Distribution of mean values of pHv and pHn of study participants (SD -
standard deviation, SE - standard error, IQR - interquartile range)
mean SD SE median range IQR
mean pHv 7.01 0.92 0.20 6.98 4.77-8.98 6.58 - 7.65
mean pH„ 7.73 0.61 0.13 7.69 6.67-8.96 7.44 - 7.97
Note on Statistics
It should also be noted that participant 03 did not have Proteus colonisation, while 
participant 11  only had Proteus for a short period during the trail. Excluding values for 
these individuals made no difference to the analysis of the study results, with the 
results remaining statistically significant or not with or without their data- The results 
shown here are using the data from all participants. A comparison of the statistical 
results with and without participants 03 and 11  included can be found in Appendix 2.
Differences in pHv and pHn
The independent samples t test was used to see if there was a difference in mean 
pHv or pHn  between rapid and slow encrusters (tables 3.5 and 3.6).  It was found that 
the rapid encrusters had a higher mean pHv than the others (7.20 compared with 
6.26), but this difference was not statistically significant (P=0.385). The difference 
was not significant even when the mean pHv values pre and post Pr.  mirabilis 
infection for participant 08 were treated separately. The lower pHn  in the rapid 
encrusters (7.32 compared with 8.03) was highly significant, however (p=0.004).
143The safety margin
From figure 3.25 it can be seen that for some individuals the ranges of pHv and pHn  
overlap considerably, whereas for others there is a considerable difference between 
the means and little overlap of the one standard deviation distributions. It can be 
hypothesised that those in the first group, where their urinary pH remains close to the 
pH at which crystals will form, will suffer more severely than those in the second 
group whose pHv usually remains below their pHn. The difference between these 
values was calculated for each urine sample and termed the safety margin, such that:
safety margin = pHn  - pHv
The mean safety margins for each participant are shown in figure 3.24. Theoretically, 
in those cases where crystal precipitation would be occurring, when pHv is higher 
than pHn, the safety margin would be negative. The more positive the value, the less 
likely crystallisation would be to occur. From observing the graphs of individual 
participants in section 3.1.1, and from previously published work [148], it seems that 
encrustation occurs when pHv is close to pH„, not just when it is above it. In other 
words, when the safety margin is small, as well as when it is negative.
This is likely to represent variability of pHn  and pHv around the values recorded, so 
that safety margins will become negative at some time, allowing crystal precipitation, 
with a frequency inversely proportional to the value of the mean safety margin.
The mean safety margins of those study participants who on average block their 
catheters within 28 days, and those with slower encrustation whose catheters on 
average lasted more than 28 days, were compared using the independent samples t 
test (table 3.4). Those catheter users who have the most rapid encrustation, the 28
144day blockers, have a safety margin significantly lower than those who block their 
catheters less frequently (P=0.003).
This can be seen in figures 3.25 and 3.24, where participants 05, 10 and 15 are 
examples of rapid catheter encrusters, and participants 06, 09 and 19 are examples 
of slow encrusters. Participant 12 is an exception to this pattern as, despite the 
results shown, he was not a rapid encruster. This is discussed in section 4.1.1.
Figure 3.24: Mean safety margin for each study participant.
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145Figure 3.25: Variability of voided pH and nucleation pH over the course of the study in each catheter user. Thick white bars indicate the mean 
voided pH plus and minus one sample standard deviation. Thick grey bars indicate the mean nucleation pH plus and minus one sample standard 
deviation. The thin black bars indicate the total range of values recorded from each category.
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participant numberOther characteristics of rapid encrusters
The mean concentration of calcium, magnesium and the summed concentration of 
magnesium and calcium was analysed as a possible difference between rapid and 
slow encrusters. The two groups were compared for these factors using the Mann- 
Whitney U test (tables 3.7, 3.8 and 3.9), as the calcium data was not normally 
distributed.
There was no significant difference between the two groups in terms of magnesium 
concentration (P=0.464) or total magnesium and calcium concentration (P=0.129).
The subjects who blocked their catheters the most frequently did, however, have an 
increased level of urinary calcium compared to the other participants (a mean of 7.6 
mM compared with 3.9 mM) which was statistically significant (P=0.007).
147Table 3.4: t test - comparison off mean safety margin (pH units) between those catheter
users with a mean catheter lifespan greater than and less than 28 days
catheter < 28 days catheter > 28 days
Mean safety margin 0.13 1.17
Variance 0.17 0.84
Observations 9 12
tStat 3.487
2-tailed p 0.003
t Critical 2.120
Table 3.5: t test - comparison of mean voided pH between those catheter users with a 
mean catheter lifespan greater than and less than 28 days
catheter < 28 days catheter > 28 days
Mean pHv 7.20 6.86
Variance 0.36 1.23
Observations 9 12
tStat 0.890
2-tailed p 0.386
t Critical 2.101
Table 3.6: t test - comparison of mean nucleation pH between those catheter users with 
a mean catheter lifespan greater than and less than 28 days
catheter < 28 days catheter > 28 days
Mean pHn 7.32 8.03
Variance 0.23 0.28
Observations 9 12
tStat 3.265
2-tailed p 0.004
t Critical 2.101
148Table 3.7: Mann-Whitney U lest - comparison of mean urinary calcium concentration
(mM) between those catheter users with a mean catheter lifespan greater than and less
than 28 days
21
[Ca] by catheter lifespan n Rank sum Mean rank U
catheter < 28 days 9 136.0 15.11 17.0
catheter > 28 days 12 95.0 7.92 91.0
Difference between medians 3.09
95.1% Cl 0.79 to 5.94
Mann-Whitney U statistic 17
2-tailed p 0.007
Table 3.8: Mann-Whitney U test - comparison of mean urinary magnesium 
concentration (mM) between those catheter users with a mean catheter lifespan greater 
than and less than 28 days
21
[Mg] by catheter lifespan n Rank sum Mean rank U
catheter < 28 days 9 110.0 12.22 43.0
catheter > 28 days 12 121.0 10.08 65.0
Difference between medians 1.40
95.1% Cl -2.46 to 4.97
Mann-Whitney U statistic 43
2-tailed p 0.464
149Table 3.9: Mann-Whitney U teat - comparison of mean total calcium and magnesium
concentration (mM) between those catheter users with a mean catheter lifespan greater
than and less than 28 days
n |  21
[Ca + Mg] by catheter lifespan n Rank sum Mean rank U
catheter < 28 days 9 121.0 13.44 32.0
catheter > 28 days 12 110.0 9.17 76.0
Difference between medians 3.88
95.1% Cl -1.35 to 10.10
Mann-Whitney U statistic 32
2-tailed p 0.129Regression analysis
As well as differences between the two groups of rapid and slow encrusters, 
calculating the Pearson correlation coefficient r showed a significant negative 
correlation between mean catheter lifespan and mean urinary calcium (r = - 0.601, 
P=0.002), and a significant positive correlation with mean nucleation pH (r = 0.562, 
P=0.004) and mean safety margin (r = 0.465, P=0.017). Scatter plots showing the 
calculated regression lines are seen in figures 3.26, 3.27 and 3.28.
Although these regression lines are certainly significant, calculating the coefficient of 
determination r2 showed that there remains considerable variation in catheter lifespan 
not predicted by independent analysis of any one of these variables. As these 
variables can all, to some extent, be thought of as determining each other, it is not 
appropriate to calculate a predictive model for all of them using multiple linear 
regression.
Conclusion
The statistically significant characteristics of those catheter users who suffer the most 
from catheter encrustation, as defined by having a mean catheter lifespan of less 
than 28 days, are that they have a higher urinary calcium concentration, a lower 
nucleation pH, and a smaller gap between their nucleation and voided pH than those 
whose catheters last longer.
151Figure 3.26: Linear regression to illustrate correlation between mean catheter lifespan
and mean urinary calcium
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152Figure 3.27: Linear regression to illustrate correlation between mean catheter lifespan
and mean urinary nucleation pH
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Pearson correlation coefficient r = 0.562 
Coefficient of determination r2 = 0.315
Regression equation: catheter lifespan = 16.6 pHn - 95.4
P = 0.004
Linear regression demonstrates a highly significant positive correlation between
mean catheter lifespan and mean urinary nucleation pH
153Figure 3,28: Linear regression to illustrate correlation between mean catheter lifespan
and mean urinary safety margin
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Coefficient of determination r2 = 0.217
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P = 0.017
Linear regression demonstrates a significant positive correlation between mean
catheter lifespan and mean safety margin3.2.2  Catheter Encrustation Rate
An attempt was made to measure the rate at which encrustation occurs on urinary 
catheters, as opposed to simply measuring the catheter lifespan. When a catheter 
was removed the amount of encrustation was calculated by measuring the mass of 
magnesium and calcium present in the urinary drainage channel of the catheter. To 
derive the encrustation rate, this was divided by the number of days the catheter had 
been in place. This would hopefully be able to give more useful data than simply the 
catheter lifespan, as some catheters were removed routinely before they could block, 
and others were removed accidentally or because of bladder spasm mimicking 
blockage. This would lead to an inaccurately short measured value of catheter 
lifespan. By calculating the encrustation rate in this way, catheters which had not 
blocked should still yield useful data on the severity of crystallisation.
The encrustation rate data for each participant is summarised in table 3.10. 
Participant 12 is not included as their only catheter was lost. As can be seen from the 
figures in the table, there is considerable variability in the results for each participant. 
In all but an insignificant number of cases each participant continued to use the same 
catheter size, type, and manufacturer throughout the study, so this does not explain 
the occurrence of the variability.
The mean encrustation rate was used to differentiate rapid from slow encrusters as 
an alternative to mean catheter lifespan. An arbitrary cut off value of 0.7 mg/day was 
chosen, as this fell in a natural gap in the results and obtained a roughly equal split. 
The participants falling into the category of rapid encruster under both cut off policies 
are detailed in table 3.11.
155Table 3.10; Encrustation rats (mg calcium and magnesium deposited per day) of 
catheters in the study, shown as minimum, maximum, mean and sample standard 
deviation values for each study participant. If only the mean value is shown, there was 
only one catheter analysed.
participant minimum maximum mean stand dev
02 0.40 1.83 0.86 0.59
03 - - 0.003 -
04 0.11 0.21 0.16 0.08
05 1.02 3.16 1.94 0.80
06 0.01 0.45 0.23 0.31
07 0.06 0.70 0.38 0.45
08 0.38 3.18 1.84 1.08
09 0.01 0.08 0.04 0.05
10 0.27 0.83 0.55 0.40
11 0.021 0.022 0.02 0.00
13 0.28 1.59 0.93 0.92
14 - - 0.99 -
15 0.45 6.55 1.60 1.79
16 0.22 9.49 3.60 3.22
17 0.02 0.16 0.11 0.08
18 0.01 0.06 0.04 0.03
19 0.001 0.002 0.002 0.000
20 - - 1.29 -
21 1.21 2.56 1.84 0.56
22 1.08 2.29 1.39 0.60
Table 3.11: List of those participants characterised as rapid encrusters using cut off 
values of mean catheter life < 28 days or mean encrustation rate > 0.7 mg/day
mean catheter i'rfe 
< 28 days participants 02, 05, 07, 08, 10, 15,16, 21, 22
mean encrustation rate 
>0.7 mg/day participants 02, 05,08,13,14,15,16,21,22
156The independent samples t tests and Mann-Whitney U tests detailed in section 3.2.1 
were repeated to determine whether differences in mean safety margin, pHv, pHn, 
urinary calcium, magnesium, and summed calcium and magnesium concentrations 
were significant between the two groups divided by encrustation rate. In most cases, 
the same results were obtained as when using a mean catheter lifespan of 28 days to 
divide the participants into two groups. The only exception is the comparison of mean 
safety margin, where the difference is statistically significant using catheter lifespan 
(P=0.003) but not when using encrustation rate (P=0.062). These results are detailed 
in Appendix 3.
3.2.3  Catheter Specific Safety Margin
An attempt was made to increase the accuracy of the calculation of the safety 
margin, the difference between voided and nucleation pH. It has been shown that pHv 
is variable within most individuals, and that pHn  is variable in some, thus causing a 
week to week variation in safety margin. This may lead to some catheters being 
exposed to a higher safety margin than others, even within one individual, and so 
may explain the variation in catheter lifespan seen. This is most obviously 
demonstrated by participant 08 (figure 3.8), whose pHv increased following 
acquisition of Pr. mirabilis, leading to a reduction in safety margin and catheter 
lifespan, but it may be a factor in other participants.
The mean safety margin to which a catheter was exposed was calculated to 
determine a catheter specific safety margin (CSSM) for each catheter. This was then 
correlated against the lifespan of that catheter to give the results shown in figure 
3.29. This demonstrates a highly significant positive correlation between CSSM and 
the lifespans of individual catheters. The value of r of 0.551 for this model is slightly
157greater than for the model of mean safety margin predicting mean catheter lifespan (r 
= 0.465).
3.2.4  Investigating the ‘Blocking pH’
The concept of the blocking pH of a catheter user is based on the idea that the pH of 
their voided urine will increase the longer the catheter is left in place, as the 
encrustation builds up. Once it reaches a certain pH, this is a sign that the catheter 
will block imminently. This can then be used clinically to predict catheter blockages, 
and to change the catheter before this happens. It is possible that each individual 
may have a different blocking pH.
Theoretically, a rise in pHv as the catheter remains in place could be caused by the 
increasing numbers of urease producing organisms in a growing biofilm. Catheter 
blockage above a certain pHv level could be explained if encrustation only occurs, or 
is much more rapid, once the biofilm generates this pHv level in the urine.  In this 
case, blocking pH would be related to nucleation pH. Another explanation is that 
crystallisation occurs steadily in a localised high pH environment in the biofilm, but 
only once the biofilm has grown to contain a certain number of urease positive 
organisms does it affect the pH of the voided urine as a whole. This may coincide 
with a crystalline biofilm of sufficient size to occlude the catheter lumen.
Although this theory has been raised in several discussions with District Nursing staff, 
and is apparently supported by enough anecdotal evidence for it to be implemented 
as a method of catheter management in parts of the Bristol region with what seems 
like some success, there is little evidence to support it.
158Figure 3,29: Unear regression to illustrate correlation between catheter specific safety
margin and individual catheter lifespans
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159Being able to accurately predict catheter blockages would be extremely useful. The 
collected data on pH variability was analysed for evidence of such a trend. Casual 
observation of the pHv data for individual study participants in section 3.1.1 did not 
immediately suggest a trend of rising values throughout the life of the catheter. If the 
theory were true, the data would at least show higher pHv at the end of each 
catheter’s lifespan than at the start. For the theory to be applied in practice to an 
individual catheter user, the mean start pHv value should be lower than their mean 
end pHv value. There should also be a corresponding fall in pHv after the blocked 
catheter has been changed. Data points at the start and end of each catheter life 
were therefore analysed.
Dates of catheter blockage and weekly voided pH readings were recorded. The pHv 
readings at the start and end of each catheter’s lifespan were taken, and the readings 
compared using the related samples t test. The same was done for those readings 
immediately before and after the date of each catheter blockage
Pairs of pHv readings were only used for catheters which had definitely blocked, not 
those that had been changed routinely or for some other reason. Readings were also 
excluded if they could not be described as a true start and end samples. A reading 
had to be in the first or last third of a catheter life to be included. For example, if the 
pre blockage reading was taken 5 days before the catheter blocked, but that catheter 
had only lasted a week, it would more accurately be described as the post blockage 
pHy for the preceding catheter. Similarly, pairs of readings were excluded if the post 
blockage pHv reading happened to be taken towards the end of the life of the next 
catheter. For this reason, most pairs of readings from individuals with very short 
catheter lifespans were excluded.
160The data from the catheters which fit these criteria shows no significant rise in pHv 
between the start and end of a catheter’s lifespan (34 catheters, P-0.071), or a 
significant lowering of pHv after the blocked catheter is replaced (36 catheters, 
P=0.072). The results are shown in tables 3.12 and 3.14.
The results are significant, however, and of a greater magnitude, in those study 
participants with the heaviest levels of encrustation, the 28 day blockers. The data 
shows a significant difference in pHv between the start and end of a catheter’s 
lifespan (21  catheters, P=0.002), and a fall in pHv when the catheter is replaced (23 
catheters, P=0.029). The results are shown in tables 3.13 and 3.15.
In all cases, however, even when the changes are statistically significant, they are 
small in magnitude (table 3.16). Observation of the data for the individual catheter 
users shows that this is not due to a few 'individuals with no observable pHv changes 
dragging down the mean scores to these low levels. There is no subset of study 
participants with a greater pHv change.
161Table 3.12:1 test - comparison of pHv at the start and end of a catheter’s lifespan in ail 
blocked catheters
pHv start pHv end
Mean 6.84 7.23
Variance 0.98 0.97
Observations 34 34
tStat 1.868
2-tailed p 0.071
t Critical 2.035
Table 3.13: t test - comparison of pHv at the start and end of a catheter’s lifespan in 
catheters from 28 day blockers
pHv start pHv end
Mean 6.73 7.54
Variance 0.99 0.94
Observations 21 21
tStat 3.513
2-tailed p 0.002
t Critical 2.086
Table 3.14: t test - comparison of pHv before and after catheter blockage in ail blocked 
catheters
pHv before pHv after
Mean 7.35 7.00
Variance 0.77 0.62
Observations 36 36
tStat 1.856
2-tailed p 0.072
t Critical 2.030
Table 3.15: t test - comparison of pHv before and after catheter blockage in catheters 
from 28 day blockers
pHv before pHv after
Mean 7.44 6.91
Variance 0.83 0.63
Observations 23 23
tStat 2.339
2-tailed p 0.029
t Critical 2.074
162Table 3.16: Mean magnitude of pHy changes during a catheter lifespan
Data set mean pHv standard
change deviation
pH change during catheter lifespan for all catheters 0.39 1.12
pH change after catheter blockage for all catheters -0.35 1.12
pH change during catheter lifespan for 28 day blockers 0.81 1.06
pH change after catheter blockage for 28 day blockers -0.53 1.08
1633.3  Factors Influencing Nucleation pH
It is clear that the nucleation pH is a major factor determining the extent of 
encrustation suffered by a catheter user with urinary tract colonisation by a urease 
positive organism. Urinary calcium and magnesium concentrations were measured 
and related to the values of the nucleation pH found in urine samples.
3.3.1  Simple Linear Regression
Calculating the Pearson correlation coefficient r showed a highly significant negative 
correlation between mean pHn and mean urinary calcium (r = -0.704, P<0.01), 
magnesium (r = -0.517, P<0.01) and total calcium and magnesium (r = -0.658, 
P<0.01).
Calculating the coefficient of determination r2 for the correlation between calcium and 
pHn  showed that almost half (r2 = 0.495) of the variability in pHn  can be explained by 
changes in urinary calcium concentration alone, more than for magnesium or 
summed calcium and magnesium concentrations when considered alone.
The degree to which changes in calcium or magnesium affect pHn is shown by the 
regression equation, which follows the pattern for an equation of a straight line:
y = c + mx
Where y is the dependent variable on the y axis, x is the independent variable on the 
x axis, c is the intercept of the straight line on the y axis, and m is the gradient of the 
line.  In this case y is pHrt>  and x is [Ca], [Mg] or [Ca + Mg]. In statistical terms, the
164intercept is known as the constant The gradient term represents the magnitude of 
the efFect of the independent variable on pHn, and is known as the B coefficient.
The values of the B coefficient predicted by the regressions equations are -1.26 for 
calcium and -0.85 for magnesium, showing calcium having a greater individual effect. 
Scatter plots showing the regression are seen in figures 3.30, 3.31 and 3.32.
In summary, both mean urinary calcium and magnesium concentrations are 
significant individual predictors of pHn, with changes in calcium producing more 
marked changes in pHn  than changes in magnesium.
165Figure 3.30: Linear regression to illustrate correlation between mean urinary calcium
concentration and mean urinary nucleation pH
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Regression equation: pHn  = 8.42 - 0.126 [Ca]
P = 0.000
Linear regression demonstrates a highly significant negative correlation between
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166Figure 3.31: Linear regression to illustrate correlation between mean urinary
magnesium concentration and mean urinary nucleation pH
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Linear regression demonstrates a highly significant negative correlation between 
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167Figure 3.32: Linear regression to illustrate correlation between the sum of mean urinary
calcium and magnesium concentrations and mean urinary nucleation pH
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Linear regression demonstrates a highly significant negative correlation between the 
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1683.3.2  Multiple Linear Regression
In order to improve on the predictive power of mean urinary calcium concentration 
alone, a multiple linear regression model was computed to determine the combined 
effects of both calcium and magnesium concentration on pHn. These models produce 
equations of the form:
y = c + m-ix-, + m2x2 ...  mn Xn
Changes in multiple independent variables (xt, x2 ...  Xn) contribute in differing 
amounts (m^ m2 ...  mn) to changes in the dependent variable (y). Obviously, 
equations of this complexity cannot be plotted graphically.
Additive Multiple Regression Model
A model was constructed in the above form using both mean urinary calcium [Ca] 
and magnesium [Mg] concentrations to predict values of pHn (table 3.17)
[Mg] was not found to be a significant predictor of pHn, allowing for the explanation of 
the variation in pHn already predicted by the [Ca] variable. In other words, the P value 
of 0.831 for the [Mg] term indicates that there is no significant evidence that [Mg] 
should be included in this model as a predictor for pHn, when [Ca] is also included as 
a predictor.
The conclusion is that the most appropriate model of those considered so far is the 
model with just [Ca] as a predictor, as used in Section 3.3.1.
169Multiple Regression Model with Interaction
Additive models assume that the effects of changes in one variable are unaffected by 
the absolute level of the other variable. In other words, changes in calcium 
concentration would produce the same change in pHn  irrespective of the value of 
magnesium concentration. This is a good model of most systems.
To examine the theory that the effect of one variable might change depending on the 
value of the other, an interaction term [Ca]*[Mg] was calculated, as the product of 
calcium and magnesium concentration (table 3.18)
In this model, all of the terms are highly significant: for the variable Ca, P<0.001, for 
the variable Mg,  P=0.003, and for the interaction term [Ca]*[Mg], P<0.001.
The linear regression prediction equation is:
pHn  = 10.55 - 0.606 [Ca] - 0.130 [Mg] + 0.027 [Ca]*[Mg]
For the model with interaction r=0.875, and so is higher than the r of 0.704 for the 
model with just [Ca] as a predictor (section 3.3.1), indicating that the model with 
interaction provides the best fit for the data.
This model shows that changing the value of either calcium or magnesium 
concentration has less effect if the value of the other variable is already high.
170Table 3.17: Multiple linear regression - a model of the effect of mean urinary calcium 
and magnesium concentrations on nucleation pH
R
R2
Adjusted R2 
SE
0.705
0.496
0.440
0.4588
Term B coefficient SE P 95% Cl of Coefficient
Intercept
[Ca]
[Mg]
8.4922
-0.1199
-0.0083
0.3962
0.0419
0.0382
<0.0001
0.0104
0.8314
7.6599  to 9.3246 
-0.2079  to-0.0319 
-0.0886  to 0.0721
Table 3.18: Multiple linear regression - a model of the effect of mean urinary calcium 
and magnesium concentrations on nucleation pH with an interaction term ([Ca]*[Mg]) 
included
R 0.875
R2 0.766
Adjusted R2 0.725
SE 0.3216
Term B coefficient SE P 95% Cl of Coefficient
Intercept 10.5482 0.5408 <0.0001 9.4073  to 11.6891
[Ca] -0.6064 0.1137 <0.0001 -0.8462  to -0.3666
[Mg] -0.1303 0.0384 0.0035 -0.2113  to-0.0492
[Ca]*[Mg] 0.0275 0.0062 0.0004 0.0144  to 0.0405
1713.4 Urease Activity
The ability of the urease enzyme to hydrolyse urea to produce ammonia is the driving 
force behind catheter encrustation. This reaction produces both the ammonium ions 
necessary to form struvite, and the required high pH.  it was decided to investigate 
whether differences in urease activity between strains of Proteus isolated from 
different catheter users were significant, and if so, whether they were responsible for 
the differing levels of encrustation seen in catheter users.
Table 3.19: Mean urease activity of isolated urinary Proteus strains from three 
replicated assays.
Participant Strain number Urease Activity (pmol urea 
hydrolysed /  mg protein /  minute)
02 SWB001 0.38
04 SWB016 0.44
05 SWB017 0.35
06 SWB037 0.60
07 SWB023 1.04
09 SWB041 0.39
10 SWB046 0.74
11 SWB053 0.30
12 SWB056 0.51
13 SWB049 0.43
14 SWB083 0.07
15 SWB085 0.34
16 SWB089 0.28
17 SWB093 0.33
18 SWB098 0.30
19 SWB102 0.36
20 SWB108 0.36
21 SWB112 0.42
control urease +ve 0.46
control urease -ve 0.06
172Table 3.19 shows the mean urease activities of the various Proteus strains isolated 
from the trial participants, as compared to a wild type urease positive Pr. mirabilis and 
a urease negative mutant as controls. Strains isolated from participants 08 and 22 
were unavailable to test as they had been inadequately stored, and Proteus was not 
isolated from participant 03.
Two values stand out in this list. Strain SWB083 from participant 14 with an activity of 
0.07 pmol urea hydrolysed / mg protein / minute is effectively urease negative. 
Although this participant had a long catheter lifespan, their mean pHv was 6.98, only 
slightly below average for the study. Strain SWB023, a Pr. vulgaris from participant 
07, has a mean urease activity of 1.04 pmol urea hydrolysed / mg protein / minute 
which is considerably above average (3 standard deviations). This participant was a 
regular catheter blocker, but although they had an above average pHv of 7.66 this 
was only the fifth highest in the sample group.  Extremes of urease activity do not 
seem to be associated with extremes of pHv as might be expected, and for this 
reason it does not seem reasonable to use this as a simple explanation for the 
behaviour of their catheters.
There is no significant difference (P=0.659) between the distribution of urease 
activities of those strains from catheter users with a mean catheter lifespan of less 
than 28 days and those whose catheters last longer when compared using the Mann- 
Whitney U test (table 3.20). The highest urease activities are not found significantly 
more often in the most rapid encrusters. In fact, without the outlying values of strains 
SWB023 and SWB083, the mean urease activities of the catheter < 28 days and 
catheter > 28 days groups are almost identical at 0.42 and 0.40 pmol urea hydrolysed 
/ mg protein / minute respectively.
173Table 3,20: Mann-Whitney U test - comparison of mean Proteus urease activity (pmol
urea hydrolysed / mg protein I minute) between those catheter users with a mean
catheter lifespan greater than and less than 28 days.
n  |  18
urease by catheter lifespan n
Rank
sum Mean rank U
catheter < 28 days 7 72.0 10.29 33.0
catheter > 28 days 12 99.0 9.00 44.0
Difference between medians 0.042
95.5% Cl -0.082 to 0.375
Mann-Whitney U statistic 33
2-tailed p 0.659
There is also no significant correlation between urease activity and mean pHv(P = 
0.093), as shown in figure 3.33.
In conclusion, the differences in urease activity between different strains of Proteus 
are small, and the differences in catheter lifespan between catheter users with 
Proteus infections cannot be explained by the differences in urease activity of the 
strains they are infected with.
174Figure 3.33: A scatter plot to illustrate the correlation between the mean urinary voided 
pH of an individual and the urease activity of their colonising Proteus strain
9.5
9.0
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
0.2 0.6 0i8 1 0 0.4
urease activity (pmol wea hyctdysed/mg protein / min|
Pearson correlation coefficient r = 0.408 
Coefficient of determination r2 = 0.166
P = 0.093
Pearson’s correlation demonstrates a significant positive correlation between urease 
activity and mean pHv
1753.5  Behaviour of Bacterial Populations
3.5.1  The Persistence of Proteus Urinary Tract Colonisation
Urinary tract colonisation with Proteus seems to be persistent In the 20 participants 
with a Proteus infection (19 cases of Pr. mirabilis and one of Pr.  vulgaris) it was 
present constantly throughout the study, in urine and on catheters, in 17 cases. It was 
unaffected by seven out of the eight courses of antibiotics given to the participants in 
its presence. In participant 03 Proteus was not present at all, despite being isolated 
from the screening urine.
In one of these cases, participant 08, the Pr. mirabilis colonisation occurred in week 7 
of the trial, but was then present in every urine sample and on all catheters until the 
end of the study 9 weeks later.
There were two other cases where Pr. mirabilis was not persistent. In participant 06 it 
was not present in the final urine sample of the trial, taken immediately following a 
course of amoxicillin, an antibiotic to which it was resistant. It was still isolated from 
the catheter removed during this course of antibiotics. This participant died from the 
respiratory infection the antibiotics were being used to treat, so it is not known if Pr. 
mirabilis would have been seen in any subsequent samples. In participant 11, the 
organism was only isolated from urine in weeks 5 and 6, and not from the catheter 
retrieved in week 5. The subject was only followed up for a further three weeks, but 
the organism did not reappear.
1763.5.2  Frequency of Co-infections Associated with Proteus
Polymicrobial cultures were universally isolated from the urine samples collected 
during the study period. Table 3.21  shows the frequency of co-infection with other 
organisms in those 19 individuals with persistent Proteus colonisation. Participants 03 
and 11  have been excluded.
The most common organism other than Pr. mirabilis was Ent. faecalis. Also 
commonly present were E.  coli and Ps. aeruginosa. Pseudomonas colonisation 
appeared to be persistent, but E. coli was frequently present only fleetingly.
While it may appear from this table that slow encrusters are more likely to have 
persistent co-infection with organisms such as E. coli, Ps. aeruginosa and Kl. 
pneumoniae, these differences in frequency are not statistically significant (Fisher’s 
Exact test).
177Table 3.21: Number of participants with persistent Proteus colonisation from which 
other species were isolated from urine samples, either at any point during the trial or 
for three consecutive weeks (participants 03 and 11 excluded).
Rapid encrusters - mean catheter lifespan < 28 days
Bacteria
Isolated at any Point 
percent  number
3 Consecutive Weeks 
percent  number
Ent. faecalis 100% 9 89% 8
E. coli 67% 6 33% 3
Ps. aeruginosa 44% 4 44% 4
Kl. pneumoniae 22% 2 22% 2
Staph, aureus 22% 2 22% 2
Ent. durans 11% 1 11% 1
Citrobacter spp - - - -
Prov. rettgeri - - - -
Staph, intermedius 11% 1 11% 1
Serr. marcescens 11% 1 11% 1
M. morganii 11% 1 0% 0
Slow encrusters - mean catheter lifespan > 28 days
Bacteria
Isolated at any Point 
percent  number
3 Consecutive Weeks 
percent  number
Ent. faecalis 100% 10 100% 10
E. coli 80% 8 70% 7
Ps. aeruginosa 70% 7 70% 7
Kl. pneumoniae 40% 4 40% 4
Staph, aureus 20% 2 10% 1
Ent. durans 10% 1 10% 1
Citrobacter spp 20% 2 0% 0
Prov. rettgeri 10% 1 10% 1
Staph, intermedius - - - -
Serr. marcescens - - - -
M. morganii - - - -
1783.5.3  Comparison of Cultures from Urine and Catheters
The tips of the catheters removed from participants in the study were cultured in 
order to determine the bacterial constituents of the catheter biofilms. The catheter 
flora was compared to the flora isolated from the urine sample taken in the same 
week. In this way it can be seen how accurate a reflection of the biofilm the urine 
cultures are. In total, 75 catheters could be analysed in this way, as, inevitably, some 
catheters were lost or were not stored correctly.
The most obvious result was the consistency of Pr. mirabilis. This organism was 
isolated from the urine in every case when it was also isolated from a catheter, and 
was isolated from the catheter when it was present in the urine in all but two cases, 
showing that urinary culture is an accurate reflection of the presence of a Pr. mirabilis 
biofilm. The two cases where Proteus was not isolated from the catheter occurred in 
different participants. In participant 15, a very frequent blocker, the Proteus was 
present in catheters removed a few days before and after. In participant 11 the 
Proteus was present in the urine for only two weeks, possibly being cleared from the 
urine as it failed to establish a biofilm, although this individual was recruited to the 
study on the basis of a urine culture positive for Pr. mirabilis a few weeks earlier.
Pr.  vulgaris, the species seen consistently in participant 07, was not isolated from the 
retrieved catheters at all.
1793.6  Antibiotic Sensitivities
The antibiotic sensitivities of isolates of urease producing organisms from study 
participants was compared with that of isolates obtained from urine specimens sent 
to a hospital pathology laboratory (Southmead Hospital, Bristol, UK) in the same area 
and during the same time period as the study specimens were collected. Breakpoint 
values for antibiotic resistance were taken from British Society for Antimicrobial 
Chemotherapy Guidelines, which were in use in Southmead Hospital at the time 
[208J.
3.6.1  Sensitivity of Pr. mirabilis Isolates from Study Participants
Table 3.22 summarises the antibiotic resistance of Proteus samples from 19 long 
term catheterised individuals from the study group. Table 3.23 shows the antibiotic 
sensitivities, including minimum inhibitory concentration (MIC) results, for the study 
participant samples. Of the 19 Proteus samples, 2 (11%) were susceptible to all the 
antibiotics on test, 7 (37%) were resistant to one antibiotic, and 10 (53%) were multi- 
drug resistant. M. morganii SWB006, from participant 03, was also multi-drug 
resistant.
Table 3.22: Antibiotic resistance summary for Proteus isolates from the study group
Antibiotic Resistance 
percentage  number
Amoxicillin 47% 9
Nalidixic acid 11% 2
Trimethoprim 84% 16
Cefalothin 21% 4
Ciprofloxacin 0% 0
Gentamicin 16% 3
Co-amoxiclav 0% 0
180Table 3.23: Antibiotic sensitivities of clinical isolates (MIC - minimum inhibitor concentration (|ig/ml), R - resistant, I - intermediate, S - sensitive). 
Gentamicin and cephalothin breakpoints are from systemic Enterobacteriaceae breakpoint data, others from UTI (gram negative rod) data.
Organism Strain ID Nalidixic acid Cephalothin Ciprofloxacin Trimethoprim Gentamicin Co amoxiclav Amoxicillin
(participant) MIC Sffi MIC SIR MIC SIR MIC SIR MIC SIR MIC SIR MIC SIR
Pr mirabilis SWB112 21) 3 S 2 S 0.016 S >32 R 0.125 S 3 S >256 R
Pr mirabilis SWB108 20) 3 S 3 s 0.023 s 0.19 S 0.38 s 0.75 s 0.75 S
Pr mirabilis SWB102 19) 12 S 1.5 s 0.023 s >32 R 4 R 32 s 32 S
Pr mirabilis SWB001 02) 3 S 1.5 s 0.023 s 1.5 S 0.038 S 0.75 s 0.75 S
Pr mirabilis SWB085 15) 6 S 6 s 0.032 s >32 R 0.75 S 6 s >256 R
Pr mirabilis SWB089 16) 4 S 6 s 0.032 s >32 R 0.25 S 3 s >256 R
Pr mirabilis SWB083 14) >256 R 16 R 6 I >32 R 12 R 6 s >256 R
Pr mirabilis SWB098 18) 3 S 1.5 S 0.016 s >32 R 0.25 S 0.75 s 0.75 S
Pr mirabilis SWB093 17) 6 S 1.5 S 0.023 s >32 R 0.05 S 0.75 s 0.75 S
Pr mirabilis SWB053 11) 3 S 3 S 0.012 s >32 R 0.125 S 3 s >256 R
Pr mirabilis SWB079 13) 3 S 1 S 0.023 s >32 R 0.5 S 0.5 s 0.5 S
Pr vulgaris SWB023 07) 1.5 S 192 R 0.012 s 0.19 S 0.094 S 1.5 s >256 R
Pr mirabilis SWB041 09) 3 S 1 S 0.023 s >32 R 0.38 S 0.5 s 0.5 S
Pr mirabilis SWB017 05) 2 S 1 S 0.023 s >32 R 0.25 S 0.38 s 0.38 S
Pr mirabilis SWB049 13) 2 S 1 S 0.023 s >32 R 0.25 S 0.5 s 0.5 S
Pr mirabilis SWB056 12) 12 S 16 R 0.064 s >32 R 1 S 32 s >256 R
Pr mirabilis SWB046 10) >256 R 4 S 0.38 s >32 R 16 R 2 s >256 R
Pr mirabilis SWB037 06) 8 S >256 R 0.047 s >32 R 0.75 S 16 s >256 R
Pr mirabilis SWB016 04) 3 S 1 S 0.016 s >32 R 0.75 S 0.5 s 0.5 S
M. morganii SWB006 03) >256 R >256 R 0.08 s >32 R 0.32 S 0.96 s >256 R
1813.6.2  Sensitivity of Pr. mirabilis isoiates from a Local Population
The levels of antibiotic resistance found in the population from which the study 
participants were drawn were determined by examining data routinely collected by 
the pathology laboratory of the local hospital covering that area over the time period 
of the study. This is summarised in tables 3.24 and 3.25. The first table shows the 
antibiotic resistance of Proteus isolates from the urine of 145 non-catheterised 
individuals, and the second, the antibiotic resistance of Proteus urinary isolates from 
36 catheterised individuals. There is no significant difference between the two groups 
(P=0.166 for the most probable difference, trimethoprim sensitivity, by Fisher’s exact 
test).
The hospital laboratory had determined amoxicillin, nitrofurantoin, trimethoprim, co- 
amoxiclav and ciprofloxacin to be the antibiotics which should be used as the initial 
treatment of the various infections of the urinary tract. Sensitivity to other antibiotics 
was only tested for if the isolate proved resistant to the majority of these first line 
agents. The sensitivity of these organisms, already shown to be multi drug resistant, 
to cefuroxime (70 isolates) and gentamicin (65 isolates) is shown in table 3.26, in 
both the catheterised and non-catheterised individuals.
182Table 3.24: Antibiotic resistance of Proteus samples from 145 non-catheterised 
individuals submitted to a local hospital pathology laboratory
Antibiotic Resistance 
percentage  number
Amoxicillin 18% 26
Nitrofurantoin 99% 143
Trimethoprim 42% 61
Co-amoxiclav 5% 7
Ciprofloxacin 4% 6
Table 3.25: Antibiotic resistance of Proteus samples from 36 catheterised individuals 
submitted to a local hospital pathology laboratory
Antibiotic Resistance
percentage number
Amoxicillin 17% 6
Nitrofurantoin 100% 36
Trimethoprim 53% 19
Co-amoxiclav 6% 2
Ciprofloxacin 0% 0
Table 3.26: Resistance of organisms isolated from the local population to second line 
antibiotics. These isolates would have already proved resistant to some first line 
antibiotics.
Antibiotic Resistance
percentage  number
cefuroxime
catheterised 14% 6 of 42
non-catheterised 7% 2 of 28
total 11% 8 of 70
gentamicin
catheterised 0% Oof 28
non-catheterised 0% Oof 37
total 0% Oof 65
1833.6.3  Differences in Antibiotic Sensitivity between Study 
Participants and the Local Population
The antibiotic sensitivities of the study population and the local non catheterised 
population are summarised in table 3.27. The frequency of observed antibiotic 
resistance in the isolates from study participants was analysed using Fisher’s exact 
test to compare the non-catheterised samples from the hospital laboratory and the 
samples from the study participants (table 3.28).
The results show that that the observed difference in trimethoprim resistance of 
Proteus isolates between the study population of long term catheter users (84%) and 
the general population of non catheterised individuals (42%) is significant (P=0.001). 
The difference in amoxicillin resistance between study participants (47%) and the 
local population (18%) is also significant (P=0.013). The differences in sensitivities to 
the other antibiotics were not tested for significance due to the low numbers of 
samples obtained.
It seems reasonable to conclude that isolates of Pr. mirabilis from individuals with 
long term catheters are more resistant to commonly used antibiotics than isolates 
from non catheterised individuals with urinary tract infections.
184Table 3.27: Comparison of the resistance of organisms isolated from the local
population and the study population to common antibiotics
Antibiotic Resistance 
study participants  local population
Amoxicillin 47% 18%
Nalidixic acid 11% -
Trimethoprim 84% 42%
Cefalothin 21% -
Cefuroxime - 7%*
Ciprofloxacin 0% 4%
Gentamicin 16% 0%*
Nitrofurantoin - 99%
Co-amoxiclav 0% 5%
*The results for cefuroxime and gentamicin in the local population samples are from a subset 
of multi drug resistant isolates.
Table 3.28: Fisher’s exact test -  differences in antibiotic sensitivities for trimethoprim 
and amoxicillin between trial isolates and those seen in the local hospital pathology 
laboratory (R - resistant, S - sensitive)
Antibiotic
number
totals difference between 2-tailed p
R S proportions
trimethoprim
study participants 16 3 19
local population 61 84 145 0.421 0.001
totals 77 87 164
amoxicillin
study participants 9 10 19
local population 26 119 145 0.294 0.013
totals 35 129 164
1853.6.4  Effects of Antibiotic Use on Urinary Bacterial Populations in 
the Study Group
Several of the study participants received courses of antibiotic during the trial, 
although not necessarily for urinary tract infections. Table 3.29 summarises the effect 
on the cultured urinary bacterial species.
After four of the seven antibiotic courses for which good data was available there was 
no change in flora at all. Of the 23 colonising organisms present before the antibiotic 
courses,  18 were still isolated from the urine afterwards. Pr. mirabilis was eliminated 
in one out of six cases, and in that case it was still isolated from the catheter 
removed during the antibiotic course. This participant died from the respiratory 
infection the antibiotics were being used to treat, so it is not know if re-colonisation of 
the urine with Pr. mirabilis would have occurred. Re-cok>nisation with the other 
successfully eradicated bacteria did not occur during the time period of the trial, 
except for the case of E. coli in participant 18. This occurred six weeks after the 
antibiotics and so was probably a new infection from a source external to the urinary 
tract.
186Table 3.29: Effects of antibiotic use on urinary flora, showing the species isolated immediately before and after the course of antibiotic shown
participant bacteria isolated before antibiotic course bacteria isolated after
06 Pr. mirabilis, Ent.  faecalis, E. coli amoxicillin Ent. faecalis
08
Ent. faecalis, E. coli,  Kl. pneumoniae,  Staph, 
aureus
minocycline Pr. mirabilis, Ent. faecalis,  Staph, aureus
10 Pr. mirabilis, Ps. aeruginosa co-amoxiclav Pr. mirabilis, Ps. aeruginosa
16 Pr. mirabilis, Ps. aeruginosa ciprofloxacin Pr. mirabilis, Ps. aeruginosa
16 Pr. mirabilis, Ent. faecalis, Ps. aeruginosa,  E. coli ciprofloxacin Pr. mirabilis, Ent. faecalis, Ps. aeruginosa, E. coli
18 Pr. mirabilis, Ent. faecalis,  Ps. aeruginosa, E. coli clarithromicin and 
ciprofloxacin
Pr. mirabilis, Ent. faecalis,  Ps. aeruginosa
21
Pr. mirabilis, Ent. faecalis, Kl. pneumoniae,  Ps. 
aeruginosa
trimethoprim
Pr. mirabilis, Ent.  faecalis, Kl. pneumoniae,  Ps. 
aeruginosa
Note: Participant 18 was one week in to a two week course of cefaiexin when the study started. The bacteria cultured in that week and after the end of the 
course were the same: Pr. mirabilis, Ps.  aeruginosa and E. coli.
187Most worrying is the emergence of a Pr. mirabilis infection in participant 08 following 
a course of minocycline (directed by antibiotic sensitivities against a wound infection 
at her suprapubic catheter site) which removed E.  coli and Kl. pneumoniae from the 
urine. While this could be a coincidence, it is also a possibility that the antibiotic 
allowed colonisation of the catheter once the existing flora had been removed. 
Following colonisation by the Proteus, this catheter user developed severe 
encrustation.
Ent. faecalis and Ps. aeruginosa survived in five out of five cases. E. coli, however, 
was cleared from the urine in three out of four cases.
Participant 16 was on a constant prophylactic course of nitrofurantoin, during which 
Pr. mirabilis, Ent. faecalis, and Ps. aeruginosa grew persistently, new colonisation 
with E. coli and M. morganii occurred, and he suffered two symptomatic urinary 
infections which required additional antibiotics as shown in the table.
1883.7  Comparison of Urine and Stool Cultures
Pairs of faecal and urinary Pr. mirabilis isolates were obtained from catheter users in 
order to compare the strain present in the subject’s urine with that present in their 
gastrointestinal flora. Both the faecal and urine sample from each subject were 
collected on the same day. From faecal cultures obtained from 18 subjects with Pr. 
mirabilis urinary tract colonisation, Pr. mirabilis was isolated from faeces in 10 cases. 
To assess whether they were the same strain of organism, and therefore whether the 
gastrointestinal tract was likely to be the source of the urinary tract colonisation, pairs 
were Dienes typed and then genotyped by Pulse Field Gel Electrophoresis (PFGE).
3.7.1  Dienes Typing
When two Proteus colonies are incubated on the same agar plate until their swarming 
fronts meet, they will either merge into one another or repel each other to form a clear 
line of demarcation. Those which repel are regarded as different strain types and the 
Dienes test is designated as positive.  If the colonies merge the test result is negative 
and the isolates are regarded as the same strain type. Figures 3.34 and 3.35 show 
examples of negative and positive Dienes typing. Table 3.30 shows the results of the 
Dienes typing.
Phenotyping using the Dienes test showed no lines of mutual inhibition between any 
of the paired isolates from the urine and faeces of an individual participant. All sample 
pairs from the same subject merged, indicating that they were of the same Dienes 
type.  Inhibition lines were seen between all isolates from different subjects.
Therefore, by Dienes typing, each subject was colonized by a distinct Pr. mirabilis 
strain, and this strain was present in both the urine and faeces of that individual.
189Figure 3.34: A negative Dienes test result. Two strains of the same Dienes type merge 
when they meet.
Figure 3.35: A positive Dienes test result. Two different strains repel each other 
forming a Dienes demarcation line between them.
190Table 3.30: Dienes typing results, showing isolate combinations which formed 
demarcation lines (+) and combinations which merged (-). Isolates are labelled as 
participant number followed by U for urinary origin and F for faecal origin.
16U 16F 23U 23F 24U 24F 25U 25F 26U 26F 02U 02F 13U 13F 18U 18F 20U 20F 21U 21F
- - + + + + + + + + + + + + + + + + + + 16U
- + + + + + + + + + + + + + + + + + + 16F
- - + + + + + + + + + + + + + + + + 23U
- + + + + + + + + + + + + + + + + 23F
- - + + + + + + + + + + + + + + 24U
- + + + + + + + + + + + + + + 24F
- - + + + + + + + + + + + + 25U
- + + + + + + + + + + + + 25F
- - + + + + + + + + + + 26U
- + + + + + + + + + + 26F
- - + + + + + + + + 02U
- + + + + + + + + 02F
- - + + + + + + 13U
- + + + + + + 13F
- - + + + + 18U
- + + + + 18F
- - + + 20U
- + + 20F
- - 21U
- 21F
1913.7.2  Pulsed Field Gel Electrophoresis
Genotyping by PFGE of bacterial DNA also showed that each subject was colonized 
by a distinct strain of Pr. mirabilis. Within the applied typing criteria, seven of the 10 
subjects had genetically indistinguishable strains in both their urine and faeces. Three 
subjects had closely related strains, differing by a single genetic event (participants 
23, 24, and 25). This degree of genetic difference can be found by repeatedly 
culturing a strain in a laboratory, or by examining multiple isolates from the same 
source taken over an extended period of time. It is therefore probable that these 
isolates originated from the same source. Figure 3.36 shows the results of the PFGE.
There was no relationship between the strains isolated from three subjects who were 
resident in the same nursing home at the same time (participants 02, 20 and 13).
192Fig. 3.36: PFGE patterns of Pr. mirabilis DNA restriction fragments from pairs of isolates of urinary (U) and faecal (F) origin. Numerals identify the 
different subjects. Lanes marked M contain the molecular size markers.Section 4 - Discussion
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194Refining our Understanding of Catheter Encrustation
The simple view of catheter encrustation has long been that crystal precipitation 
occurs when the pH of the catheter user’s urine became alkaline as a result of urinary 
tract colonisation with a urease positive organism. Strategies to control catheter 
encrustation have therefore been directed towards preventing this rise in pH, by 
aiming to prevent colonisation or eradicate the bacteria, to acidify the urine, or to 
inhibit the actions of bacterial urease. None of these methods has proved successful.
What was obvious to the clinician, however, was that despite being colonised by the 
same bacteria and having alkaline urine, catheter users blocked their catheters at 
markedly different rates. Unfortunately, by comparing ‘blockers’ with ‘non-blockers’ in 
an attempt to discover the factors leading to catheter encrustation, most previous 
studies had compared those with urease positive bacteriuria to those without, but in 
the absence of organisms such as Proteus, encrustation is unlikely irrespective of 
other urinary factors. This study aimed to define the limits of the variation in the 
severity of encrustation in long term catheter users with Proteus bacteriuria and 
investigate whether different individuals had different susceptibilities to encrustation 
which may be exploited in future treatments.
1954.1  The Prospective Study
4.1.1  Noteworthy Participants
Among the individual participants in the study, several show interesting patterns of 
results which may provide insight into the problem of catheter encrustation.
Participant 03
Although participant 03 tested positive for Pr. mirabilis in the pre-trial screening, this 
organism was not isolated again during the study follow up, either from catheters or 
urine. Both the M. morganii and the Ps. aeruginosa isolates were urease positive 
according to the standard urease test used during the identification process, but both 
organisms have very low urease activity compared to Proteus. This is reflected in the 
low pHv and minimal catheter encrustation seen. Although this study focuses on 
Proteus as the leading cause of encrustation related catheter blockage, it should be 
noted that urease positive organisms other than Proteus can certainly cause 
encrustation.
Participant 06
Participant 06 was a 101  year old individual resident in a nursing home (see figure 
3.6).  Despite her age, she was reasonably healthy until her final illness. She had 
previously suffered a stroke, limiting her mobility and suppressing her gag reflex. As 
well as requiring a urinary catheter for functional incontinence due to her limited 
mobility, she was unable to swallow thin liquids without risk of choking. She was able 
to eat normally, but had quite a suppressed appetite. Because of these two issues,
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enables liquids to be fed directly into the stomach, bypassing the throat and 
swallowing mechanism. In this lady’s case, it was used to increase the amount of 
water she could drink as well as providing some enteral feeding to top up her slightly 
inadequate daily nutrition. As a resuit of this, she had a greater daily fluid intake than 
many other participants in the study.
Her results show a consistently high voided pH (mean 7.65), ranked 6th  overall. She 
maintained a nucleation pH which was always higher than this (mean 8.96), and was 
the highest recorded in the study. This gave a mean safety margin of 1.33, the 6th 
highest in the study, and led to her first catheter only blocking after 13 weeks, and 
then showing only a small area of encrustation. Her mean urinary magnesium 
concentration was among the lowest in the trial group, and her calcium concentration 
was the lowest. This might suggest dilute urine, with the obvious factor contributing to 
this being her PEG feed.
Morris and Stickler studied the effects of increased fluid intake and urinary dilution 
[211]. Pooled urine was collected from test subjects who drank normally, or who 
drank an extra 1000 ml of water per day, and was tested in an artificial catheterised 
bladder model. The urine was inoculated with Pr. mirabilis, and encrustation, as the 
amount of calcium and magnesium recovered from the catheters in the model after a 
set time period, was measured. Significantly less encrustation was formed using the 
urine from the subjects who supplemented their fluid intake. In a similar test by the 
same authors, artificial urine was diluted to various strengths to model an increased 
fluid intake. It was run through the catheterised model bladders at increased rates 
according to the degree of dilution such that the same quantity of solute flowed 
through the catheter per unit time in each case. Those catheters tested with the 
dilute, high flow urine took longer to block. This suggests a highly beneficial role for
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between blockers and non-blockers as defined by the degree of observed 
encrustation [46}. However, in those with no trace of encrustation their fluid intake is 
irrelevant. Without urease producing organisms in their urinary tract they will not 
encrust, at least by the crystalline btofilm mechanism. Comparing possible risk factors 
for encrustation between blockers and non-blockers is unhelpful unless a group of 
non-blockers colonised with urease positive organisms is found.
Participant 12
In contrast is participant 12 (see figure 3.12). This gentleman was a resident at the 
same nursing home as participant 06. He had a urethral catheter for bladder outlet 
obstruction caused by locally advanced prostate cancer. He was fed normally, 
although he also had a poor appetite and low fluid intake. Like participant 06, he had 
a long catheter life.
Although he had the third highest mean nucleation pH (8.58) in the group, probably 
partly due to having the lowest and second lowest mean urinary magnesium and 
calcium concentrations respectively, he also had a consistently high voided pH (mean 
8.98), the highest in the trial. This led to a negative safety margin of -0.5, which would 
have been thought to encourage more severe encrustation than actually occurred. It 
is unclear as to why there was not more encrustation. This pHv result is an obvious 
outlier among the other mild encrusters.
This participant dropped out of the trial after only five weeks, so there is less 
confidence in the data than with the other trial participants, and it could be that his 
usual urinary state was as shown in his first and last urine samples, with his 
nucleation pH clearly above his voided pH.  Due to the short period of time that he
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data set had been in for three weeks when urine was not being analysed, and this 
could explain the discrepancy. It should be noted that the period of time he was in the 
trial was not obviously unrepresentative, looking at his past health records. His 
catheter lifespan was typical for him, and there was no change in diet, fluid intake, 
medication, level of function, or health. What is clear is that the low calcium and 
magnesium concentrations he exhibited could not be due to dilute urine. Although 
urine output was not formally measured in this trial, he was being cared for by the 
same nursing staff as participant 06. They reported his urine output to always be 
extremely poor, as compared to participant 06’s which was reported to be very good. 
This agrees with the experience of this researcher. Part of the reason for lack of data 
on this gentleman is that even after clamping his catheter for an hour, sufficient urine 
could not be obtained to perform a nucleation pH analysis.
Participant 08
It is a common finding that catheter users do not suffer from encrustation when 
initially catheterised. They describe a few months, or sometimes even years, of using 
a catheter without any problems with encrustation, before suddenly the catheter 
starts to block. This is thought to be due to the colonisation of the urinary tract with a 
urease positive organism, and is demonstrated by participant 08 (see figure 3.8).
This lady grew Ent. faecalis, E. coli, Kl. pneumoniae and Staph,  aureus for the first 
six weeks of the study before she was given a course of minocycline for a wound 
infection at her suprapubic catheter site in week 6. This cleared her urine of the E. 
coli and Kl. pneumoniae, but immediately following the antibiotics, a urease positive 
Pr. mirabilis was isolated. After two weeks the Staph, aureus disappeared from the 
urine leaving only Ent. faecalis and the Proteus for the last seven weeks of the study.While the Kl. pneumoniae isolate was urease positive according to the standard 
urease test used to identify bacteria, this organism has a considerably lower urease 
activity than Proteus. The urinary pHv increased noticeably over the two weeks 
following the arrival of Pr. mirabilis from a mean of 5.23 in the first six weeks to a 
mean of 8.27 in the last seven. The pHn, however, remained approximately the same 
at means of 6.94 compared to 7.11 over these same periods. This resulted in the 
voided urine changing from being comfortably below the nucleation pH to being 
above it. The mean safety margin changed from 1.71  in the first six weeks to -0.85 in 
the last seven.
This resulted in a change from a catheter non-blocker to a blocker. The catheter that 
had been in place for eight weeks since the start of the study blocked two weeks after 
the colonisation with Proteus. Catheters then started to block on a weekly basis, 
being heavily encrusted each time. Each of these catheters was colonised with Pr. 
mirabilis and Ent. faecalis. The catheter recovered in week 1 was colonised only with 
Ent. faecalis. While calcium deposits were found on the first catheter there was very 
little magnesium. In contrast, the catheters colonised with Proteus showed high levels 
of magnesium deposits, perhaps indicating a change to struvite from a previously 
different mineral type.
Participant 15
Participant 15 was the most rapid encruster in the study (see figure 3.15). She was 
an 88 year old female with a urethral catheter for functional incontinence. She had 
extremely poor mobility following several strokes, and was cared for at home by her 
husband. She received treatment with Suby G (3% citric acid) catheter maintenance
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lifespan of 3.2 days, with a consistent range of 2 to 4 days.
Her pHv was average for a catheter user with Pr. mirabilis, at a mean of 6.98. She 
did, however, have the highest mean urinary calcium (16.2 mM) and magnesium 
(20.2 mM) levels in the study group, and, probably as a result of this, had the second 
lowest mean pH„ at 6.89. Her pHv was normally higher or only slightly lower than her 
pHn, resulting in extensive crystal precipitation.
Once again, the reason for this particularly high concentration of calcium and 
magnesium is likely to be concentrated urine.  Urine output was not formally 
measured, but judging by the frequency with which the drainage bag was emptied it 
was very low, and fluid intake was reported to be poor.
She received twice weekly instillations of an acidic catheter maintenance solution 
throughout the trial. The lack of clear evidence for the effectiveness of acidification 
has been discussed, but in this case there is the practical point that these catheters 
blocked so quickly that many were subject to no installations, and even those that 
were received only one treatment.
Participant 16
Participant 16 was a reasonably fit 80 year old gentleman with a suprapubic catheter 
for a combination of bladder outlet obstruction and detrusor underactivity (see figure 
3.16). He had a history of suffering from recurrent episodes of symptomatic urinary 
tract infection. As a result, he was prescribed a regular treatment of prophylactic low 
dose nitrofurantoin to try and prevent these episodes. He had been taking this for 
several months before the study and continued taking it throughout the period of
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catheterised individuals or those with uncomplicated urinary tract infections, had 
resistance rates to this antibiotic of almost 100%. It was used as more common 
uropathogens such as E. coli were still overwhelmingly sensitive. It should be noted 
that this individual did develop colonisation with E. coli during the study, suggesting 
the selective pressures which may be placed on bacterial populations by persistent 
antibiotic use. The possible advantages of not eliminating reasonably easy to treat, 
urease negative organisms such as E. coli are discussed further in this section with 
regards to participant 19.
Even with this prophylaxis, participant 16 developed two symptomatic urinary 
infections towards the end of the study period, both of which were treated with 
ciprofloxacin.  It is unclear which of the several urinary tract organisms carried by this 
gentleman was responsible for his symptoms, as is often the case with catheter 
associated infection. What is clear, however, is that despite his symptoms resolving 
with treatment, his urinary flora remained completely unchanged on both occasions. 
The strain of Pr. mirabilis he was colonised with was sensitive to ciprofloxacin when 
tested, but despite this it persisted along with Ps. aeruginosa,  E. coli and Ent faecalis 
(of unknown sensitivities). This is also despite the suggestion that ciprofloxacin and 
the other fluoroquinolones may be effective anti-biofilm agents, as demonstrated in 
experimental models of Ps. aeruginosa catheter biofilms [212,213} and in a clinical 
trial previously discussed in section 1.4.4 [112].
Participant 19
This gentleman had a urethral catheter because of bladder outlet obstruction caused 
by benign prostatic enlargement.  He declined an operation on his prostate as he had 
a degree of cardiac failure which would have increased the risks of anaesthesia. He
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catheter encrustation and blockage despite being catheterised for several years.
He had a mean nucleation pH of 7.87 which was fairly average for the study 
participants, with average urinary calcium and slightly above average magnesium 
concentration (see figure 3.19). What was surprising, given his persistent urinary tract 
and catheter colonisation with Pr. mirabilis, was his extremely low mean voided pH of 
4.77, the lowest in the group and over two standard deviations from the mean. Both 
the pHv and pHn  also showed little week to week variability.  It is clear to see why 
crystals did not precipitate from this gentleman’s urine to form encrustation on his 
catheters, given the mean difference between pHn  and pHv was 3.11.
What is interesting is why his pHv was not raised higher by his Proteus infection. The 
Proteus strain he carried had a urease activity which was slightly below average, but 
still higher than the two most rapid encrusters in the study, so this does not offer an 
explanation. A greater than average fluid intake may reduce encrustation, but this 
would likely be by lowering the calcium and magnesium concentrations and raising 
the nucleation pH. The voided pH may not change substantially as the urease 
enzyme should be able to increase urea hydrolysis to compensate for the ammonia 
dilution, although this may be limited by the flow through the system. Even so, this 
participant did not seem to have a significantly higher than normal fluid intake.
The low pH may be due to the presence of other bacterial species. An in vitro study 
by Edin-Liljegren et al demonstrated that urease added to urine inoculated with E. coli 
produced less ammonium, less of a pH rise, and fewer precipitating crystals than 
urease added to sterile urine [214]. This gentleman did have E. coli isolated from his 
urine almost every week, and it was isolated from both his catheters, even when not 
concurrently present in the urine. In most trial participants isolation of E. coli was not
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reducing the urease activity of the Proteus. However, reasonably consistent E. coli 
colonisation was also found from the urine samples of participants 02, 04,09, and 14, 
and they had average or above average voided pH. Except in the case of participant 
02, and on one occasion from participant 04, E.  coli was not found on their catheters, 
and this may be more important.
The Pr. mirabilis in this gentleman’s urine showed colony counts of around 5.0 x 106. 
While colony counts were not performed routinely on the urinary isolates, on those 
occasions when it was tested, the Proteus species in the urine of other participants 
had similar counts. For example, in participant 20, Pr. mirabilis counts were found to 
be 6.8 x 106. What is perhaps more interesting is the counts of the other organisms 
present in the urine. In participant 20, Proteus was the dominant organism, with Prov. 
rettgeri and Ent.  faecalis having counts of 9.0 x 105 and 1.0 x 105 respectively. In 
participant 19, the other organisms had higher counts than the Proteus, with Kl. 
pneumoniae and Citrobacter spp having counts of 1.3 x 107 and 1.37 x 108.  It is 
possible that the Proteus was prevented from increasing in numbers by the presence 
of other organisms on the catheter, or in the urine.
The phenomenon of bacterial interference may offer an explanation. This involves 
clinically using deliberate colonisation with non-pathogenic organisms to prevent 
symptomatic infection caused by pathogenic organisms [215]. Trautner et al have 
investigated the role of bacterial interference in catheter colonisation in an in vitro 
model. Lengths of hydrogel coated latex catheter were incubated in broth with E.  coli 
83972, an avirulent strain, for 24 hours. These sections, along with controls which 
had been incubated in sterile broth, were then exposed to pathogenic urinary tract 
organisms, isolated from individuals with symptomatic infections, for 30 minutes. The 
colony counts of pathogenic organisms were significantly lower on the pre-inoculated
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colonisation by Ent faecalis, pathogenic E. coli, Prov stuartii, and the fungal 
uropathogen Candida albicans [216,217]. It could be argued that the ability of an 
existing biofilm to reduce the colony counts of recently invading organisms over a 
period of 30 minutes, even in the growth enhancing medium of culture broth, may not 
translate into an ability to resist colonisation in a clinical situation over a period of 
many months.  Investigations into bacterial interference in non-catheterised 
individuals suggest that the effects could be long lasting. By purposefully colonising 
the bladders of spinal cord injured individuals with E. coli 83972, the safety and 
efficacy of this approach as a therapeutic tool was demonstrated in prospective 
clinical trials [218,219]. A significant reduction in the incidence of symptomatic urinary 
tract infections was seen when those whose bladders were successfully colonised 
were compared with their own pre-colonisation infection rates and the rates in those 
individuals where colonisation failed. A moderate reduction in infection rates of 
women suffering from recurrent urinary tract infections was also observed after 
deliberate vaginal colonisation with non-pathogenic Lactobacillus spp [220,221]. 
Would an organism such as E. coli, whether pathogenic or not, be capable of 
suppressing the growth of Pr. mirabilis?
Work by Sabbuba et al has shown that Pr. mirabilis is capable of swarming over 
catheters in the presence of several other bacterial species [146]. Two separate 
blocks of agar were linked by a bridge of catheter material. At one side of the bridge 
the agar had been colonised by a bacterial species isolated from a catheterised 
individual. Pr. mirabilis was inoculated to this side of the bridge, and its ability to 
migrate through the other species, across the catheter bridge, and to colonise the 
other agar block was assessed. Isolates of E. coli, Kl. pneumoniae, Staph, aureus 
and Ent faecalis did not significantly inhibit the Proteus, although the isolates of Serr. 
marcescens and Ps. aeruginosa did. Kl. pneumoniae and Staph,  aureus, unlike the
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degree of cooperation between the species. Again, there may be important 
differences in the mechanisms interacting in such an in vitro experiment, and those 
which govern species dominance in a catheter biofilm over a period of months.
As well as E.  coii, this participant also had persistent urine and catheter isolates of Kl. 
pneumoniae and Ps. aeruginosa, so if bacterial interference was responsible for the 
low Proteus counts, it may not have been due to, or solely due to, E. coli.
Even though the urease activity of this strain of Pr. mirabilis was not unusual, and it 
possessed normal swarming activity, it is possible that it lacked some virulence factor 
which may have allowed other Proteus strains to more fully dominate their 
environments despite the presence of other organisms. It is also possible that one of 
the other species present may have possessed an uncommon virulence factor 
allowing K to suppress the growth of other bacteria.
4.1.2  Variation in Catheter Lifespans in Individuals
The classic study on catheter lifespans was produced by Norberg et al [178J. They 
conducted a survey of 20 inpatients with indwelling catheters from long stay geriatric 
wards in a Swedish hospital. The patients all suffered from forms of dementia. They 
used silicone coated latex catheters of various sizes which were aimed to be 
changed routinely every 30 days, although this was not always done. They were 
selected as problem patients from a larger group of 50 because they had shortened 
catheter lives, due either to ‘catheter blockage’ or ‘the patients wrenching their 
catheters out’. The authors demonstrated considerable variation in catheter lifespans 
both between individuals and within the experience of a single patient.  They describe 
the scatter of catheter lifespans as being wide and skew in most patients, with those
206who tended to have long lifespans occasionally having very short ones and vice 
versa. They did,  however, conclude that a useful measure of catheter lifespan in a 
patient could be obtained from measuring the time to blockage of 3 to 5 catheters.
In their study, the median value of median catheter lifespans was 9 days (range 3-35, 
interquartile range 6-16).  In the present study, the distribution of catheter lifespan 
means (and medians) was normally distributed, possibly due to not imposing an 
upper limit to catheter lifespan of 30 days, but for comparison the median of median 
catheter lifespans was 29 days (range 3-70, interquartile range 15-47.5). The mean 
of means was 32.7 days.
The different selection criteria in the two studies are probably responsible for a large 
part of this disparity. In the Norberg study, patients were recruited whose catheters 
tended to be changed more often than the planned period of 30 days, which was the 
desired interval in their hospital. They selected the worst affected patients. In the 
present study, recruitment was on the basis of urine microbiology, with no reference 
to catheter lifespan. This was deliberate, as it was intended to take account of those 
slow encrusters who were normally excluded from studies which define catheter 
encrustation by a short catheter lifespan. The usual definitions of catheter blockage 
used in studies are catheters lasting less than either one month or six weeks. As can 
be seen from figure 3.23 and table 3.1, up to eight of the participants in the present 
study could have been excluded using a 30 day criteria, even though they did suffer 
from unpredictable encrustation related blockage. The present study demonstrates 
that encrustation does occur at median or mean intervals greater than 30 days, and 
indeed greater than six weeks. Getliffe also found that a few individuals whose 
catheters usually lasted longer than six weeks had encrustation visible on those 
catheters [46]. As it is arguably the unpredictability of blockage, more than the 
frequency, which is actually inconvenient to the catheter user, it is important to
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severe problems, the mechanisms by which these individuals are resistant to 
encrustation will not be appreciated. As these mechanisms may be applicable to all 
catheter users, opportunities to improve the management of this problem may be 
missed.
The goal of the Norberg study was to investigate shortened catheter life from all 
causes, not specifically to study catheter encrustation. As well as those who had their 
catheters changed prematurely by the nursing staff, the researchers also recruited 
patients who had removed their own catheters. This would include those who 
suffered from spontaneous catheter expulsion due to urethral sphincter damage, as 
well as those who pulled out their catheters because of their dementia.  It is not 
difficult to remove a catheter by simply pulling on it, even if the balloon is inflated. The 
proportion of the study group made up by these patients is not specified. In the 
clinical experience of the current author, catheter expulsion would probably not be 
particularly common. However, in a study consisting entirely of patients hospitalised 
with dementia, self-removal of catheters may occur quite frequently. This could affect 
the data in two ways: a patient with a normally long catheter lifespan may experience 
occasional short lifespans due to catheter removal, or a confused patient particularly 
irritated by their catheter may remove it very regularly. Both of these patterns are 
seen in the Norberg data.  However, both of these patterns are also seen in the 
present study, represented by participants 04 and 15, where it is known that the 
catheters were blocked by encrustation.
Another area of possible inaccuracy is the common phenomenon of detrusor 
overactivity causing catheter bypassing and so mimicking a catheter blockage. A 
carer will often assume that a blockage has occurred and change the catheter, 
leading to a shortened catheter lifespan unrelated to encrustation.  It is unclear how
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der Meer found that only 18% of long term catheters were changed at the planned 
one month interval. 54% were changed early because of blockage, 25% because of 
bypassing, and 3% removed by the patient [44]. The most common replacement 
interval for blocked catheters was 2 weeks and for bypassing catheters, 3 weeks. 
Data about catheters rather than average lifespan values per patient will, of course, 
over-represent those individuals with particularly short catheter lives. In the present 
study, looking only at encrusted catheters, only 25% lasted for 30 days or more, but 
mean catheter lifespans greater than 30 days were found in 12 of the 21 participants. 
Another indication of the frequency of bypassing mimicking blockage is a study by 
Kunin et al [45]. Of catheters which were removed prematurely, only 50% were 
blocked or showed poor flow on subsequent testing. Getliffe found that 21% of those 
whose catheters were changed more often than every six weeks had no visible 
catheter encrustation, although the reasons for these changes were not explored 
[46]. It is vital that in studies of encrustation, catheters are examined to exclude those 
who suffer from other problems.
Even with these caveats, it appears that the present data follows the pattern 
previously described by Norberg et al, except that it is possible for encrustation to be 
a slower process than sometimes appreciated.
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4.2.1  Variability in Measured Values
Individual values of nucleation pH, voided pH, calcium and magnesium concentration 
showed considerable week to week variability. Individual measured values cannot be 
used as rf they were representative of a catheter user. Several measurements must 
be taken in order to use a mean value, which can then be used to characterise an 
individual.
Considerable differences exist in the mean pHv values of the participants, even 
between those colonised with Pr. mirabilis. In the literature, average values of pHv for 
non-blockers (however defined) range from 5.97 to 6.42, and for blockers, from 6.88 
to 7.85 [46,148,149,222]. Most of these non-blockers did not have urease positive 
bacteriuria. The mean pHv values from the Proteus colonised individuals in the 
present study overlap this entire range. It is clear from the individual patient graphs 
(figures 3.02 to 3.22) that individual values of pHv are unreliable for determining the 
severity of the encrustation suffered by a Proteus colonised catheter user.  It appears 
that even mean values of pHv are not reliable, given the lack of significant difference 
between the rapidly and slowly encrusting groups.  Participant 05, with a mean pHv of 
6.42, has a very short mean catheter lifespan, while participant 06, with a mean pHv 
of 7.65, has a considerably longer one.
Hedelin et al suggest that struvite precipitation occurs predominantly above a critical 
pHv value of 6.7 to 6.8, based on their findings that very little encrustation is 
deposited on the catheters of those with a mean pH below this [223]. Choong et al 
show mean pHn  values for non-blockers of 7.46 (SD 0.73) and for blockers with
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single urine specimen per subject. These investigators also identified a small subset 
of blockers without detectable urease positive organisms. They found that they had a 
significantly lowered nucleation pH of 6.45, and hypothesised that crystal formation 
might occur in some catheter users due to this abnormality of urinary chemistry rather 
than a rise in urinary pH, much as calculi occur in the upper urinary tract largely in the 
absence of infection. This group did have a raised pHv, however, at 7.36, which 
would have put them at risk of encrusting even had they had the mean pHn  of the 
non-blocking group. It is therefore possible that urease positive bacteria were present 
on the catheters, which were not analysed, but not found in the urine on the single 
sample taken. The results of the present study show that pHn is variable between 
individuals with urease positive bacteriuria, even when means of values sampled 
over many weeks are compared. This study has uncovered individuals with 
consistently high values (participants 06 and 17), as well as those with consistently 
low values (participants 05 and 15). This demonstrates that real differences exist in 
this value between the urines of different individuals, contributing to their differing 
susceptibilities to encrustation. This is reflected in the highly significant difference in 
pHn  between rapid and slow encrusters. However, in some subjects, this value varied 
dramatically from week to week (participants 20 and 22), suggesting that it is not 
fixed in an individual.
Overall, the variability of mean pH„ follows a normal distribution, not suggesting a 
clear distinction between a normal pHn  and an abnormally low pHn  due to some 
distinct metabolic defect in this group. It would seem logical, however, that those 
metabolic defects responsible for aseptic calculus formation in the upper urinary 
tracts of some individuals would predispose them to encrustation, even in the 
absence of urease positive bacteriuria, should they ever be catheterised. None of the 
participants in this study had a history of non-infective renal calculi.
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catheter encrustation and those without is due to a narrowing of the gap between the 
pH of the urine and the pH at which the salts in it will precipitate out of solution.  In 
those who have urease producing organisms in their urine, at least in some cases 
this narrowing can be explained by a lower value of the nucleation pH rather than an 
increased urinary pH.  For example, from figure 3.25 it can be seen that the mean pHv 
for participants 15 and 18 is similar (6.98 and 6.89 respectively), but that because of 
a much lower mean pHn  in participant 15 (6.89) compared with participant 18 (8.73), 
the mean safety margin seen in figure 3.24 is negative for participant 15 (-0.10) and 
positive for participant 18 (1.83). This explains why participant 15 was a very rapid 
blocker and participant 18 rather slow (shown in figures 3.15 and 3.18).
It therefore seems that there may be a way of treating the problem of catheter 
encrustation other than simply lowering pHv, which is the effective goal of current 
strategies. It is possible that if the factors determining these differences in pHn  could 
be determined, it may be possible to raise pHn  to a point at which little crystal 
deposition would occur.
4.2.2  Catheter Encrustation Rate
Dividing the participants into rapid and slow encrusters on the basis of their 
calculated encrustation rate demonstrated the same significant differences in urinary 
constituents as when they were divided by using their mean catheter lifespan, except 
that the difference in safety margin was no longer significant. There was also 
considerable variability in the results for each individual participant (table 3.10).
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the problem of catheter blockage than the catheter lifespan, for the purposes of 
experimental data collection. Theoretically, all catheters could be used to calculate 
the value. Even if they had been removed before blockage had occurred, either 
routinely or accidentally, some encrustation would have formed that would allow a 
value to be calculated. It was also hoped that it would prove more consistent between 
catheters in any individual than the value of catheter lifespan. Norberg et al showed 
that catheter lifespan was a useful parameter for measuring catheter function, but 
that the scatter of individual catheter lifespan results for any given catheter user 
meant that isolated readings could not be used [178]. This was found to be quite 
variable in this study, as is widely recognised clinically, and there are several reasons 
which might account for this.
in the clinical situation, catheters may be changed because of a number of conditions 
which mimic blockage. The catheter may be blocked by twisting of the tubing, or a 
severe episode of spasm may imitate a blockage. These conditions can occur in 
those known to have catheter encrustation. In these cases where the exact problem 
is not known, the care staff will change the catheter. If the cause was encrustation, 
the immediate problem is solved.  If it is not, no harm is done. It is the safe option to 
change the catheter, and as most catheters are not inspected for encrustation, 
catheter blockage will be recorded in the notes as the ‘reason for change’.
The final event leading to catheter blockage may not actually be the formation of new 
crystals. While a steady rate of crystal deposition will gradually narrow the catheter 
lumen until it is completely occluded, it is possible that this rarely occurs in the in vivo 
situation. Once the catheter lumen is sufficiently narrowed, it may become suddenly 
occluded by a piece of debris. The random size of these debris particles would lead 
to obstruction with differing amounts of encrustation at each blockage event. The
213debris could be a dislodged piece of encrustation from more proximaliy in the 
catheter, a piece of bladder stone, a blood clot, or a mucus plug. Mucus is formed in 
the catheterised, bacterially colonised bladder in large quantities, and this is 
commonly seen being passed through the catheter tubing. This random and 
uncontrollable final blockage event would add considerable variability to the catheter 
lifespan, masking the underlying and more important process of encrustation which is 
what actually needs to be measured.
The differences in luminal diameter between catheters of the same size, even when 
made of the same material, may not be appreciated [224], and this may lead to 
differences in catheter lifespan.
Several authors have used a measure similar to encrustation rate. Desgrandchamps 
et al used mass of deposited calcium and magnesium to assess levels of 
encrustation on different types of ureteric stent and urethral catheter in vitro using 
human urine and purified urease [225]. Choong et al used mass of deposited calcium 
to develop an in vitro encrustation model to test ureteric stents and urinary catheters 
using either artificial or human urine, but again, this wasn’t an infected system [171]. 
Choong et al later advised that both calcium and magnesium should be measured as 
both are important in encrustation [148]. Calcium and magnesium mass has been 
used in a Proteus infected model of urinary catheterisation using artificial or human 
urine and given equivalent results to catheter lifespan [226]. In their clinical study 
demonstrating the high voided pH of those with encrustation, Hedelin et al measured 
encrustation as magnesium and phosphate per catheter, irrespective of the size of 
catheter or duration of placement, and achieved meaningful results [223].
In the present study, encrustation rate was much more variable between the 
catheters of a given participant than expected. The variability could be explained by
214several mechanisms. Most importantly, the encrustation rate concept assumes that 
encrustation is being laid down in a linear fashion. That is, the same amount of 
mineralization occurs in the first week as in every other. If the pattern is exponential, 
for example, a greater mass of encrustation will form in latter weeks. This would lead 
to calculated rates being lower for those catheters changed before they block, 
removing one of the supposed advantages of this method. Even when used over a 
fixed time period, as in some of the in vitro studies using this method, it makes 
comparison of different materials less effective. With exponential encrustation, a 
material with half the encrustation of another after a set time period may not be that 
much further away from blocking.
As with catheter lifespan, variability will also be caused by using different catheters. 
The differences in lumen diameter between catheters of different size, constructed 
from different materials, between different manufacturers, and even between different 
batches from the same manufacturer may lead to variation in both catheter lifespan 
and encrustation rate. Cox has described the surfaces of various catheters as viewed 
by electron microscopy and demonstrated considerable variation in surface 
roughness between different manufacturers, especially in the internal surfaces of 
latex based devices [16]. However, an increased lumen diameter may lead to a far 
greater increase in encrustation rate than catheter lifespan. This is because, 
assuming that encrustation is laid down uniformly and at a constant rate on the 
luminal surface, catheter lifespan will increase in proportion to luminal diameter, 
whereas encrustation rate will increase in proportion to luminal surface area.
The distribution of encrustation down the length of the catheter will also be very 
important in determining encrustation rate. Someone who forms encrustation only at 
the catheter eyeholes will have a much lower encrustation rate than someone who 
deposits crystals along the full length of a catheter. In their artificial bladder models,
215Morris et at described a fairly consistent pattern of encrustation on different types of 
catheter [168].  Deposits are mainly laid down in the 10 cm blow the catheter eye 
holes. The maximum deposition, and therefore the area which blocks, is in the 2 cm 
immediately below the eye holes.  From the present study, and the author’s clinical 
experience, this fits with the pattern seen in many catheter blockers, but certainly not 
all.  Encrustation can develop along varying lengths of the catheter and the blockage 
point can be some distance from the eyeholes. In model bladders, the catheters are 
straight, and are not moved, unlike in the clinical situation. The catheter in the patient 
will be curved depending on how they wear it, and this may set up areas of turbulent 
flow or repeated flexing which could produce differing patterns of encrustation.
if encrustation rate is no less variable than catheter lifespan, why should it be used?
It is time consuming to measure, and it relies on catheters being collected rather than 
discarded. Encrustation rate also has some conceptual disadvantages. Firstly, the 
catheter user is not worried about their encrustation rate. They are worried about their 
catheter lifespan. This is the clinical endpoint to be altered by any proposed 
intervention. Secondly, crystalline biofilms have an organic as well an inorganic 
component. The secreted bacterial extracellular polysaccharide matrix makes up a 
considerable bulk of the biofilm, and this may possibly vary in volume between 
catheter users, and between catheters from the same user. This inorganic 
component will not be measured by calculating the encrustation rate.
Where the two techniques may be useful is in the comparison of individuals using 
catheters with different drainage lumen diameters. As explained above, as compared 
to a hypothetical situation in which every catheter lumen was identical, both 
encrustation rate and catheter lifespan should be too high in those with larger 
catheters. This would give the impression that the encrustation problem was more 
severe than it was when using encrustation rate, but less severe than it was when
216using catheter lifespan. Combining both techniques may help correct for differences 
in catheter lumen. The exact method for doing this would have to be worked out in a 
controlled environment, probably in vitro, before being applied to the clinical situation.
In conclusion, calculated encrustation rates can be used to distinguish between mild 
and severe encrusters, however, this method does not appear to offer any real 
advantages over the far simpler technique of measuring catheter lifespan.
4.2.3  Catheter Specific Safety Margin
To compensate for any week to week variability in safety margin which may be 
responsible for that part of the variability in mean catheter lifespan not accounted for 
by comparison with mean safety margin, a catheter specific safety margin (CSSM) 
term was calculated. This would give the mean safety margin experienced by any 
one particular catheter, and this could be compared with the lifespan of that catheter. 
This method, however, only produced a minimal improvement over the comparison of 
mean catheter lifespan with mean safety margin (figure 3.29).
The obvious flaw in the measurement of CSSM is that readings of pHn  and pHv were 
only taken at weekly intervals. Variation could have occurred between these 
measurements, and the magnitude of the variation this would produce in the safety 
margin on a daily or hourly basis is not known. It could be possible that CSSM does 
not give a better indication of the average safety margin environment to which a 
catheter is exposed than does mean safety margin for the full study period. It is 
known that pHv undergoes a small diurnal variation in both normal subjects and those 
with long term catheters, being higher in the early morning [223]. Measurements were 
taken at the same time of day for each participant to account for this in this study.
The possibility of diumal variation in pHn  has not been studied, however. It is also
217clear that for some catheters in very rapid encrusters, no readings were taken during 
its lifespan. These would have to be excluded from analysis. For others, the reading 
was taken at the start of a catheter’s lifespan, but it was changed immediately before 
the next reading, which happened to give a markedly different safety margin. It could 
not be confidently assumed that the reading taken at the start of that catheter’s 
lifespan represented the environment to which it was exposed.
It was also considered possible that the variation in catheter types used by 
participants may obscure a correlation. The analysis was repeated using only 
catheters of the most common types, but no improvement in the correlation was 
evident.
4.2.4  The Blocking pH
The concept of blocking pH, as used by many District Nurses in the Bristol area, 
relies on the hypothesis that pHv will gradually increase over the lifetime of a catheter, 
that this will be measurable, and that above a certain value catheter blockage will be 
imminent.
The results shown in tables 3.12 to 3.16 demonstrate that even when there appears 
to be such a pHv rise, it is small in magnitude. Even for those severe encrusters with 
the greatest mean pHv changes, this severely limits the clinical usefulness of this 
method of predicting catheter blockage. For all catheters the mean difference in pHv 
is only 0.39 pH units. For those with the heaviest encrustation the mean difference in 
pHv is greater, but is still just 0.81  pH units. A standard urine dipstick as used by most 
District Nurses is calibrated in intervals of 0.5 pH units, so using this as a method of 
registering these small changes would be unreliable. Even using a more accurate 
measure of pHv may not prove useful given the variability of individual pHv changes
218around these means (sample standard deviations of change in pHv were 1.12 for ali 
catheters and 1.06 for 28 day blockers) set against the background week to week 
variability in pHv already described (see figure 3.25). It seems likely that such an 
inconsistent increase in pHv seen before catheter blockage, at least measured by 
weekly urine sampling, would be disguised by the noise of the normal variability in 
pHv. It may be that this could be overcome by more frequent pH sampling and by 
calculating a moving average to smooth out the variability, perhaps combined with a 
more accurate method of pH measurement than a urine dipstick. This would require 
increased effort and expenditure on the part of catheter users and care staff.
Another problem is that while the pHv did, on average, increase slightly during the 
lifespan of a catheter, there did not seem to be an obvious ‘blocking pH’ in any given 
participant which could be used as a cut off value to signal that the catheter should 
be changed. It may be that this would become apparent with more catheter samples 
from each participant, or that a rise in pH above the baseline for each catheter taken 
at the time of catheter insertion could be used.
From the data collected in the present study,  it is clear that when there is an increase 
in pHv with catheter life, this is too small to be picked up on the measuring devices 
used by District Nurses, and, more importantly, smaller in magnitude than the normal 
variability in urinary pHv readings. This could explain the apparent success of this 
technique in those areas where it has been used. Once a blocking pH is set, the 
normal random variability in pHv will tend to produce a reading higher than this value 
before the catheter encrusts to the point of blockage. This will trigger a catheter 
change, and the result will be that catheters are changed before they block, 
apparently validating the technique.  It is possible that the pHv would have fallen the 
next week in any case as a result of random variation. Although catheters will 
probably be changed before they block, they will likely be changed long before this
219would have occurred. The technique really results in catheter changes which are 
essentially random, but for many catheter users, at a higher mean frequency than 
catheter blockage would normally occur. The standard recommended technique of 
establishing a mean catheter lifespan and changing the catheter slightly more often 
than this [46} would be expected to give as good a result, but with fewer catheter 
changes, reducing health care expenditure and inconvenience to the catheter user.
A more direct trial of the scientific basis behind this technique would be to establish a 
blocking pH, but still allow a catheter user to keep their catheter in place until 
blockage. The difference in the time at which the blocking pH is reached and the time 
at which the catheter actually blocks could be evaluated to determine if there is any 
useful relationship between blocking pH and catheter blockage, or whether it really is 
as random as suggested by this study. At the very least, this technique must be 
trialled against the standard ‘mean catheter lifespan’ technique before it could be 
recommended.
2204.3  Factors Influencing Nucleation pH
4.3.1  Crystal Formation
Hedetin et al measured the amount of phosphate precipitated onto catheters which 
had been removed from 11  long term catheterised patients after three weeks [223]. 
They found that there was a critical urinary pH of between 6.7 and 6.8. Those with a 
mean urinary pH above this level precipitated 10 times more phosphate onto their 
catheters than those with a mean pH below this. This concept of a critical pH of 6.8 
above which a catheter user will become a catheter blocker is widely quoted in 
articles on management of catheter blockers as almost a definition of the problem. 
Experiments on model systems by Cox et al using artificial urine supplemented with 
urease showed precipitation of calcium phosphates and then struvite as the pH rises 
above 7.2 [147]. Choong et al measured the nucleation pH of catheter blockers and 
non-blockers, as defined by whether their catheters lasted longer than six weeks or 
not. The mean pHn of blockers was 7.58, similar to the 7.66 measured in the non­
blockers [222].
These figures have ali been taken as static values, both within an individual patient 
and between different patients. While it is certainly true that catheter blockers have a 
higher mean urinary pH than non-blockers [150,151}, and that precipitation of the 
phosphate containing crystals of encrustation occurs at high pH [227], it is not evident 
from the experimental literature that the pH above which precipitation occurs is fixed.
It is useful to describe the theory of crystal formation. This is detailed in many 
chemical and urological texts [227-229], and is summarised here.
221As described earlier, crystallisation depends on the availability of the ions which 
make up that crystal, not on the pH, although the pH may influence the availability of 
some of these ions. Whether crystal formation (nucleation) or crystal growth 
(aggregation) occurs in a solution is determined by the product of the concentrations 
of the constituent ions which form the crystal. This is known as the ionic product A 
more concentrated solution has a higher ionic product. Changing the concentration of 
only one of the ions which make up the crystal will change the ionic product, and if 
any of the constituent ions is missing from the solution the product will obviously be 
zero.
Consider a system in which solid crystal is added to an aqueous solution of the 
constituent ions of that crystal. At a low ionic product, the solid will be completely 
dissolved. Any solid crystal added to the solution will lose ions from its surface at a 
faster rate than they are deposited, so the crystal will dissolve. If the concentration of 
ions in solution is increased to a certain critical point, ions from solution will be 
deposited onto any solid crystal at exactly the same rate as they are lost. The mass 
of any solid will remain constant as the system is in a stable equilibrium. This is 
known as a saturated solution. The value of ionic product at which this occurs is 
termed the solubility product
At values of ionic product above the solubility product, any added crystals wiH 
increase in mass as deposition onto their surface will be faster than loss of ions to 
solution. This will occur until enough material has precipitated out of solution so that 
the ionic product of the ions remaining in solution drops to equal the solubility 
product. In this situation, the ionic product cannot exceed the solubility product for 
any length of time.
222Interestingly, if a solution can be produced that has an ionic product greater than the 
solubility product, but that contains none of the solid crystal, spontaneous 
precipitation of solid will not necessarily occur. A solution in which the ionic product is 
maintained above the solubility product without crystal precipitation is known as a 
supersaturated solution. Such a solution could obviously not be produced by adding 
solid crystal to a saturated solution. It is possible, though, if ions are added in a form 
different from the crystal under study.  For example, adding extra chloride ions in the 
form of sodium chloride to a saturated solution of silver chloride will not cause the 
precipitation of silver chloride crystals, even though the ionic product of silver chloride 
will now be greater than the solubility product, because no solid silver chloride was 
ever present. If the ionic product is increased by the addition of individual ions, for 
example by the ion pumps present in the cell membranes of the renal tubules, the 
same effect occurs. Precipitation does not occur because there is no solid crystal on 
which to precipitate, and a supersaturated solution may be formed.
There is, however, a limit to the degree of supersaturation that is obtainable. Once 
the concentration of the solution increases further it encounters another critical level 
above which spontaneous precipitation of crystals occurs. This spontaneous 
precipitation is known as homogeneous nucleation, and the ionic product above 
which this occurs is known as the formation product Solutions with ionic products 
above the formation product are unstable.
The solubility product of a solution is thought to be a constant (at a given 
temperature), although experimentally measured values of the more complex crystals 
found in biological systems show some variability. The value of the formation product 
is quite variable, for reasons that are not fully understood.
223Between the solubility product and formation product, in a supersaturated solution, 
crystallisation may occur under certain circumstances. Crystal growth will occur if 
crystals are already present. Crystals may precipitate onto the surface of other solid 
materials which may be added to the solution, such as cellular debris, foreign objects 
or other species of crystal (this is known as heterogeneous nucleation). Spontaneous 
nucleation may also occur, but is very slow.  In these solutions, certain substances 
known as nucleation inhibitors can prevent crystal formation by binding to tiny 
crystals before they can aggregate (there is also another group of substances that 
can reduce crystal formation, but these work by chelating ions such as calcium, so 
are actually reducing the ionic product). Above the formation product, these inhibitors 
tend to be overwhelmed.
In the case of crystal precipitation in the human urinary tract, many healthy 
individuals have urine which is supersaturated with respect to various minerals which 
make up renal calculi, yet they do not form stones. Some combination of the 
presence of nucleation inhibitors, the absence of heterogeneous nucleation sites, and 
the rapid transit of urine out of the body before spontaneous nucleation can occur 
keeps most individuals free of stones.
In catheterised individuals, precipitation could occur even if the urine is only 
supersaturated.  It is possible that the catheter, the biofilm organisms, or the 
extracellular polysaccharide matrix may act as heterogeneous nucleation sites. Small 
pockets of urine may remain pooled for long enough for spontaneous nucleation to 
occur. The biofilm may act as a microenvironment in which the increased 
concentration of certain species could raise the ionic product above the formation 
product locally, even if the ionic product is lower in the bulk of the urine. Once 
crystallisation starts it will continue until the ionic product drops to the solubility 
product, which is unlikely as the urine will be being continually refreshed and urease
224will continue to act on it. Once started, catheter encrustation will probably continue to 
form.
Dumanski et al conducted a study on the ability of the extracellular polysaccharide 
produced by Pr. mirabilis to influence struvite formation [230]. They used a model 
system with purified capsule polymers from several organisms including Pr. mirabilis, 
Kl. pneumoniae and E. coli in artificial urine, with the pH raised using ammonium 
hydroxide. They found that the Pr. mirabilis capsule polymers enhanced struvite 
precipitation at moderately raised pH, up to 8.5, compared to controls or the capsule 
polymers of other species. They actually found that E.  coli polymer inhibited crystal 
formation. They theorised that the anionic bacterial polymers attract the magnesium 
cations. Strongly anionic polymers, such as those produced by E. coli, will bind the 
magnesium, chelating it and so preventing it from complexing with other ions to form 
crystals. The weakly anionic Pr. mirabilis polymers, however, will attract the 
magnesium ions and concentrate them in a localised area, raising the ionic product, 
but without binding them so tightly that they are unavailable to form crystals. At very 
high pH, struvite precipitation will occur rapidly even without this concentrating effect, 
due to the increased concentrations of the other ionic species which form struvite.
The ionic product of struvite is given by multiplying the concentrations of the 
constituent free ions:
[Mg2* ]. [NH4‘] . [PO*3!
In the case of the precipitation of struvite in urine containing urease, it is thought that 
the huge amount of ammonium generated raises the ionic product above the 
formation product, making spontaneous nucleation inevitable provided the pH is high 
enough to provide some dissociation of hydrogenphosphate species to free
225phosphate ions. Studies and calculations by Elliot et a/ suggest that struvite wili not 
precipitate below a pH of 7.1  [231].
The ionic product of apatite involves raising the concentration of the free ions to the 
power which represents their relative abundance in the crystal matrix:
[Ca2+]5 . [PO43"]3 . [OH]
As can be seen, changes in concentrations of calcium and phosphate produce 
correspondingly greater changes in ionic product.  In the case of carbonate apatite, as 
either carbonate or phosphate ions can be incorporated into the matrix, both their 
concentrations contribute to the ionic product.
It can be seen from this outline of crystal formation that there are factors which affect 
the likelihood of crystal precipitation which are not pH dependent.
The concentration of free magnesium and calcium ions are largely dependant on the 
concentrations of total dissolved calcium and magnesium (the calcium and 
magnesium which is not ionised exists as stable ion pairs with positively charged 
species, from which, in most cases, they can easily dissociate). The total quantity of 
phosphate species available to dissociate may be fixed, but the proportion of these 
species which exist as free phosphate ions is pH dependent as described earlier. 
Ammonium, and much of the carbonate present, is derived from the urease catalysed 
hydrolysis of urea. All of these may vary in concentration at any particular pH. At a 
given pH, for example, ionic products and the chance of crystal precipitation will be 
lowered in more dilute urine. By varying the concentrations of the non pH dependent 
species in these ionic product equations, the concentrations of the pH dependent
226species needed, in other words the pH needed, to achieve a total ionic product of a 
particular level will change.
Urine may also vary in its concentration of crystallisation inhibitors and chelating 
agents. Glycosaminoglycans, protein macromolecules and a variety of low molecular 
weight substances are though to prevent precipitation in supersaturated urine, 
although the exact mechanisms of action have not been determined. They may 
prevent initial crystal nucleation, or bind to formed crystals to prevent further growth. 
A lack of these factors has been suggested to lead to stone formation in susceptible 
individuals, although the contribution which this has to the overall burden of stone 
disease is not known. Most of this work has also been done with regards to non- 
infective urinary tract calculi, although pyrophosphate, citrate and albumin have been 
shown to inhibit struvite growth in some in vitro studies [230,232,233].
Alterations in these factors would provide a reason for why urine from different 
individuals may precipitate crystals at differing pH levels, thus explaining the 
differences in nucleation pH measured.
4.3.2  Determinants of Nucleation pH
It would seem intuitive that the concentrations of calcium and magnesium in the 
voided urine would correlate with a urease positive catheter user’s propensity to form 
encrustation, as their supply is not virtually unlimited as is the case of ammonium, or 
dramatically increased by small rises in pH as is the case with phosphate, carbonate 
and hydroxide.
As expected, in an in vitro study using human urine incubated with urease, Hugosson 
et al found a positive relationship between the precipitation of magnesium ammonium
227phosphate and calcium phosphate, and the urinary concentration of magnesium and 
calcium, respectively [234]. However, in studies comparing the urine of catheter 
blockers and non blockers, no differences in calcium or magnesium concentrations 
were found by Choong et at [148], or Getliffe [46], but significant differences in urinary 
calcium were found by Kunin et at [45], and Burr and Nuseibeh [150]. This variation in 
results may be because the non-blockers in these studies were not colonised by 
urease positive organisms and so were unlikely to encrust irrespective of their urinary 
composition.
In the present study of catheter encrusters with persistent Proteus colonisation, there 
was found to be a significantly higher urinary calcium concentration in rapid 
encrusters as compared with slow encrusters (table 3.7), and a significant correlation 
between mean calcium concentration and mean catheter lifespan (figure 3.26).
What the concentration of calcium is affecting is the propensity of the urine to 
precipitate crystals of carbonate apatite, which is reflected in the nucleation pH. The 
causative relationship is shown by the addition of calcium, in the form of calcium 
chloride, to samples of uninfected human urine, which decreases the nucleation pH 
[206]. The same effect was seen with the addition of magnesium, also as a chloride. 
As changes in both magnesium and calcium concentrations, along with variations in 
other factors, should influence the propensity of crystals to precipitate, nucleation pH 
as measured by optical density changes should provide a more valuable measure of 
crystallisation than calcium concentration alone.
The study showed that it is possible to have a Proteus infection leading to a rise in pH 
above the levels at which encrustation should occur, but to have few problems as a 
result, due to having urine possessing a high nucleation pH. One avenue for future 
treatment is to accept that voided pH cannot be lowered in the presence of urease
228positive organisms, that urease positive organisms may not be eradicated, and that 
urease itself may not be inhibited, but that the nucleation pH may be raised 
sufficiently to alleviate the problem of encrustation.
The multiple linear regression analysis showed that both calcium and magnesium 
concentrations were important determinants of nucleation pH in this group of patients 
(table 3.18). Calcium was found to have a greater influence than magnesium on pHn. 
Certainly, calcium containing carbonate apatite crystals precipitate at lower pH than 
the magnesium containing struvite [148], and so could be expected to have more 
influence on the pH above which encrustation occurs. There may be considerable 
therapeutic value in altering calcium concentrations, or those urinary constituents 
which chelate calcium. The regression model also seems to show that the effects of 
calcium reduction will only be pronounced if urinary magnesium is also low, due to 
the interaction term. Lowering both of these constituents may be necessary to 
achieve any noticeable improvement. In catheter users where both these 
concentrations are high, such as those with a low urine output, improvement may be 
impossible.
4.3.3  Calculated Theoretical Variability of Nucleation pH
The equation derived in section 3.3.2 can be used to predict the possible effects of 
varying urinary constituents on the nucleation pH:
pHn  = 10.55 - 0.606 [Ca] - 0.130 [Mg] + 0.027 [Ca]*[Mg]
This relationship shows that over the commonly encountered range, as the 
concentration of calcium or magnesium in the urine increases, the pHn  of the urine
229decreases. This effect is markedly more pronounced for calcium concentration than 
for magnesium concentration.
This effect of a change in the concentration of one element is less pronounced, 
however, in the presence of a pre-existing high concentration of the other element. 
For example, if the magnesium concentration is high,  increasing calcium 
concentration results in a less pronounced lowering of pHn  than if the magnesium 
concentration is low. At even higher concentrations, this retardation of the effects of 
concentration change would actually become a reversal of the effect. According to 
the equation, while in the range of magnesium concentrations above 22.1 mM, 
increasing calcium concentration would be predicted to increase pHn  rather than 
decrease it. With calcium concentrations remaining above 4.7 mM,  increasing 
magnesium concentrations would be predicted to increase pHn. Mean magnesium 
concentrations this high are not found in the data, but mean calcium concentrations 
above 4.7 mM do occur.
Therefore, when using the equation within the range of data found in the study 
participants, it can be seen that the effect of a change in calcium concentration is an 
inverse change in pHn, whereas a change in magnesium concentration will affect pHn  
to a lesser extent but in either direction. This is shown in figure 4.1, where the 
reversal of the effect of magnesium is seen at high calcium concentrations.
230Figure 4.1: Predicted effect of changing calcium concentration in the presence of a 
magnesium concentration of 10 mM (dotted line), 13 mM (dashed line) and 16 mM (solid
line)
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Figure 4.2: Predicted change in nucleation pH as concentrations of calcium and 
magnesium are varied in proportion from the mean figures for participants 02 (solid 
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231The effects of varying both calcium and magnesium concentration simultaneously, 
and in proportion, are demonstrated in figure 4.2. This may simulate the effects of 
diluting or concentrating the urine by varying fluid intake. The initial concentrations of 
solute were chosen from participants 02, 06 and 16 and give the pHn  results shown at 
the value 0 on the x axis. As the solutes are diluted, pHn  is predicted to increase. The 
majority of graphs generated from the participants’ results are similar to those for 
participants 06 and 16, with slight variations in gradient, intercept and degree of 
curvature. They predict that a rise in pHn  of around 0.3 to 0.4 pH units could be 
achieved by a 25% reduction in calcium and magnesium concentration in most 
cases, and a rise of 0.8 to 1.0 pH units with a 50% reduction. For comparison, the 
difference in mean safety margin between the rapid and stow encruster groups was 
1.04, and the difference in mean pHn  was 0.71.
Interestingly, the graphs created using a few participants’ results, such as that for 
participant 02, demonstrate the possibility of pHn  increasing with more concentrated 
urine within a range which may occur clinically. This could be a real phenomenon, or 
it is possible that it is an artefact of an incomplete mathematical model. The model 
may not be accurate for values outside, or at the limits of, the range of variables used 
to derive it.  It may be imperfectly simulating the behaviour of urinary variables other 
than calcium and magnesium which may not be diluted proportionally, or may have 
an effect on pHn  which is not directly proportional to their concentration. Further 
experimental work is needed to refine the model, although the potential for altering 
pHn  by varying calcium concentration over the range found in the majority of subjects 
in this study is clear.
It should be noted, however, that the values for calcium concentrations found in the 
present trial are higher than those found in some other studies. Mean values of 2.2 to 
4.4 mM are reported from catheterised populations with standard deviations of 1.0 to
2322.2 mM [46,149,150]. This compares with a mean of 5.48 mM (median is 4.59 mM as 
the data is skew) and standard deviation of 3.42 mM in this study. A greater 
difference is noted in the magnesium concentrations, although these values have 
been less frequently reported in the literature on catheter users. Concentrations 
recorded in this study (mean 13.3 mM, standard deviation 3.8 mM) were considerably 
higher than those found in other literature on catheter users (mean 1.91  mM, 
standard deviation 1.54 mM [46]), although higher values are found in studies on 
normal populations (mean 3.91  mM, standard deviation 2.5 mM [234]) and there is 
considerable overlap in the ranges. For comparison, examples of the values used in 
artificial urine recipes during in vitro studies on encrustation are calcium 4.3 mM and 
magnesium 3.2 mM [157]. The obvious cause for differences between the results 
would be differences in the characteristics of the populations being sampled. A 
sizeable proportion of the catheter users in the present study were elderly nursing 
home residents with very limited mobility and low fluid intakes compared to the 
general population. The other studies on catheter encrustation quoted have looked at 
either spinal cord injured patients, who are generally young and fit and often quite 
mobile despite their injuries, or catheter users living independently or in warden 
controlled accommodation who would have had considerably less co-morbidity than 
the group in the present study.  Differences in diet and medication which could alter 
urinary composition would also be expected between these populations. The result of 
these differences, however, may be that there is less potential for reducing 
encrustation by urinary dilution in these other populations as compared to those 
studied in this present trial. As all the studies, including the present one, used small 
numbers of participants, it is not clear that the typical range of urinary calcium or 
magnesium for catheter users has been determined.
2334.3.4  Theoretical Inaccuracies of the Nucleation pH Method
The experimental method used in this, and other, studies for determining the 
propensity of urine samples to precipitate catheter blocking crystals has limitations.
The pH of the urine test samples in the experimental protocol was obviously not 
altered by varying their hydrogen ion concentration in isolation,  but by the addition of 
chemicals which would have this effect. These chemicals, hydrochloric acid and 
sodium hydroxide, are not the substances which would alter the pH in vivo. A 
decrease in hydrogen ion concentration in the urine of a catheter blocker in vivo 
would be accompanied by a rise in the ammonium concentration, but in the test 
protocol in vitro it would be accompanied by a rise in sodium ion concentration. 
Sodium ions do not contribute to the ionic product of the crystals of catheter 
encrustation, but ammonium ions do. This would result in the pHn  derived 
experimentally being higher than the pH at which crystals would tend to precipitate in 
vivo. This discrepancy may be more pronounced in those samples where the 
measured pHv was furthest below the pHn, as to cause crystal precipitation more 
sodium ions would need to be added experimentally, as opposed to ammonium ions 
being produced naturally, than in those samples where the pHv was close to the pHn. 
The degree to which this actually affects the results is unclear, but could be checked 
by repeating the experiment using ammonium hydroxide in place of sodium 
hydroxide.
It should also be noted that the reactions involved in crystal precipitation are not 
instantaneous. The time taken for the products to reach equilibrium following addition 
of alkali to raise the pH may be long enough that different results would be obtained if 
the time taken to complete each step of the protocol varied significantly between 
batches. If the protocol were run through very quickly the crystals may not have time
234to precipitate before the optical density reading was taken, and the pHn  reading would 
be erroneously high compared to if the sample were left to equilibrate for a long 
period of time between each alkali addition. Although timings of alkali additions were 
not standardised in this study, the time taken between additions was approximately 
equal. However, for future work it would seem sensible to include more rigid timings 
in the protocol design.
4.3.5  Alternative Methods of Estimating the Potential for Crystal 
Precipitation from Urine
The present study has deliberately adopted an empirical approach to the 
measurement of crystal precipitation: the pH of a urine sample was altered 
experimentally to determine the point at which crystallisation occurred and this 
nucleation pH value was correlated with the catheter lifespan and the concentrations 
of two of the chemical species present in urine. An alternative strategy is to calculate 
the likelihood of crystal precipitation for a urine sample mathematically based on the 
concentrations of chemical species present and known thermodynamic principles.
Urine contains many chemical species participating in various equilibrium reactions in 
addition to those discussed earlier. Indeed, most species are involved in more than 
one equilibrium reaction. For any given species, a proportion will be complexed to 
various other species in a variety of chemical compounds, and the remainder will be 
free in ionic form and therefore contributing to the ionic product of one or more crystal 
varieties. For any single equilibrium reaction in a dilute solution it is a relatively simple 
matter to calculate the ratio of complexed to free ions given the total amount of the 
species present and the equilibrium constant of the reaction. This constant can be 
thought of as the tendency of the reaction to occur in a particular direction, and will 
indicate the position of the equilibrium in terms of the proportion of products and the
235proportion of reactants In a mixture which has been left to settle to a steady state. 
With multiple species participating in multiple reactions in more concentrated 
solutions the calculations to determine the free ion concentrations and hence the 
ionic products become much more complicated.
In order to perform the complex calculations required in biological systems, computer 
based speciation programs are available. The programs EQUIL2 and JESS have 
both been used to model the risk of formation of the common non-infective calcium 
oxalate urinary tract stones [235,236]. As an example, EQUIL2 requires the input of 
the total concentrations of Na, K, Ca, Mg, NH4, P04, S 04, C20 4, citrate, urate, 
pyrophosphate, C 02, Cl in a sample, along with the solution’s pH [237]. The program 
then calculates the concentrations of free and complexed species using a database 
of thermodynamic parameters and an iterative mathematical technique. From this the 
ionic products for the common crystal types are calculated, and compared to a 
database of solubility products to determine whether the solution is supersaturated 
for any crystals. The degree of supersaturation can be quantified to give the tendency 
of the solution to precipitate crystals, either as a simple supersaturation ratio, or by 
calculating a thermodynamic potential known as the Gibbs free energy of the transfer 
of the supersaturated solution to one which is saturated and contains crystals. More 
recent updates of the EQUIL software model crystal surface chemistry effects as well 
as the chemical equilibria in solution [238].
Like nucleation pH, the degree of supersaturation for struvite or apatite should 
indicate which urines might be at greatest risk of precipitating crystals, and this 
should be expected to show a correlation with the catheter lifespan. The theorised 
effects of dilution of urine could also be studied in a similar way to that using the 
regression model in the previous section, by varying the concentrations of urinary 
constituents used as input data.
236The disadvantage of using a speciation program, as opposed to measuring 
precipitation empirically, is that it obviously cannot predict the effects of any 
substances not included in the calculation. Many urinary constituents are not 
accounted for in the mathematical model, including some proposed nucleation 
inhibitors such as proteins and glycosaminoglycans. While it is clear from the r2 value 
of the regression model that some factors affecting the nucleation pH are not being 
accounted for, it is not necessarily the case that these would be accounted for in a 
speciation program model. In addition, many more urinary constituents must be 
measured to use these programs which complicate the experiments, certainly beyond 
the scale of the current study. The speciation programs also model the state of urine 
at equilibrium, and given the continuous flow through the urinary tract it is likely that 
not all reactions have time to establish equilibrium (calcium oxalate equilibrium, for 
example, requiring 6 to 10 hours [239]) which would lead to the estimated free ion 
concentrations being inaccurate to some degree. However, it is probable that in the in 
vitro nucleation pH test the equilibria are not at the state found in the urinary tract.
The advantage of speciation programs is that they allow changes in crystal 
precipitation to be explained using well established chemical principles rather than 
simply observed, especially in terms of changes in chemical species only indirectly 
involved in crystal formation which may nonetheless affect free ion availability for the 
crystals of encrustation in ways which would be unexpected without this fuller 
consideration of the complexity of urinary chemistry. Even so, this sophisticated 
chemical model would still be expected to fall short of a comprehensive description of 
a crystalline bacterial biofilm.  Both empirical and theoretical methods have the 
common failing that they measure what occurs in the bulk urine, which may differ 
from conditions found in the biofilm matrix.
2374.4 Urease Activity
The urease enzyme is probabfy the most important factor in the production of 
catheter encrustation, providing both ammonium ions for struvite formation and 
hydroxide ions to raise the pH. Strains of Proteus isolated from the study participants 
were tested for urease activity to test the hypothesis that catheter users colonised 
with high urease activity strains would encrust more rapidly.
In a study of the levels of urease activity of different strains of Pr mirabilis, Mobley 
and Chippendale found no difference in those isolated from the urine of patients with 
symptomatic acute pyelonephritis, the urine of those with catheter associated 
bacteriuria, and 20 faecal samples [240]. Sabbuba et al also found no difference in 
urease activities between isolates from retrieved catheters, catheter associated 
bacteriuria, other clinical sources, and environmental sources [226]. This group did 
find, however, a significant positive correlation between urease activity and the ability 
of a strain of Pr. mirabilis to encrust test catheters in an in vitro bladder model using 
artificial urine, with encrustation measured as the summed mass of calcium and 
magnesium deposited within defined sections of the catheter lumen over the test 
period or per hour.
It could be argued that the lack of difference between the urease activities in rapid 
and slow catheter encrusters in the present study (table 3.20), and between isolates 
from different environments in the other studies mentioned above, is an artefact of 
the method used. The cells tested were grown in suspension in Luria broth in a 
shaking incubator, and were therefore in their planktonic form. In vivo, cells are 
present in both the planktonic and biofilm mode. As described earlier, the change 
from planktonic to biofilm form results in changes in protein expression [95], and this
238may include a change in the rate of urease production. Urease production is known to 
increase in the swarmer state of Pr. mirabilis as compared to the vegetative or 
swimmer states [194]. If the biofilm form of Proteus expresses different levels of 
urease activity, and these are not proportional to those levels expressed in the 
planktonic state measured in this protocol, then this would explain the lack of 
correlation.
It could be that the experimental set up does not represent the clinical situation in 
other important respects. The enzyme assay involves a reaction in a static, fixed 
volume of solution over a fixed period of time. In the clinical situation the reaction is 
taking place in a flow through system in which the substrate is being continuously 
supplied. The environment in the biofilm may differ form that in the bulk of the urine, 
and may even expose the urease enzyme to a high local pH which could radically 
reduce its activity.
If these factors were significant criticisms, however, it does not seem likely that a 
correlation would have been achieved in the case of Sabbuba’s experiment with 
catheter encrustation in the artificial bladder model. This result would seem to 
validate this urease assay technique, as there were no obvious variables other than 
urease activity.  It seems more likely that in the clinical situation other factors are a 
more important determinant of encrustation than urease activity.  In the artificial urine 
model, factors such as urinary ion concentrations would be standardised, and host 
immune defences and possible nucleation inhibitors would be entirely absent, yet 
these may play a vital role in the clinical setting.
It could be that in a clinical setting, once a low threshold activity has been crossed, 
any amount of urease will be sufficient to cause severe encrustation if other factors 
are favourable.  It is also possible that in a polymicrobial setting, other organisms inthe catheter biofilm may produce substances which could inhibit urease. This is 
discussed in more detail in section 4.5.
2404.5 Behaviour of Bacterial Populations
The individuals in the study were not selected randomly,  but because of the presence 
of urease positive organisms in their urine, and in particular, the presence of Proteus 
spp. Even so, the other organisms present in these individual’s urinary cultures were 
typical of those previously found in long term catheter users: Ent. faecalis, E. coli, Ps. 
aeruginosa, Kl. pneumoniae and Staph, aureus being isolated as persistent urinary 
tract colonists in many cases [38,70,116]. The less common Providencia, Morganella 
and Serratia were also seen, again as persistent urinary tract colonists.
A casual study of table 3.21  perhaps suggests that slow encrusters are more likely to 
have persistent co-infection with other organisms, such as E. coli, Ps. aeruginosa and 
Kl. Pneumoniae. These differences in frequency are not statistically significant, but 
this seems worthy of further investigation. The phenomenon of bacterial interference, 
discussed in section 4.1.1 with regards to participant 19, may provide a reason to 
expect a difference in frequency of stable co-infections between these groups. As 
establishing that an individual is a rapid encruster and that their various co-infecting 
organisms are stable involves considerable time in a clinical setting, it may be 
worthwhile conducting such a study in a laboratory encrustation model initially.
Mobley and Warren conducted a survey of long term catheter users using weekly 
urine samples [241]. They found that the most commonly isolated organisms were Pr. 
mirabilis and M. morganii, each found in more than half of all specimens. They found 
that Pr. mirabilis was conclusively associated with the problem of catheter blockage, 
but that M.  morganii had a more complex role, perhaps acting in some way to inhibit 
catheter encrustation even in the presence of high counts of Proteus. Other urease 
positive organisms were not associated with catheter blockage.
241It may be that as well as restricting the growth of other species of bacteria, and so, in 
the case of Proteus numbers being diminished, reducing the amount of urease 
available, organisms might act to reduce encrustation in other ways. Some bacteria 
may alter urinary composition or pH.  For example, some strains of E. coli can break 
down citrate. Citrate has been shown in a study by Mclean et al to retard the Pr. 
mirabilis induced growth of struvite crystals in artificial urine [232]. The presence of E. 
coli might therefore increase the catheter encrustation caused by Proteus. However, 
an in vitro study by Edin-Liljegren et al demonstrated that urease added to human 
urine inoculated with a strain of E. coli produced less ammonium, less of a pH rise, 
and fewer precipitating crystals than urease added to sterile urine [214].  It was found 
that this E. coli did not alter urinary pH, phosphate, magnesium, calcium, ammonium 
or citrate in the absence of urease, and it was concluded that the organism was not 
exerting its effect by altering urinary composition.  It was suggested that a direct 
action on urease may be occurring.  It should be noted that Jack bean urease was 
used in this experiment, rather than Proteus urease or Proteus bacteria.
2424.6 Antibiotic Sensitivities
4.6.1  Resistance of Urinary Isolates
There was no significant difference in antibiotic sensitivities between the Proteus 
isolates derived from catheterised and non-catheterised individuals sent to the local 
hospital pathology laboratory (tables 3.24 and 3.25). This could possibly be explained 
if the majority of these individuals had only short term catheters. They would not have 
had time to develop the multi-organism colonisation characteristic of long term 
catheter users. They may not have been previously exposed to antibiotics, so the 
resistance profile of their infecting organisms would echo that of the local population 
they originated from. Hospital laboratories also tend to report multi-organism cultures 
as ‘mixed growth’ and do not report sensitivities, assuming them to be contaminated 
samples. Isolates from long term catheters may have been missing from the local 
population data for this reason.
The antibiotic resistance of urinary organisms isolated from elderly people and 
residents of long term care facilities has been studied by several authors. The 
general elderly population share many similarities with the long term catheterised 
population, and indeed, a significant minority will use long term catheters.  In order to 
acquire antibiotic resistance there must be a pool of organisms present to develop 
resistance, and exposure to suboptimal concentrations of antibiotic,  in the population 
aged over 65, asymptomatic bacteriuria is observed commonly with a prevalence 
ranging from 5% in older men living independently in the community to 50% in some 
studies of long term care facilities [242J. These individuals are often treated on the 
basis of these urinary cultures, even if not suffering from a symptomatic urinary tract 
infection. They may also be treated for a presumed infection without cultures being
243taken, due to the high incidence of chronic non-infective genitourinary symptoms also 
suffered by this group [243]. This population is also susceptible to other infectious 
diseases, such as respiratory tract infections, which may require antibiotic treatment. 
This may be given in such a way as to eradicate the infection being treated, but 
deliver suboptimal therapy to those organisms coincidentally colonising the urinary 
tract, thus leading to the development of a pool of resistant urinary organisms. 
Penicillins and fluoroquinolones are commonly used antibiotics for both respiratory 
and urinary infection. Respiratory infections are also commonly treated with 
antibiotics when, in fact, they have a viral origin. This elderly group is also more likely 
to need care by community medical staff, or to be admitted to a care facility, which 
allows transference of bacteria from other individuals who may have previously 
acquired resistant strains.
Chronic bacteriuria and chronic medical conditions leading to repeated antibiotic and 
medical care exposure are even more common findings in the long term catheterised 
than the general elderly population, as previously described, and so their risks of 
developing antibiotic resistance may be correspondingly higher.
Wingard et al conducted a study of levels of trimethoprim resistance of asymptomatic 
colonising gram negative bacilli from 67 residents in a nursing home setting [244]. 
The majority of organisms were isolated from urinary or perineal sources. They found 
that colonisation with resistant organisms was significantly associated with decreased 
mobility,  poor functional status, length of stay and the presence of a urinary catheter. 
In multivariate analysis, however, the only independent predictor was functional 
status.
Other studies have looked at the rates of antibiotic resistance among those 
presenting with a symptomatic urinary tract infection, rather than merely having
244resistant colonising organisms. Terpenning et at, looking at urinary tract infection with 
gentamicin and ceftriaxone resistant Gram-negative bacilli in a long term care facility, 
found resistant organisms significantly associated with intermittent and indwelling 
urethral catheterisation [245].
Wright et al conducted a study of patients presenting to a hospital emergency 
department with symptomatic urinary infection [246]. After multivariate analysis, the 
risk factors for infection with multi-drug resistant organisms were age > 65, recent or 
current antibiotic use, and the presence of a urinary catheter. In this study, the 
isolated urinary tract pathogen was multi-drug resistant (resistant to more than one of 
nitrofurantoin, co-amoxiclav, gentamicin, ampicillin, TMP/SMX or a quinolone) in 12 
to 14% of otherwise healthy individuals under the age of 50. The multi-drug 
resistance rate for otherwise healthy individuals aged 65 or older was 23%, but for all 
individuals aged 65 or older it was 45%, and for those from long term care facilities it 
was 61%.
While these studies suggest that long term catheter users are at risk from multi-drug 
resistant organisms, the study of Wazait et al has examined the changing patterns of 
antibiotic resistance in urinary isolates from catheterised individuals over the period 
1996 to 2001  in the United Kingdom [247]. The isolates examined were obtained in 
the same way as those local hospital pathology laboratory samples used in the 
present study, and suffer from the same problems. A large, and unknown, proportion 
of them were probably from hospitalised patients with short term catheters, rather 
than community based long term catheter users. Overall, organisms have shown 
increased resistance to cefalexin and ciprofloxacin over this period, while resistance 
to co-amoxiclav and nitrofurantoin has remained steady. Specifically, the organisms 
associated with short term catheterisation such as E. coli and Enterococci showed a 
marked increase in ciprofloxacin resistance, probably due to its increasingly frequent
245use, but remain susceptible to nitrofurantoin.  Bacteria associated with long term 
catheterisation, such as Proteus, which has consistently had almost universal 
resistance to nitrofurantoin, are still largely susceptible to ciprofloxacin. The most 
recent Proteus data from this paper, for the year 2001, is shown in table 4.1.
Two studies have looked at resistance rates for Proteus spp in residents of long term 
care facilities. Smith et al looked at routine isolates from those with urinary catheters, 
tracheostomies, gastrostomies or wounds across several different facilities in 
Nebraska and Iowa, USA [248]. 39 of 104 Proteus isolates were from the urinary 
tract. Muder et al conducted a five year survey of isolates from blood cultures of 
symptomatic individuals in a single large institution in Pittsburgh, USA, 15 of the 26 
Proteus isolates were of a confirmed urinary tract origin [249]. Table 4.1  compares 
the results from these studies and the study of Wazait et al with those obtained from 
long term catheter users in the present study.
Table 4.1: Percentage of Proteus isolates resistant to various antibiotics from the 
studies of Muder et al (1992), Smith et al (2000), Wazait et al (2003), and the present 
study.
Antibiotic Muder et al Smith et al Wazait et al Present study
ampicillin 39% 2% - -
amoxicillin - - 39% 47%
piperacillin 22% 1% - -
co-amoxiclav - - 21% 0%
trimethoprim - - 46% 84%
TMP/SMX 46% - - -
nalidixic acid - - - 11%
ciprofloxacin - 10% 4% 0%
gentamicin 8% 0% - 16%
cefalexin - - 18% -
cefalothin 21% - - 21%
246AmpiciHin and amoxicillin are closely related penicillin compounds having very similar 
spectrums of antibacterial activity. TMP/SMX is a mixture of trimethoprim and 
sulfamethoxazole, commonly used as a first line agent for uncomplicated urinary tract 
infection in the United States, but rarely used in the UK where trimethoprim alone is 
favoured. Piperacillin is a penicillin with increased activity against gram negative 
bacilli such as Proteus and Pseudomonas, and, again, would not be used routinely in 
the UK.
Although the antibacterials tested in the present study differ slightly from those in the 
American studies, they do reflect the antibiotic classes used commonly in the UK, just 
as those drugs tested in the American studies reflect those commonly used in the 
USA. They should therefore give an indication of resistance against those drugs likely 
to be used against the isolates in question. It seems as if antibiotic resistance among 
Proteus is a more serious problem in long term catheter users than even the high risk 
group in long term care facilities. It is comparable with the data from catheter users in 
the Wazait study in the UK, except for the higher trimethoprim resistance and lower 
co-amoxiclav resistance in the present study. There does seem to be a higher level of 
antibiotic resistance in the Wazait samples than in the hospital laboratory samples 
used in the present study, however. It is interesting to note that the Wazait results 
show a much higher resistance to co-amoxiclav, possibly reflecting different patterns 
of prescribing between the two areas, as well as perhaps a different selection of 
patients.
4.6.2  Effects of Treatment
As can be seen from table 3.29, the study participants received several courses of 
antibiotics, some for non-urinary infections, and some directed at the organisms in 
the urinary tract.  All the agents which were used are usually active against a broad
247range of urinary pathogens and, with the exception of minocycline, are commonly 
used to treat urinary tract infections.
Participants 06 and 10 were treated for respiratory tract infections with penicillins, 
with courses which would also have been adequate for treatment of an 
uncomplicated urinary tract infection. Although the previously consistent Pr. mirabilis 
cleared from participant 06’s urine at this time, the strain was resistant to the 
amoxicillin used, suggesting that this may have been unrelated to the antibiotic. E.coli 
was also cleared, although it had only recently appeared in the urine. As this 
participant died before another urine sample could be collected, it is not known if the 
bacteria would have returned. Participant 10 showed no effect of co-amoxiclav on his 
urinary tract organisms, although his Pr. mirabilis was sensitive to it.
Participants 16,18 and 21 were treated specifically for catheter associated urinary 
tract infection. Participant 21 was treated with trimethoprim which had no effect on 
urinary or catheter flora, and to which her Pr. mirabilis strain was resistant. Due to 
pre-existing antibiotic resistance, and the possibility of promoting more, it is 
recommended that catheter associated urinary tract infection should only be treated 
before the results of antibiotic sensitivities are known in the most severe cases [42], 
which this was not.  Even then, trimethoprim is not recommended as empirical therapy 
due to the high levels of resistance among many uropathogens, and its use is even 
being questioned in uncomplicated infections [250]. Both participants 16 and 18 were 
treated with courses of ciprofloxacin, an effective treatment for even complicated 
urinary infection, and considered useful for empirical treatment due to low, although 
increasing, levels of resistance [247]. The Pr. mirabilis isolates in these individuals 
were both sensitive to ciprofloxacin, but in both cases, were not eradicated.
Participant 18’s Proteus also survived a course of cefalexin (despite being sensitive
248to the similar cefalothin) and clarithromicin. Other than participant 18’s E. co//, the 
other bacteria present also survived these antibiotics.
It would seem that this study supports the view that biofilm resident bacteria have a 
decreased susceptibility to antibiotics which is not based on classical antibiotic 
resistance. While the planktonic bacteria sampled by urine culture would be 
eradicated by the antibiotic treatment, provided the correct antibiotic was chosen, 
organisms could survive in biofilm communities on the catheter. While these surviving 
organisms may not necessarily reinvade the patient’s tissues to cause a recurrent 
symptomatic infection, this would be a risk.  Raz et at conducted a randomised study 
of the technique of catheter replacement in combination with antibiotics or antibiotics 
alone in the treatment of long term catheterised patients with symptomatic urinary 
infection [251]. Replacing the catheter immediately before the start of antibiotic 
therapy was hypothesised to be beneficial for two reasons. Firstly, it would remove 
the protected biofilm organisms which could rapidly repopulate the urine. Secondly, it 
would allow a urine culture specimen to be taken from the new catheter which would 
sample only those bacteria which were planktonic. Those which were purely biofilm 
resident and therefore not responsible for symptoms would not be sampled, 
potentially giving fewer polymicrobial cultures and therefore allowing more accurately 
directed therapy. The most accurately directed therapy would of course be obtained if 
the infecting organism could be identified in the patient’s tissues, but even this group, 
who advocate that treatment should be reserved for markedly symptomatic infections, 
only report successful blood culture in 25% of these cases. Patients were initially 
treated empirically with fluoroquinolones, and these were then changed if necessary 
on the basis of the urine culture results. The study found that catheter replacement 
did lead to less complex initial urinary cultures, a more rapid resolution of symptoms 
and a lower recurrence rate at one month.
249Treatment of the participants in the present study did not follow the Raz protocol. 
Even so, In the Raz study, recurrence did sometimes occur even when the catheter 
was changed. Catheters are regularly changed in all patients and yet the new 
catheters are immediately colonised by, in most cases, the same organisms. 
Certainly, this occurs too quickly to be ascending bacteria from the perineum. 
Participant 16 had a catheter change the day after the start of a course of antibiotics 
to which his Pr. mirabilis strain was sensitive, yet, after the antibiotic course finished 
his new catheter was found to be colonised with Pr. mirabilis again. It would seem 
that there are other sources of bacterial re-coionisation than just the catheter. In 
cases where antibiotics are not used, this could just be planktonic organisms in small 
pools of residual urine, but in this case the numbers of species should decrease as 
biofilm resident only organisms would not reappear.  In cases where antibiotics are 
used, the organisms must be in a protected environment. Suggestions for this could 
be bladder calculi, which have been shown to harbour the same Proteus strain as 
seen in the patient’s catheter biofilm [49]. They could also survive in biofilm 
communities on the bladder mucosa, or possibly in small pieces of biofilm, crystalline 
or not, which break off from the old catheter during its removal. These may be more 
vulnerable to antibiotics than a calculus or well developed catheter biofilm, but this 
would still explain the difficulty in eradicating bacteriuria, even temporarily.
2504.7 Comparison of Urine and Faecal Cultures
The present study was not primarily designed to assess the rate of faecal carriage of 
Pr. mirabilis in catheter users, and the numbers surveyed were small for this purpose, 
but it appears that isolation of faecal Pr. mirabilis may be more common among those 
with Pr. mirabilis urinary tract colonization than in the general population. The normal 
faecal carriage rates reported in the literature in studies by Muller [183], Peerbooms 
et al [180], Krickler [182], and Rustigian and Stuart [181] were, respectively, 2.7%,
8.5 %,  17%, and 24%, whereas in this study Pr. mirabilis was isolated in 56% (10 out 
of 18 samples). This may be because the organism is found more frequently in these 
catheterised individuals, or because it exists in larger numbers allowing it to be 
isolated more easily. It is not possible to say with certainty that those from whom we 
did not isolate faecal Pr. mirabilis did not have this organism in their gastrointestinal 
flora based on a single culture. Half of long term catheter users are not troubled with 
encrustation, and it is possible that this is because they are not faecal carriers of Pr. 
mirabilis, or that they carry it at low counts.  In the current study there was an equal 
chance of a participant from whom faecal Pr. mirabilis was isolated being a rapid or a 
slow encruster. It could be hypothesised that faecal carriage of Pr. mirabilis is a risk 
factor for urinary colonisation and catheter encrustation, but that once colonisation is 
established other factors determine the severity of that encrustation.
Urinary tract colonisation usually occurs by the ascending route via the catheter, 
either through the internal drainage lumen as a result of contamination of the 
drainage apparatus, or along the external catheter surface by bacteria from the 
urethral meatus [109]. This external route is likely to be more important since closed 
drainage systems have become standard, as the lumen of the catheter is not 
exposed. However, it is usual in the United Kingdom to change catheter drainage
251bags every week for long term catheter users, and this cannot be regarded as a 
closed system.  Bacteria may be introduced by those changing the drainage bag. 
Long-term catheter users are frequently elderly or disabled and often reside in care 
facilities or have their catheter managed by visiting health care staff [24], who may 
facilitate transmission of uropathogens between patients [42]. Pr. mirabilis is, 
however, a common constituent of the normal human gastrointestinal flora, and a 
phenotyping study of catheter associated bacteriuria in short-term catheterisation has 
suggested a gastrointestinal origin for several common species [252]. The majority of 
catheter users develop Proteus colonisation and encrustation only after having been 
catheterised for many months or years, and so, conceivably, it arises from a different 
source than the initial colonising organisms. It is therefore unclear whether the origin 
of Proteus colonisation is mainly endogenous, from the patient’s own gastrointestinal 
flora, or exogenous, possibly as a result of transmission by health care staff.
It has been shown previously that the Pr. mirabilis strains isolated from urine culture 
are identical to those found in the crystalline biofilms and bladder calculi which 
develop in those patients with catheter encrustation [49,191]. The current study 
suggests that the strains responsible for this urinary colonisation commonly originate 
in the catheter user’s gastrointestinal tract. From there they most likely contaminate 
the perineum and urethral meatus, before ascending to the bladder along the external 
catheter surface and causing bacteriuria, biofilm formation and then encrustation. A 
technique to prevent colonisation with urease producing bacteria would therefore be 
of great benefit, even if bacteriuria with other species could not be prevented.
The origin of encrustation-causing urinary tract colonisation in individuals in the 
community or long term care facilities does not seem to be an exogenous source 
such as spread by health care workers in the majority of cases. Such routes of 
transmission are effectively managed by simple and well established techniques such
252as hand hygiene. While this does not exclude the possibility of poor technique by 
care staff leading to contamination of the catheter drainage apparatus with faecal 
organisms, the demonstrated ease with which bacteria can ascend from the 
perineum to the bladder in the face of a rigidly applied closed drainage technique 
[99], and the ability of Pr. mirabilis to rapidly colonise any available catheter surface 
even in the presence of other organisms [146], leads to the conclusion that Proteus 
colonisation would arise irrespective of the level of care taken.
A solution to preventing colonisation from the perineum may be a regime of meatal 
cleansing or the application of topical antibacterial agents to this area. As described 
is section 1.4.4, these technique have proven ineffective in short term catheterisation, 
or have actually promoted the emergence of urease positive or multi-drug resistant 
organisms,  in these trials the goal has been to prevent the initial colonisation of the 
previously sterile urinary tract, but as the mechanism of colonisation is the same as in 
the acquisition of Proteus their results should be applicable. The acquisition of Pr. 
mirabilis reported in some of these studies suggests that this method of meatal care 
may actually increase the risk of catheter encrustation if this policy was adopted in 
long term catheter users.
The route of colonisation of the urinary tract in suprapubic catheters has not been 
studied in detail. Initial onset of bacteriuria seems to be delayed slightly with 
suprapubic as compared to urethral catheters in short-term use [133], but in the long­
term, the same rates of bacteriuria are seen with the same type of organisms 
isolated. These results demonstrate a gastrointestinal origin for Pr. mirabilis in the 
five patients tested who used suprapubic catheters. It could be postulated that 
urethral ascension of perineal organisms occurs in these cases, as in the majority of 
non-catheterised individuals who develop urinary tract infection. However, in the 
current study two of the females with suprapubic catheters had undergone a urethral
253closure procedure, eliminating this route of infection. It would seem that 
contamination of the cystostomy site may occur.  It may be that cleansing of this site 
would be as ineffective as cleansing the urethral meatus, but further study in this area 
is warranted.
254Section 5 - Conclusions
5.1  Conclusions
A summary of conclusions from the study
5.2  Future Work
Possible further investigation of the topics examined in this study
2555.1 Conclusions
•  There is considerable variation in mean catheter lifespan between individuals 
with Pr. mirabilis urinary tract colonisation, and within any particular individual. 
Lifespans ranging from less than 48 hours to over 3 months were recorded.
•  Individuals exist who have persistent colonisation with Pr. mirabilis and yet 
have little or no problem with encrustation related catheter blockage.
•  In catheter users with Proteus bacteriuria, rapid encrustation is associated 
with a lowered nucleation pH and a voided pH which is above or only just 
below their nucleation pH, rather than solely a raised voided pH. The 
difference in pHv between rapid and slow encrusters is not significant, but the 
difference in safety margin (pHn  - pHv) is. Rapid blockers had a mean safety 
margin of only 0.13, compared to 1.17 in those who encrusted more slowly.
•  The pHn  is a variable factor both between and within individuals.  Rapid 
encrusters had a mean pHn  of 7.3 compared to 8.0 in those who encrusted 
more slowly. This raises the possibility of altering pHn  as a treatment for 
catheter encrustation.
•  While the pHv of urine does seem to increase slightly between the start and 
end of a catheter’s lifespan in those with Proteus colonisation and rapid 
encrustation, the ‘blocking pH’ method of predicting catheter blockage is not 
useable in its present form due to the small magnitude of this rise (0.8 pH 
units in the most rapid encrusters, 0.4 pH units overall) compared with the
256normal variability of urinary pHv readings in an individual (standard deviations 
ranging from 0.12 to 1.56). Alkaline urine does not necessarily indicate that 
catheter blockage is imminent, or, indeed, that it will occur at all.
•  In catheter users with Proteus urinary colonisation, the urinary nucleation pH 
is dependent on the calcium concentration and, to a lesser extent, the 
magnesium concentration of urine. Rapid encrusters have higher urinary 
calcium concentrations than slow encrusters. The calculated regression 
equation predicts that a rise in pHn  of around 0.3 to 0.4 pH units could be 
achieved by a 25% reduction in calcium and magnesium concentration in 
most cases, and a rise of 0.8 to 1.0 pH units with a 50% reduction.
•  Strains of Proteus with higher urease activities do not necessarily produce 
voided urines with a higher mean pH, and there is no relationship between 
increased urease activity and a shorter catheter lifespan.
•  Once acquired, Proteus appears to be a stable component of a polymicrobial 
urinary and catheter flora.
•  Proteus isolates from long term catheter users have higher levels of antibiotic 
resistance, particularly to trimethoprim and amoxicillin, than those from urinary 
infections in the general population. Courses of antibiotic appear ineffective at 
altering the urinary flora.
•  The source of Pr. mirabilis urinary colonisation in long term catheter users is 
commonly their own intestinal flora.
2575.2 Future Work
The variability ofpHn and the safety margin
The variability of pHn >  and therefore the safety margin, is unknown beyond the weekly 
data presented in this study.  In order to more fully understand the environment to 
which an encrusting catheter is exposed, this variable needs to be studied more 
closely. An examination of any diurnal variation and the degree of day to day 
variation is required. This could be used to study the concept of catheter specific 
safety margin in greater detail.
Manipulating pH„ as a means of controlling catheter encrustation
It has been shown that pHn  is variable, and is determined to some extent by factors 
which may be controllable. The extent to which this value can be deliberately 
manipulated, and the effect this would have on catheter encrustation rate, could be 
studied in a clinical trial. A study has recently shown what should be a beneficial 
effect of citrate on the pHn  of healthy subjects [206]. It would be interesting to see if 
this effect is also seen in those with Proteus colonisation. Attempts could also be 
made to lower urinary calcium with dietary modification, or perhaps by simply 
increasing fluid intake to dilute the urine.
Developing measurements of catheter encrustation rate
The concept of encrustation rate, measuring the amount of calcium and magnesium 
deposited on a catheter per unit time, failed to provide a more useful measure of the 
severity of catheter encrustation in the clinical setting than the existing method of
258catheter lifespan. A technique to compensate for the frequent removal of catheters for 
reasons other than catheter blockage would prove invaluable in future clinical trials of 
strategies to reduce encrustation. Laboratory studies of the development of Pr 
mirabilis biofilms on catheters over time, using artificial urine for consistency, would 
be the logical first step in this process. The mathematical pattern of growth of the 
measurable portion of the biofilm would need to be defined. It may be necessary to 
limit measurement to a short section of catheter at a standard point, or at the point of 
maximum occlusion. The effects of different catheter materials and sizes would need 
to be compensated for. This model would then need to be confirmed and assessed 
for consistency in human urine.
The effects of co-infecting organisms on encrustation
The possibility exists that some organisms present in stable catheter biofilm 
communities in addition to Pr mirabilis may influence the degree of encrustation 
produced in an individual, either by reducing the numbers of Proteus organisms 
present, or by inhibiting or counteracting their effect on the urine. This could be 
studied in an artificial catheterised bladder model by comparing time to blockage for 
catheters exposed to pure Pr mirabilis inoculated urine, with urine inoculated with Pr 
mirabilis in addition to strains of other organisms such as E. coli, Ps. aeruginosa and 
Kl. Pneumoniae. Using standard strains of bacteria in known proportions under 
controlled conditions would be more efficient than further clinical investigation, now 
that it is known from this and other studies which organisms are commonly present.
Faecal Proteus carriage as a risk factor for encrustation
The source of Pr mirabilis colonisation in long term catheter users appears to be 
their own gastrointestinal flora in the majority of cases, and certainly in those with
259faecal colonisation. A larger survey is needed to determine the rates of faecal 
carriage of these organisms in long term catheter users, both those with and without 
catheter encrustation and urinary Pr. mirabilis. This would assess the degree to which 
faecal carriage of Pr. mirabilis is a risk factor for catheter encrustation.
The effects of bladder calculi
It was hoped to find catheter users with bladder calculi for recruitment into the study. 
Unlike in many regions, catheter users in the area where the study was conducted 
are regularly checked and these calculi removed, so it is perhaps unsurprising that no 
calculi were found in this group. It would be interesting to analyse the effects of the 
acquisition and removal of calculi on catheter lifespan, voided urinary pH and 
bacterial populations.
260Section 6 - AppendicesAppendix 1: Example Calculation of Nucleation pH
The following example demonstrates a calculation of nucleation pH according to the 
method described in section 2.3.2. The data is from the urine sample collected from 
participant 21  in week 2, and is typical of the samples studied.
Figure 6.1 shows the plot of optical density of the acidified urine sample as it is re- 
alkalinised. As the pH approaches 7.0, a sudden rise in optical density can be 
observed causing an abrupt increase in the gradient of the trace. This increase in 
optical density is the point during the protocol at which crystals start to precipitate 
from solution, and it is the pH of the sample at this point which is defined as the 
nucleation pH. As the urine is alkalinised further, precipitation continues, resulting in a 
steady rise in optical density.
It can be observed that the two segments of the trace representing pH values 
immediately above and below this value are straight lines. The point at which the 
trace changes gradient wilt be the intersection of these two line segments, and 
determining this point will therefore give the nucleation pH. The data points contained 
in the ranges of these straight line segments can be used to calculate the regression 
equations which describe the lines of best fit through them. These lines have been 
plotted graphically in figure 6.2.
The graphical and statistical tools in Microsoft Excel were used.
262Figure 6.1: Changes in optical density of a urine sample as it is alkalinised
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Figure 6.2: Regression lines for the straight segments of the trace shown in figure 6.1 
for pH values immediately above and below the abrupt change in optical density. The 
intersection of these lines gives the nucleation pH.
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263The regression equations for these two line segments are, for the low pH segment:
optical density = -0.019pH + 0.438 
...and for the high pH segment:
optical density = 0.192pH -1.006
Solving these as a pair of simultaneous linear equations will give their point of 
intersection. The value of pH at this point is the nucleation pH. Substituting for optical 
density gives an expression which can be solved for pH. The optical density at this 
point does not need to be calculated.
0.438 + 1.006 
P  " “ 0.192 + 0.019
pHn = 6.84
In this case the value of pH„ is 6.84. This can also be determined by plotting the 
graph of the two straight line segments, as in figure 6.2, and reading off the pH value 
at the intersection. If plotted using computer software and mathematically calculated 
best fit lines, the graph can be magnified to a point where accurate readings can be 
taken visually.
264Appendix 2: Analysis Excluding Participants 03 & 11
Participants 03 and 11 did not have Proteus colonisation during the majority of the 
trial. The results shown in section 3.2 used the data from all participants. Excluding 
values for participants 03 and 11 made no difference to the results of comparisons 
between rapid and slow encrusters (table 6.1) or correlation tests (table 6.2).
Table 6.1: Comparison of the p-values for statistical tests comparing rapid and slow 
encrusters using data from all participants, and for tests excluding data from
participants 03 and 11
Statistical test all
participants
excluding 
03 & 11
t test - comparison of mean safety margin 0.003 0.014
t test - comparison of mean pHv 0.385 0.680
t test - comparison of mean pH„ 0.004 0.002
U test - comparison of mean urinary calcium 0.007 0.010
U test - comparison of mean urinary magnesium 0.464 0.400
U test - comparison of mean total calcium and magnesium 0.129 0.133
Table 6.2: Comparison of the p-values and Pearson’s correlation coefficient r between 
correlation tests using data from all participants, and for tests excluding data from
participants 03 and 11
Correlation
all
participants
excluding 
03 & 11
r  P r  P
mean catheter lifespan and mean urinary calcium
mean catheter lifespan and mean pHn
mean catheter lifespan and mean safety margin
mean urinary calcium and mean pHn
mean urinary magnesium and mean pHn
mean urinary calcium and magnesium and mean pHn
0.60  0.002 
0.56  0.004 
0.47  0.017 
0.70  0.000 
0.52  0.008 
0.66  0.001
0.59  0.004 
0.61  0.003 
0.46  0.023 
0.74  0.000 
0.53  0.009 
0.68  0.001
265Appendix 3: Analysis Using Encrustation Rate
The independent samples t tests and Mann-Whitney U tests detailed in section 3.2.1 
were repeated to determine whether differences in mean pHV l pHn >  safety margin, 
urinary calcium, magnesium, and summed calcium and magnesium concentrations 
were significant between rapid and slow encrusters when the two groups where 
defined by encrustation rate rather than mean catheter lifespan. In most cases, the 
same results, with the same general level of significance, were obtained using an 
encrustation rate of greater than or less than 0.7 mg/day as when using a mean 
catheter lifespan of greater than or less than 28 days to divide the participants into 
two groups. The only exception is the comparison of mean safety margin, where the 
difference is significant using catheter lifespan but not encrustation rate. This is 
shown in table 6.3.
Table 6.3: Comparison of the p-values for statistical tests comparing the grouping of 
participants into rapid and slow encrusters as defined by either mean catheter lifespan 
or encrustation rate
Statistical test catheter
lifespan
encrustation
rate
t test - comparison of mean safety margin 0.003 0.062
t test - comparison of mean pHv 0.385 0.964
t test - comparison of mean pHn 0.004 0.002
U test - comparison of mean urinary calcium 0.007 0.007
U test - comparison of mean urinary magnesium 0.464 0.370
U test - comparison of mean total calcium and magnesium 0.129 0.080
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